# num of genes	num of total genes	Log of odds ratio	P-value	Adjusted p-value	GO term ID	GO term name	GO type
4	4	4.32077599163	-	6.22e-06	GO:0035791	platelet-derived growth factor receptor-beta signaling pathway	BP
3	3	4.32077599163	-	1.25e-04	GO:0070141	response to UV-A	BP
3	3	4.32077599163	-	1.25e-04	GO:0002902	regulation of B cell apoptotic process	BP
3	3	4.32077599163	-	1.25e-04	GO:0060168	positive regulation of adenosine receptor signaling pathway	BP
3	3	4.32077599163	-	1.25e-04	GO:2000973	regulation of pro-B cell differentiation	BP
2	2	4.32077599163	-	2.50e-03	GO:0001865	NK T cell differentiation	BP
2	2	4.32077599163	-	2.50e-03	GO:0071226	cellular response to molecule of fungal origin	BP
2	2	4.32077599163	-	2.50e-03	GO:0098868	bone growth	BP
2	2	4.32077599163	-	2.50e-03	GO:0010652	positive regulation of cell communication by chemical coupling	BP
2	2	4.32077599163	-	2.50e-03	GO:0060512	prostate gland morphogenesis	BP
2	2	4.32077599163	-	2.50e-03	GO:0045066	regulatory T cell differentiation	BP
2	2	4.32077599163	-	2.50e-03	GO:0034391	regulation of smooth muscle cell apoptotic process	BP
2	2	4.32077599163	-	2.50e-03	GO:0002327	immature B cell differentiation	BP
2	2	4.32077599163	-	2.50e-03	GO:0033277	abortive mitotic cell cycle	BP
2	2	4.32077599163	-	2.50e-03	GO:0090218	positive regulation of lipid kinase activity	BP
2	2	4.32077599163	-	2.50e-03	GO:0032817	regulation of natural killer cell proliferation	BP
2	2	4.32077599163	-	2.50e-03	GO:0032615	interleukin-12 production	BP
2	2	4.32077599163	-	2.50e-03	GO:0005986	sucrose biosynthetic process	BP
2	2	4.32077599163	-	2.50e-03	GO:0031959	mineralocorticoid receptor signaling pathway	BP
2	2	4.32077599163	-	2.50e-03	GO:0038179	neurotrophin signaling pathway	BP
2	2	4.32077599163	-	2.50e-03	GO:1990051	activation of protein kinase C activity	BP
2	2	4.32077599163	-	2.50e-03	GO:0050906	detection of stimulus involved in sensory perception	BP
2	2	4.32077599163	-	2.50e-03	GO:0038188	cholecystokinin signaling pathway	BP
2	2	4.32077599163	-	2.50e-03	GO:0035607	fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development	BP
2	2	4.32077599163	-	2.50e-03	GO:0032878	regulation of establishment or maintenance of cell polarity	BP
2	2	4.32077599163	-	2.50e-03	GO:0038109	Kit signaling pathway	BP
2	2	4.32077599163	-	2.50e-03	GO:0048378	regulation of lateral mesodermal cell fate specification	BP
2	2	4.32077599163	-	2.50e-03	GO:0035728	response to hepatocyte growth factor	BP
2	2	4.32077599163	-	2.50e-03	GO:0002752	cell surface pattern recognition receptor signaling pathway	BP
2	2	4.32077599163	-	2.50e-03	GO:0086098	angiotensin-activated signaling pathway involved in heart process	BP
1	1	4.32077599163	-	5.00e-02	GO:0010752	regulation of cGMP-mediated signaling	BP
1	1	4.32077599163	-	5.00e-02	GO:0010758	regulation of macrophage chemotaxis	BP
1	1	4.32077599163	-	5.00e-02	GO:0039650	suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process	BP
1	1	4.32077599163	-	5.00e-02	GO:0002333	transitional one stage B cell differentiation	BP
1	1	4.32077599163	-	5.00e-02	GO:0071351	cellular response to interleukin-18	BP
1	1	4.32077599163	-	5.00e-02	GO:2000646	positive regulation of receptor catabolic process	BP
1	1	4.32077599163	-	5.00e-02	GO:0046824	positive regulation of nucleocytoplasmic transport	BP
1	1	4.32077599163	-	5.00e-02	GO:0061324	canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation	BP
1	1	4.32077599163	-	5.00e-02	GO:0002371	dendritic cell cytokine production	BP
1	1	4.32077599163	-	5.00e-02	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	BP
1	1	4.32077599163	-	5.00e-02	GO:0086055	Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling	BP
1	1	4.32077599163	-	5.00e-02	GO:0086054	bundle of His cell to Purkinje myocyte communication by electrical coupling	BP
1	1	4.32077599163	-	5.00e-02	GO:0035790	platelet-derived growth factor receptor-alpha signaling pathway	BP
1	1	4.32077599163	-	5.00e-02	GO:0003174	mitral valve development	BP
1	1	4.32077599163	-	5.00e-02	GO:0097254	renal tubular secretion	BP
1	1	4.32077599163	-	5.00e-02	GO:0061360	optic chiasma development	BP
1	1	4.32077599163	-	5.00e-02	GO:0061582	intestinal epithelial cell migration	BP
1	1	4.32077599163	-	5.00e-02	GO:0038154	interleukin-11-mediated signaling pathway	BP
1	1	4.32077599163	-	5.00e-02	GO:0070447	positive regulation of oligodendrocyte progenitor proliferation	BP
1	1	4.32077599163	-	5.00e-02	GO:0098906	regulation of Purkinje myocyte action potential	BP
1	1	4.32077599163	-	5.00e-02	GO:0098902	regulation of membrane depolarization during action potential	BP
1	1	4.32077599163	-	5.00e-02	GO:0003284	septum primum development	BP
1	1	4.32077599163	-	5.00e-02	GO:0032361	pyridoxal phosphate catabolic process	BP
1	1	4.32077599163	-	5.00e-02	GO:0070304	positive regulation of stress-activated protein kinase signaling cascade	BP
1	1	4.32077599163	-	5.00e-02	GO:1904206	positive regulation of skeletal muscle hypertrophy	BP
1	1	4.32077599163	-	5.00e-02	GO:0010021	amylopectin biosynthetic process	BP
1	1	4.32077599163	-	5.00e-02	GO:0032773	positive regulation of monophenol monooxygenase activity	BP
1	1	4.32077599163	-	5.00e-02	GO:0043610	regulation of carbohydrate utilization	BP
1	1	4.32077599163	-	5.00e-02	GO:0043618	regulation of transcription from RNA polymerase II promoter in response to stress	BP
1	1	4.32077599163	-	5.00e-02	GO:1904075	positive regulation of trophectodermal cell proliferation	BP
1	1	4.32077599163	-	5.00e-02	GO:0002663	positive regulation of B cell tolerance induction	BP
1	1	4.32077599163	-	5.00e-02	GO:1905317	inferior endocardial cushion morphogenesis	BP
1	1	4.32077599163	-	5.00e-02	GO:1905313	transforming growth factor beta receptor signaling pathway involved in heart development	BP
1	1	4.32077599163	-	5.00e-02	GO:1990859	cellular response to endothelin	BP
1	1	4.32077599163	-	5.00e-02	GO:0002840	regulation of T cell mediated immune response to tumor cell	BP
1	1	4.32077599163	-	5.00e-02	GO:0035711	T-helper 1 cell activation	BP
1	1	4.32077599163	-	5.00e-02	GO:0070640	vitamin D3 metabolic process	BP
1	1	4.32077599163	-	5.00e-02	GO:2000486	negative regulation of glutamine transport	BP
1	1	4.32077599163	-	5.00e-02	GO:0043371	negative regulation of CD4-positive, alpha-beta T cell differentiation	BP
1	1	4.32077599163	-	5.00e-02	GO:0042774	plasma membrane ATP synthesis coupled electron transport	BP
1	1	4.32077599163	-	5.00e-02	GO:0090648	response to environmental enrichment	BP
1	1	4.32077599163	-	5.00e-02	GO:0032072	regulation of restriction endodeoxyribonuclease activity	BP
1	1	4.32077599163	-	5.00e-02	GO:0003336	corneocyte desquamation	BP
1	1	4.32077599163	-	5.00e-02	GO:0060817	inactivation of paternal X chromosome	BP
1	1	4.32077599163	-	5.00e-02	GO:0000097	sulfur amino acid biosynthetic process	BP
1	1	4.32077599163	-	5.00e-02	GO:0120072	positive regulation of pyloric antrum smooth muscle contraction	BP
1	1	4.32077599163	-	5.00e-02	GO:0060552	positive regulation of fructose 1,6-bisphosphate metabolic process	BP
1	1	4.32077599163	-	5.00e-02	GO:0060550	positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity	BP
1	1	4.32077599163	-	5.00e-02	GO:0033028	myeloid cell apoptotic process	BP
1	1	4.32077599163	-	5.00e-02	GO:0006055	CMP-N-acetylneuraminate biosynthetic process	BP
1	1	4.32077599163	-	5.00e-02	GO:0035744	T-helper 1 cell cytokine production	BP
1	1	4.32077599163	-	5.00e-02	GO:1904213	negative regulation of iodide transmembrane transport	BP
1	1	4.32077599163	-	5.00e-02	GO:1990774	tumor necrosis factor secretion	BP
1	1	4.32077599163	-	5.00e-02	GO:1901666	positive regulation of NAD+ ADP-ribosyltransferase activity	BP
1	1	4.32077599163	-	5.00e-02	GO:1900133	regulation of renin secretion into blood stream	BP
1	1	4.32077599163	-	5.00e-02	GO:1904793	regulation of euchromatin binding	BP
1	1	4.32077599163	-	5.00e-02	GO:1904651	positive regulation of fat cell apoptotic process	BP
1	1	4.32077599163	-	5.00e-02	GO:0051249	regulation of lymphocyte activation	BP
1	1	4.32077599163	-	5.00e-02	GO:0010768	negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage	BP
1	1	4.32077599163	-	5.00e-02	GO:0002460	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	BP
1	1	4.32077599163	-	5.00e-02	GO:0051796	negative regulation of timing of catagen	BP
1	1	4.32077599163	-	5.00e-02	GO:0060709	glycogen cell differentiation involved in embryonic placenta development	BP
1	1	4.32077599163	-	5.00e-02	GO:0021998	neural plate mediolateral regionalization	BP
1	1	4.32077599163	-	5.00e-02	GO:0034972	histone H3-R26 methylation	BP
1	1	4.32077599163	-	5.00e-02	GO:0032423	regulation of mismatch repair	BP
1	1	4.32077599163	-	5.00e-02	GO:1902068	regulation of sphingolipid mediated signaling pathway	BP
1	1	4.32077599163	-	5.00e-02	GO:0036399	TCR signalosome assembly	BP
1	1	4.32077599163	-	5.00e-02	GO:1905045	negative regulation of Schwann cell proliferation involved in axon regeneration	BP
1	1	4.32077599163	-	5.00e-02	GO:0019089	transmission of virus	BP
1	1	4.32077599163	-	5.00e-02	GO:2000655	negative regulation of cellular response to testosterone stimulus	BP
1	1	4.32077599163	-	5.00e-02	GO:0038129	ERBB3 signaling pathway	BP
1	1	4.32077599163	-	5.00e-02	GO:0014896	muscle hypertrophy	BP
1	1	4.32077599163	-	5.00e-02	GO:0070572	positive regulation of neuron projection regeneration	BP
1	1	4.32077599163	-	5.00e-02	GO:0032667	regulation of interleukin-23 production	BP
1	1	4.32077599163	-	5.00e-02	GO:1905716	negative regulation of cornification	BP
1	1	4.32077599163	-	5.00e-02	GO:1990402	embryonic liver development	BP
1	1	4.32077599163	-	5.00e-02	GO:0099551	trans-synaptic signaling by neuropeptide, modulating synaptic transmission	BP
1	1	4.32077599163	-	5.00e-02	GO:0099557	trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission	BP
1	1	4.32077599163	-	5.00e-02	GO:0030826	regulation of cGMP biosynthetic process	BP
1	1	4.32077599163	-	5.00e-02	GO:0034477	U6 snRNA 3'-end processing	BP
1	1	4.32077599163	-	5.00e-02	GO:0010533	regulation of activation of Janus kinase activity	BP
1	1	4.32077599163	-	5.00e-02	GO:0035789	metanephric mesenchymal cell migration	BP
1	1	4.32077599163	-	5.00e-02	GO:1903755	positive regulation of SUMO transferase activity	BP
1	1	4.32077599163	-	5.00e-02	GO:0044330	canonical Wnt signaling pathway involved in positive regulation of wound healing	BP
1	1	4.32077599163	-	5.00e-02	GO:0051282	regulation of sequestering of calcium ion	BP
1	1	4.32077599163	-	5.00e-02	GO:1901187	regulation of ephrin receptor signaling pathway	BP
1	1	4.32077599163	-	5.00e-02	GO:1903911	positive regulation of receptor clustering	BP
1	1	4.32077599163	-	5.00e-02	GO:0048352	paraxial mesoderm structural organization	BP
1	1	4.32077599163	-	5.00e-02	GO:0032814	regulation of natural killer cell activation	BP
1	1	4.32077599163	-	5.00e-02	GO:1990029	vasomotion	BP
1	1	4.32077599163	-	5.00e-02	GO:2000597	positive regulation of optic nerve formation	BP
1	1	4.32077599163	-	5.00e-02	GO:0002676	regulation of chronic inflammatory response	BP
1	1	4.32077599163	-	5.00e-02	GO:0060283	negative regulation of oocyte development	BP
1	1	4.32077599163	-	5.00e-02	GO:2000753	positive regulation of glucosylceramide catabolic process	BP
1	1	4.32077599163	-	5.00e-02	GO:2000755	positive regulation of sphingomyelin catabolic process	BP
1	1	4.32077599163	-	5.00e-02	GO:0072302	negative regulation of metanephric glomerular mesangial cell proliferation	BP
1	1	4.32077599163	-	5.00e-02	GO:0048611	embryonic ectodermal digestive tract development	BP
1	1	4.32077599163	-	5.00e-02	GO:0072262	metanephric glomerular mesangial cell proliferation involved in metanephros development	BP
1	1	4.32077599163	-	5.00e-02	GO:0060587	regulation of lipoprotein lipid oxidation	BP
1	1	4.32077599163	-	5.00e-02	GO:0061185	negative regulation of dermatome development	BP
1	1	4.32077599163	-	5.00e-02	GO:0061181	regulation of chondrocyte development	BP
1	1	4.32077599163	-	5.00e-02	GO:1905285	fibrous ring of heart morphogenesis	BP
1	1	4.32077599163	-	5.00e-02	GO:0038002	endocrine signaling	BP
1	1	4.32077599163	-	5.00e-02	GO:1904414	positive regulation of cardiac ventricle development	BP
1	1	4.32077599163	-	5.00e-02	GO:0061847	response to cholecystokinin	BP
1	1	4.32077599163	-	5.00e-02	GO:1901389	negative regulation of transforming growth factor beta activation	BP
1	1	4.32077599163	-	5.00e-02	GO:0061026	cardiac muscle tissue regeneration	BP
1	1	4.32077599163	-	5.00e-02	GO:1903465	positive regulation of mitotic cell cycle DNA replication	BP
1	1	4.32077599163	-	5.00e-02	GO:0061550	cranial ganglion development	BP
1	1	4.32077599163	-	5.00e-02	GO:0060981	cell migration involved in coronary angiogenesis	BP
1	1	4.32077599163	-	5.00e-02	GO:0046318	negative regulation of glucosylceramide biosynthetic process	BP
1	1	4.32077599163	-	5.00e-02	GO:0019481	L-alanine catabolic process, by transamination	BP
1	1	4.32077599163	-	5.00e-02	GO:0010948	negative regulation of cell cycle process	BP
1	1	4.32077599163	-	5.00e-02	GO:0051838	cytolysis by host of symbiont cells	BP
1	1	4.32077599163	-	5.00e-02	GO:2001286	regulation of caveolin-mediated endocytosis	BP
1	1	4.32077599163	-	5.00e-02	GO:0048691	positive regulation of axon extension involved in regeneration	BP
1	1	4.32077599163	-	5.00e-02	GO:1905208	negative regulation of cardiocyte differentiation	BP
1	1	4.32077599163	-	5.00e-02	GO:0032960	regulation of inositol trisphosphate biosynthetic process	BP
1	1	4.32077599163	-	5.00e-02	GO:0090367	negative regulation of mRNA modification	BP
1	1	4.32077599163	-	5.00e-02	GO:2000351	regulation of endothelial cell apoptotic process	BP
1	1	4.32077599163	-	5.00e-02	GO:1904501	positive regulation of chromatin-mediated maintenance of transcription	BP
1	1	4.32077599163	-	5.00e-02	GO:0003409	optic cup structural organization	BP
1	1	4.32077599163	-	5.00e-02	GO:0001710	mesodermal cell fate commitment	BP
1	1	4.32077599163	-	5.00e-02	GO:2000830	positive regulation of parathyroid hormone secretion	BP
1	1	4.32077599163	-	5.00e-02	GO:1900163	positive regulation of phospholipid scramblase activity	BP
1	1	4.32077599163	-	5.00e-02	GO:0009817	defense response to fungus, incompatible interaction	BP
1	1	4.32077599163	-	5.00e-02	GO:1902910	positive regulation of melanosome transport	BP
1	1	4.32077599163	-	5.00e-02	GO:0032928	regulation of superoxide anion generation	BP
1	1	4.32077599163	-	5.00e-02	GO:0060901	regulation of hair cycle by canonical Wnt signaling pathway	BP
1	1	4.32077599163	-	5.00e-02	GO:0006343	establishment of chromatin silencing	BP
1	1	4.32077599163	-	5.00e-02	GO:0043969	histone H2B acetylation	BP
1	1	4.32077599163	-	5.00e-02	GO:1900085	negative regulation of peptidyl-tyrosine autophosphorylation	BP
1	1	4.32077599163	-	5.00e-02	GO:0045938	positive regulation of circadian sleep/wake cycle, sleep	BP
1	1	4.32077599163	-	5.00e-02	GO:0035409	histone H3-Y41 phosphorylation	BP
1	1	4.32077599163	-	5.00e-02	GO:0072428	signal transduction involved in intra-S DNA damage checkpoint	BP
1	1	4.32077599163	-	5.00e-02	GO:0097274	urea homeostasis	BP
1	1	4.32077599163	-	5.00e-02	GO:1904588	cellular response to glycoprotein	BP
1	1	4.32077599163	-	5.00e-02	GO:0033320	UDP-D-xylose biosynthetic process	BP
1	1	4.32077599163	-	5.00e-02	GO:1903926	cellular response to bisphenol A	BP
1	1	4.32077599163	-	5.00e-02	GO:0019056	modulation by virus of host transcription	BP
1	1	4.32077599163	-	5.00e-02	GO:0098968	neurotransmitter receptor transport postsynaptic membrane to endosome	BP
1	1	4.32077599163	-	5.00e-02	GO:2000097	regulation of smooth muscle cell-matrix adhesion	BP
1	1	4.32077599163	-	5.00e-02	GO:0001840	neural plate development	BP
1	1	4.32077599163	-	5.00e-02	GO:0044329	canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion	BP
1	1	4.32077599163	-	5.00e-02	GO:0044328	canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration	BP
1	1	4.32077599163	-	5.00e-02	GO:0036323	vascular endothelial growth factor receptor-1 signaling pathway	BP
1	1	4.32077599163	-	5.00e-02	GO:0002863	positive regulation of inflammatory response to antigenic stimulus	BP
1	1	4.32077599163	-	5.00e-02	GO:1904197	positive regulation of granulosa cell proliferation	BP
1	1	4.32077599163	-	5.00e-02	GO:1904193	negative regulation of cholangiocyte apoptotic process	BP
1	1	4.32077599163	-	5.00e-02	GO:0060601	lateral sprouting from an epithelium	BP
1	1	4.32077599163	-	5.00e-02	GO:0070662	mast cell proliferation	BP
1	1	4.32077599163	-	5.00e-02	GO:0070667	negative regulation of mast cell proliferation	BP
1	1	4.32077599163	-	5.00e-02	GO:1904056	positive regulation of cholangiocyte proliferation	BP
1	1	4.32077599163	-	5.00e-02	GO:0051463	negative regulation of cortisol secretion	BP
1	1	4.32077599163	-	5.00e-02	GO:0071206	establishment of protein localization to juxtaparanode region of axon	BP
1	1	4.32077599163	-	5.00e-02	GO:0060479	lung cell differentiation	BP
1	1	4.32077599163	-	5.00e-02	GO:1901563	response to camptothecin	BP
1	1	4.32077599163	-	5.00e-02	GO:1901976	regulation of cell cycle checkpoint	BP
1	1	4.32077599163	-	5.00e-02	GO:0030264	nuclear fragmentation involved in apoptotic nuclear change	BP
1	1	4.32077599163	-	5.00e-02	GO:1903452	positive regulation of G1 to G0 transition	BP
1	1	4.32077599163	-	5.00e-02	GO:0007037	vacuolar phosphate transport	BP
1	1	4.32077599163	-	5.00e-02	GO:0003311	pancreatic D cell differentiation	BP
1	1	4.32077599163	-	5.00e-02	GO:0019101	female somatic sex determination	BP
1	1	4.32077599163	-	5.00e-02	GO:0019102	male somatic sex determination	BP
1	1	4.32077599163	-	5.00e-02	GO:0002761	regulation of myeloid leukocyte differentiation	BP
1	1	4.32077599163	-	5.00e-02	GO:0071538	SH2 domain-mediated complex assembly	BP
1	1	4.32077599163	-	5.00e-02	GO:1904635	positive regulation of glomerular visceral epithelial cell apoptotic process	BP
1	1	4.32077599163	-	5.00e-02	GO:0097326	melanocyte adhesion	BP
1	1	4.32077599163	-	5.00e-02	GO:2001145	negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity	BP
1	1	4.32077599163	-	5.00e-02	GO:0002721	regulation of B cell cytokine production	BP
1	1	4.32077599163	-	5.00e-02	GO:0043299	leukocyte degranulation	BP
1	1	4.32077599163	-	5.00e-02	GO:1902947	regulation of tau-protein kinase activity	BP
1	1	4.32077599163	-	5.00e-02	GO:0090104	pancreatic epsilon cell differentiation	BP
1	1	4.32077599163	-	5.00e-02	GO:0044111	development involved in symbiotic interaction	BP
1	1	4.32077599163	-	5.00e-02	GO:0003251	positive regulation of cell proliferation involved in heart valve morphogenesis	BP
1	1	4.32077599163	-	5.00e-02	GO:1904531	positive regulation of actin filament binding	BP
1	1	4.32077599163	-	5.00e-02	GO:0007403	glial cell fate determination	BP
1	1	4.32077599163	-	5.00e-02	GO:2000118	regulation of sodium-dependent phosphate transport	BP
1	1	4.32077599163	-	5.00e-02	GO:2000119	negative regulation of sodium-dependent phosphate transport	BP
1	1	4.32077599163	-	5.00e-02	GO:2000808	negative regulation of synaptic vesicle clustering	BP
1	1	4.32077599163	-	5.00e-02	GO:0050793	regulation of developmental process	BP
1	1	4.32077599163	-	5.00e-02	GO:2000639	negative regulation of SREBP signaling pathway	BP
1	1	4.32077599163	-	5.00e-02	GO:0070512	positive regulation of histone H4-K20 methylation	BP
1	1	4.32077599163	-	5.00e-02	GO:0001971	negative regulation of activation of membrane attack complex	BP
1	1	4.32077599163	-	5.00e-02	GO:0035604	fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow	BP
1	1	4.32077599163	-	5.00e-02	GO:0035602	fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow	BP
1	1	4.32077599163	-	5.00e-02	GO:0035603	fibroblast growth factor receptor signaling pathway involved in hemopoiesis	BP
1	1	4.32077599163	-	5.00e-02	GO:0002152	bile acid conjugation	BP
1	1	4.32077599163	-	5.00e-02	GO:0051884	regulation of timing of anagen	BP
1	1	4.32077599163	-	5.00e-02	GO:2001239	regulation of extrinsic apoptotic signaling pathway in absence of ligand	BP
1	1	4.32077599163	-	5.00e-02	GO:1901723	negative regulation of cell proliferation involved in kidney development	BP
1	1	4.32077599163	-	5.00e-02	GO:0086044	atrial cardiac muscle cell to AV node cell communication by electrical coupling	BP
1	1	4.32077599163	-	5.00e-02	GO:0097090	presynaptic membrane organization	BP
1	1	4.32077599163	-	5.00e-02	GO:0035644	phosphoanandamide dephosphorylation	BP
1	1	4.32077599163	-	5.00e-02	GO:0002695	negative regulation of leukocyte activation	BP
1	1	4.32077599163	-	5.00e-02	GO:0052547	regulation of peptidase activity	BP
1	1	4.32077599163	-	5.00e-02	GO:2000739	regulation of mesenchymal stem cell differentiation	BP
1	1	4.32077599163	-	5.00e-02	GO:0071441	negative regulation of histone H3-K14 acetylation	BP
1	1	4.32077599163	-	5.00e-02	GO:0090025	regulation of monocyte chemotaxis	BP
1	1	4.32077599163	-	5.00e-02	GO:0090237	regulation of arachidonic acid secretion	BP
1	1	4.32077599163	-	5.00e-02	GO:0003294	atrial ventricular junction remodeling	BP
1	1	4.32077599163	-	5.00e-02	GO:0002066	columnar/cuboidal epithelial cell development	BP
1	1	4.32077599163	-	5.00e-02	GO:0036060	slit diaphragm assembly	BP
1	1	4.32077599163	-	5.00e-02	GO:0071873	response to norepinephrine	BP
1	1	4.32077599163	-	5.00e-02	GO:0071250	cellular response to nitrite	BP
1	1	4.32077599163	-	5.00e-02	GO:0060405	regulation of penile erection	BP
1	1	4.32077599163	-	5.00e-02	GO:0060400	negative regulation of growth hormone receptor signaling pathway	BP
1	1	4.32077599163	-	5.00e-02	GO:0002651	positive regulation of tolerance induction to self antigen	BP
1	1	4.32077599163	-	5.00e-02	GO:1905305	negative regulation of cardiac myofibril assembly	BP
1	1	4.32077599163	-	5.00e-02	GO:0100002	negative regulation of protein kinase activity by protein phosphorylation	BP
1	1	4.32077599163	-	5.00e-02	GO:1903632	positive regulation of aminoacyl-tRNA ligase activity	BP
1	1	4.32077599163	-	5.00e-02	GO:0035491	positive regulation of leukotriene production involved in inflammatory response	BP
1	1	4.32077599163	-	5.00e-02	GO:0042703	menstruation	BP
1	1	4.32077599163	-	5.00e-02	GO:0051531	NFAT protein import into nucleus	BP
1	1	4.32077599163	-	5.00e-02	GO:0061040	female gonad morphogenesis	BP
1	1	4.32077599163	-	5.00e-02	GO:1903676	positive regulation of cap-dependent translational initiation	BP
1	1	4.32077599163	-	5.00e-02	GO:0048241	epinephrine transport	BP
1	1	4.32077599163	-	5.00e-02	GO:1900383	regulation of synaptic plasticity by receptor localization to synapse	BP
1	1	4.32077599163	-	5.00e-02	GO:0060014	granulosa cell differentiation	BP
1	1	4.32077599163	-	5.00e-02	GO:2000184	positive regulation of progesterone biosynthetic process	BP
1	1	4.32077599163	-	5.00e-02	GO:0002344	B cell affinity maturation	BP
1	1	4.32077599163	-	5.00e-02	GO:0060751	branch elongation involved in mammary gland duct branching	BP
1	1	4.32077599163	-	5.00e-02	GO:0006991	response to sterol depletion	BP
1	1	4.32077599163	-	5.00e-02	GO:0032535	regulation of cellular component size	BP
1	1	4.32077599163	-	5.00e-02	GO:0002758	innate immune response-activating signal transduction	BP
1	1	4.32077599163	-	5.00e-02	GO:0098761	cellular response to interleukin-7	BP
1	1	4.32077599163	-	5.00e-02	GO:0007063	regulation of sister chromatid cohesion	BP
1	1	4.32077599163	-	5.00e-02	GO:0071298	cellular response to L-ascorbic acid	BP
1	1	4.32077599163	-	5.00e-02	GO:0010232	vascular transport	BP
1	1	4.32077599163	-	5.00e-02	GO:1901860	positive regulation of mitochondrial DNA metabolic process	BP
1	1	4.32077599163	-	5.00e-02	GO:1901863	positive regulation of muscle tissue development	BP
1	1	4.32077599163	-	5.00e-02	GO:0036119	response to platelet-derived growth factor	BP
1	1	4.32077599163	-	5.00e-02	GO:1900148	negative regulation of Schwann cell migration	BP
1	1	4.32077599163	-	5.00e-02	GO:0009441	glycolate metabolic process	BP
1	1	4.32077599163	-	5.00e-02	GO:0002270	plasmacytoid dendritic cell activation	BP
1	1	4.32077599163	-	5.00e-02	GO:0060520	activation of prostate induction by androgen receptor signaling pathway	BP
1	1	4.32077599163	-	5.00e-02	GO:1905229	cellular response to thyrotropin-releasing hormone	BP
1	1	4.32077599163	-	5.00e-02	GO:0032633	interleukin-4 production	BP
7	7	4.32077599163	-	7.63e-10	GO:0004679	AMP-activated protein kinase activity	MF
2	2	4.32077599163	-	2.50e-03	GO:0004951	cholecystokinin receptor activity	MF
2	2	4.32077599163	-	2.50e-03	GO:0047322	[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity	MF
2	2	4.32077599163	-	2.50e-03	GO:0008269	JAK pathway signal transduction adaptor activity	MF
2	2	4.32077599163	-	2.50e-03	GO:0005011	macrophage colony-stimulating factor receptor activity	MF
2	2	4.32077599163	-	2.50e-03	GO:0005019	platelet-derived growth factor beta-receptor activity	MF
2	2	4.32077599163	-	2.50e-03	GO:0086075	gap junction channel activity involved in cardiac conduction electrical coupling	MF
2	2	4.32077599163	-	2.50e-03	GO:0010465	nerve growth factor receptor activity	MF
2	2	4.32077599163	-	2.50e-03	GO:0042132	fructose 1,6-bisphosphate 1-phosphatase activity	MF
2	2	4.32077599163	-	2.50e-03	GO:0050405	[acetyl-CoA carboxylase] kinase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0004586	ornithine decarboxylase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0001011	transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting	MF
1	1	4.32077599163	-	5.00e-02	GO:0005020	stem cell factor receptor activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0035033	histone deacetylase regulator activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0004508	steroid 17-alpha-monooxygenase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0052816	long-chain acyl-CoA hydrolase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0052817	very long chain acyl-CoA hydrolase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0042497	triacyl lipopeptide binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0047305	(R)-3-amino-2-methylpropionate-pyruvate transaminase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0070856	myosin VI light chain binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0005018	platelet-derived growth factor alpha-receptor activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0004676	3-phosphoinositide-dependent protein kinase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0002135	CTP binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0060175	brain-derived neurotrophic factor-activated receptor activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	MF
1	1	4.32077599163	-	5.00e-02	GO:0001087	transcription factor activity, TFIIB-class binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0030379	neurotensin receptor activity, non-G-protein coupled	MF
1	1	4.32077599163	-	5.00e-02	GO:0004900	erythropoietin receptor activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0001626	nociceptin receptor activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0005017	platelet-derived growth factor-activated receptor activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0038049	transcription factor activity, ligand-activated RNA polymerase II transcription factor binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0050462	N-acetylneuraminate synthase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0036326	VEGF-A-activated receptor activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0050429	calcium-dependent phospholipase C activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0047444	N-acylneuraminate-9-phosphate synthase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0047442	17-alpha-hydroxyprogesterone aldolase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0015929	hexosaminidase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0030616	transforming growth factor beta receptor, common-partner cytoplasmic mediator activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0061656	SUMO conjugating enzyme activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0036458	hepatocyte growth factor binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0086079	gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling	MF
1	1	4.32077599163	-	5.00e-02	GO:0086078	gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling	MF
1	1	4.32077599163	-	5.00e-02	GO:0086076	gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling	MF
1	1	4.32077599163	-	5.00e-02	GO:0035401	histone kinase activity (H3-Y41 specific)	MF
1	1	4.32077599163	-	5.00e-02	GO:0036327	VEGF-B-activated receptor activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0038021	leptin receptor activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0004728	signal transducer, downstream of receptor, with protein tyrosine phosphatase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0019970	interleukin-11 binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0070320	inward rectifier potassium channel inhibitor activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0017172	cysteine dioxygenase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0005009	insulin-activated receptor activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0005008	hepatocyte growth factor-activated receptor activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0000990	transcription factor activity, core RNA polymerase binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0009020	tRNA (guanosine-2'-O-)-methyltransferase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0051427	hormone receptor binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0070974	POU domain binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0036332	placental growth factor-activated receptor activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0042131	thiamine phosphate phosphatase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0061609	fructose-1-phosphate aldolase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0031687	A2A adenosine receptor binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0050038	L-xylulose reductase (NADP+) activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0016430	tRNA (adenine-N6-)-methyltransferase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0052666	tRNA (cytosine-2'-O-)-methyltransferase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0005133	interferon-gamma receptor binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0048040	UDP-glucuronate decarboxylase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0043423	3-phosphoinositide-dependent protein kinase binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0004921	interleukin-11 receptor activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0046817	chemokine receptor antagonist activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0010858	calcium-dependent protein kinase regulator activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0050379	UDP-glucuronate 5'-epimerase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0031741	type B gastrin/cholecystokinin receptor binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0015054	gastrin receptor activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0005030	neurotrophin receptor activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0047464	heparosan-N-sulfate-glucuronate 5-epimerase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0017082	mineralocorticoid receptor activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0047963	glycine N-choloyltransferase activity	MF
8	9	4.15085099019	-	3.25e-10	GO:0004716	signal transducer, downstream of receptor, with protein tyrosine kinase activity	MF
5	6	4.0577415858	-	1.78e-06	GO:0005168	neurotrophin TRKA receptor binding	MF
9	11	4.03126937444	-	9.40e-11	GO:0043560	insulin receptor substrate binding	MF
4	5	3.99884789674	-	2.99e-05	GO:0071681	cellular response to indole-3-methanol	BP
3	4	3.90573849235	-	4.80e-04	GO:0035404	histone-serine phosphorylation	BP
3	4	3.90573849235	-	4.80e-04	GO:0042490	mechanoreceptor differentiation	BP
3	4	3.90573849235	-	4.80e-04	GO:0033686	positive regulation of luteinizing hormone secretion	BP
3	4	3.90573849235	-	4.80e-04	GO:0048408	epidermal growth factor binding	MF
3	4	3.90573849235	-	4.80e-04	GO:0043125	ErbB-3 class receptor binding	MF
3	4	3.90573849235	-	4.80e-04	GO:0043121	neurotrophin binding	MF
35	47	3.8954701569	-	2.58e-37	GO:0038083	peptidyl-tyrosine autophosphorylation	BP
6	9	3.73581349091	-	1.13e-06	GO:0010863	positive regulation of phospholipase C activity	BP
4	6	3.73581349091	-	8.60e-05	GO:0038202	TORC1 signaling	BP
4	6	3.73581349091	-	8.60e-05	GO:0033210	leptin-mediated signaling pathway	BP
2	3	3.73581349091	-	2.50e-03	GO:0002803	positive regulation of antibacterial peptide production	BP
2	3	3.73581349091	-	2.50e-03	GO:0060916	mesenchymal cell proliferation involved in lung development	BP
2	3	3.73581349091	-	2.50e-03	GO:0021847	ventricular zone neuroblast division	BP
2	3	3.73581349091	-	2.50e-03	GO:0060769	positive regulation of epithelial cell proliferation involved in prostate gland development	BP
2	3	3.73581349091	-	7.25e-03	GO:0002553	histamine secretion by mast cell	BP
2	3	3.73581349091	-	7.25e-03	GO:0002513	tolerance induction to self antigen	BP
2	3	3.73581349091	-	7.25e-03	GO:0038091	positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway	BP
2	3	3.73581349091	-	7.25e-03	GO:0001827	inner cell mass cell fate commitment	BP
2	3	3.73581349091	-	7.25e-03	GO:0072277	metanephric glomerular capillary formation	BP
2	3	3.73581349091	-	7.25e-03	GO:0070602	regulation of centromeric sister chromatid cohesion	BP
2	3	3.73581349091	-	7.25e-03	GO:2000366	positive regulation of STAT protein import into nucleus	BP
2	3	3.73581349091	-	7.25e-03	GO:0002366	leukocyte activation involved in immune response	BP
2	3	3.73581349091	-	7.25e-03	GO:0050849	negative regulation of calcium-mediated signaling	BP
2	3	3.73581349091	-	7.25e-03	GO:0038162	erythropoietin-mediated signaling pathway	BP
2	3	3.73581349091	-	7.25e-03	GO:0006549	isoleucine metabolic process	BP
2	3	3.73581349091	-	7.25e-03	GO:0000255	allantoin metabolic process	BP
2	3	3.73581349091	-	7.25e-03	GO:0060672	epithelial cell morphogenesis involved in placental branching	BP
2	3	3.73581349091	-	7.25e-03	GO:0045218	zonula adherens maintenance	BP
2	3	3.73581349091	-	7.25e-03	GO:0032613	interleukin-10 production	BP
2	3	3.73581349091	-	7.25e-03	GO:0003093	regulation of glomerular filtration	BP
2	3	3.73581349091	-	7.25e-03	GO:0061198	fungiform papilla formation	BP
2	3	3.73581349091	-	7.25e-03	GO:0003310	pancreatic A cell differentiation	BP
2	3	3.73581349091	-	7.25e-03	GO:0051097	negative regulation of helicase activity	BP
2	3	3.73581349091	-	7.25e-03	GO:2000058	regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process	BP
2	3	3.73581349091	-	7.25e-03	GO:0060399	positive regulation of growth hormone receptor signaling pathway	BP
2	3	3.73581349091	-	7.25e-03	GO:2000345	regulation of hepatocyte proliferation	BP
2	3	3.73581349091	-	7.25e-03	GO:1903527	positive regulation of membrane tubulation	BP
2	3	3.73581349091	-	7.25e-03	GO:2000111	positive regulation of macrophage apoptotic process	BP
2	3	3.73581349091	-	7.25e-03	GO:1901299	negative regulation of hydrogen peroxide-mediated programmed cell death	BP
2	3	3.73581349091	-	7.25e-03	GO:0043009	chordate embryonic development	BP
2	3	3.73581349091	-	7.25e-03	GO:0038145	macrophage colony-stimulating factor signaling pathway	BP
2	3	3.73581349091	-	7.25e-03	GO:0021697	cerebellar cortex formation	BP
2	3	3.73581349091	-	7.25e-03	GO:0043366	beta selection	BP
2	3	3.73581349091	-	7.25e-03	GO:0002232	leukocyte chemotaxis involved in inflammatory response	BP
2	3	3.73581349091	-	7.25e-03	GO:0051389	inactivation of MAPKK activity	BP
4	6	3.73581349091	-	2.99e-05	GO:0046935	1-phosphatidylinositol-3-kinase regulator activity	MF
2	3	3.73581349091	-	7.25e-03	GO:0004992	platelet activating factor receptor activity	MF
2	3	3.73581349091	-	7.25e-03	GO:0050816	phosphothreonine residue binding	MF
2	3	3.73581349091	-	7.25e-03	GO:0031752	D5 dopamine receptor binding	MF
2	3	3.73581349091	-	7.25e-03	GO:0055100	adiponectin binding	MF
2	3	3.73581349091	-	7.25e-03	GO:0001156	TFIIIC-class transcription factor binding	MF
2	3	3.73581349091	-	7.25e-03	GO:0001030	RNA polymerase III type 1 promoter DNA binding	MF
2	3	3.73581349091	-	7.25e-03	GO:0001031	RNA polymerase III type 2 promoter DNA binding	MF
2	3	3.73581349091	-	7.25e-03	GO:0043398	HLH domain binding	MF
2	3	3.73581349091	-	7.25e-03	GO:0004924	oncostatin-M receptor activity	MF
23	35	3.71505493074	-	4.02e-22	GO:0001784	phosphotyrosine residue binding	MF
5	8	3.64270408652	-	1.53e-05	GO:0060396	growth hormone receptor signaling pathway	BP
10	16	3.64270408652	-	5.62e-10	GO:0005001	transmembrane receptor protein tyrosine phosphatase activity	MF
3	5	3.58381039747	-	4.80e-04	GO:0002318	myeloid progenitor cell differentiation	BP
3	5	3.58381039747	-	1.16e-03	GO:0050882	voluntary musculoskeletal movement	BP
3	5	3.58381039747	-	1.16e-03	GO:0019530	taurine metabolic process	BP
3	5	3.58381039747	-	1.16e-03	GO:0010543	regulation of platelet activation	BP
3	5	3.58381039747	-	1.16e-03	GO:0090335	regulation of brown fat cell differentiation	BP
3	5	3.58381039747	-	1.16e-03	GO:0003161	cardiac conduction system development	BP
3	5	3.58381039747	-	1.16e-03	GO:0042976	activation of Janus kinase activity	BP
6	10	3.58381039747	-	2.71e-06	GO:0045295	gamma-catenin binding	MF
3	5	3.58381039747	-	4.80e-04	GO:0005007	fibroblast growth factor-activated receptor activity	MF
3	5	3.58381039747	-	1.16e-03	GO:0035174	histone serine kinase activity	MF
3	5	3.58381039747	-	1.16e-03	GO:0030235	nitric-oxide synthase regulator activity	MF
3	5	3.58381039747	-	1.16e-03	GO:0005131	growth hormone receptor binding	MF
7	12	3.54316841297	-	4.84e-07	GO:0035635	entry of bacterium into host cell	BP
18	31	3.53650468269	-	6.43e-17	GO:0005158	insulin receptor binding	MF
8	14	3.51342106957	-	1.56e-08	GO:1901185	negative regulation of ERBB signaling pathway	BP
4	7	3.51342106957	-	8.60e-05	GO:0043551	regulation of phosphatidylinositol 3-kinase activity	BP
16	28	3.51342106957	-	2.26e-14	GO:0004714	transmembrane receptor protein tyrosine kinase activity	MF
4	7	3.51342106957	-	1.93e-04	GO:0005021	vascular endothelial growth factor-activated receptor activity	MF
5	9	3.47277908508	-	3.29e-05	GO:0042304	regulation of fatty acid biosynthetic process	BP
21	38	3.46516590097	-	9.88e-19	GO:0038128	ERBB2 signaling pathway	BP
11	20	3.45827951538	-	5.06e-10	GO:0043548	phosphatidylinositol 3-kinase binding	MF
28	51	3.45570557172	-	1.45e-24	GO:0004715	non-membrane spanning protein tyrosine kinase activity	MF
6	11	3.44630687372	-	2.71e-06	GO:0005068	transmembrane receptor protein tyrosine kinase adaptor activity	MF
7	13	3.42769119555	-	1.00e-06	GO:0060334	regulation of interferon-gamma-mediated signaling pathway	BP
7	14	3.32077599163	-	1.92e-06	GO:0048009	insulin-like growth factor receptor signaling pathway	BP
4	8	3.32077599163	-	1.93e-04	GO:0060020	Bergmann glial cell differentiation	BP
4	8	3.32077599163	-	3.70e-04	GO:0007172	signal complex assembly	BP
3	6	3.32077599163	-	1.16e-03	GO:0010594	regulation of endothelial cell migration	BP
3	6	3.32077599163	-	2.23e-03	GO:0003158	endothelium development	BP
3	6	3.32077599163	-	2.23e-03	GO:0046881	positive regulation of follicle-stimulating hormone secretion	BP
3	6	3.32077599163	-	2.23e-03	GO:0060440	trachea formation	BP
2	4	3.32077599163	-	2.50e-03	GO:0010868	negative regulation of triglyceride biosynthetic process	BP
2	4	3.32077599163	-	7.25e-03	GO:1904037	positive regulation of epithelial cell apoptotic process	BP
2	4	3.32077599163	-	7.25e-03	GO:0060742	epithelial cell differentiation involved in prostate gland development	BP
2	4	3.32077599163	-	7.25e-03	GO:0070857	regulation of bile acid biosynthetic process	BP
2	4	3.32077599163	-	7.25e-03	GO:2000757	negative regulation of peptidyl-lysine acetylation	BP
2	4	3.32077599163	-	7.25e-03	GO:1904058	positive regulation of sensory perception of pain	BP
2	4	3.32077599163	-	7.25e-03	GO:0060571	morphogenesis of an epithelial fold	BP
2	4	3.32077599163	-	7.25e-03	GO:0002768	immune response-regulating cell surface receptor signaling pathway	BP
2	4	3.32077599163	-	7.25e-03	GO:0051055	negative regulation of lipid biosynthetic process	BP
2	4	3.32077599163	-	1.40e-02	GO:0071801	regulation of podosome assembly	BP
2	4	3.32077599163	-	1.40e-02	GO:0038110	interleukin-2-mediated signaling pathway	BP
2	4	3.32077599163	-	1.40e-02	GO:0043201	response to leucine	BP
2	4	3.32077599163	-	1.40e-02	GO:0060665	regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling	BP
2	4	3.32077599163	-	1.40e-02	GO:0032079	positive regulation of endodeoxyribonuclease activity	BP
2	4	3.32077599163	-	1.40e-02	GO:0010883	regulation of lipid storage	BP
2	4	3.32077599163	-	1.40e-02	GO:0003186	tricuspid valve morphogenesis	BP
2	4	3.32077599163	-	1.40e-02	GO:0038127	ERBB signaling pathway	BP
2	4	3.32077599163	-	1.40e-02	GO:0038165	oncostatin-M-mediated signaling pathway	BP
2	4	3.32077599163	-	1.40e-02	GO:0021631	optic nerve morphogenesis	BP
2	4	3.32077599163	-	1.40e-02	GO:2000491	positive regulation of hepatic stellate cell activation	BP
2	4	3.32077599163	-	1.40e-02	GO:0051450	myoblast proliferation	BP
2	4	3.32077599163	-	1.40e-02	GO:0030950	establishment or maintenance of actin cytoskeleton polarity	BP
2	4	3.32077599163	-	1.40e-02	GO:0048679	regulation of axon regeneration	BP
2	4	3.32077599163	-	1.40e-02	GO:0006344	maintenance of chromatin silencing	BP
2	4	3.32077599163	-	1.40e-02	GO:0051048	negative regulation of secretion	BP
2	4	3.32077599163	-	1.40e-02	GO:0046449	creatinine metabolic process	BP
2	4	3.32077599163	-	1.40e-02	GO:0010822	positive regulation of mitochondrion organization	BP
2	4	3.32077599163	-	1.40e-02	GO:1990834	response to odorant	BP
2	4	3.32077599163	-	1.40e-02	GO:0006573	valine metabolic process	BP
2	4	3.32077599163	-	1.40e-02	GO:0031999	negative regulation of fatty acid beta-oxidation	BP
2	4	3.32077599163	-	1.40e-02	GO:0051098	regulation of binding	BP
2	4	3.32077599163	-	1.40e-02	GO:0014878	response to electrical stimulus involved in regulation of muscle adaptation	BP
2	4	3.32077599163	-	1.40e-02	GO:0010748	negative regulation of plasma membrane long-chain fatty acid transport	BP
2	4	3.32077599163	-	1.40e-02	GO:0060442	branching involved in prostate gland morphogenesis	BP
2	4	3.32077599163	-	1.40e-02	GO:0038028	insulin receptor signaling pathway via phosphatidylinositol 3-kinase	BP
2	4	3.32077599163	-	1.40e-02	GO:0051385	response to mineralocorticoid	BP
2	4	3.32077599163	-	1.40e-02	GO:0097350	neutrophil clearance	BP
2	4	3.32077599163	-	1.40e-02	GO:0021955	central nervous system neuron axonogenesis	BP
1	2	3.32077599163	-	5.00e-02	GO:0072079	nephron tubule formation	BP
1	2	3.32077599163	-	5.00e-02	GO:0070564	positive regulation of vitamin D receptor signaling pathway	BP
1	2	3.32077599163	-	5.00e-02	GO:0002072	optic cup morphogenesis involved in camera-type eye development	BP
1	2	3.32077599163	-	5.00e-02	GO:0045720	negative regulation of integrin biosynthetic process	BP
1	2	3.32077599163	-	5.00e-02	GO:0044381	glucose import in response to insulin stimulus	BP
1	2	3.32077599163	-	5.00e-02	GO:0051446	positive regulation of meiotic cell cycle	BP
1	2	3.32077599163	-	5.00e-02	GO:0033594	response to hydroxyisoflavone	BP
1	2	3.32077599163	-	5.00e-02	GO:1901857	positive regulation of cellular respiration	BP
1	2	3.32077599163	-	5.00e-02	GO:1904251	regulation of bile acid metabolic process	BP
1	2	3.32077599163	-	5.00e-02	GO:0021842	chemorepulsion involved in interneuron migration from the subpallium to the cortex	BP
1	2	3.32077599163	-	5.00e-02	GO:0070106	interleukin-27-mediated signaling pathway	BP
1	2	3.32077599163	-	5.00e-02	GO:2001204	regulation of osteoclast development	BP
1	2	3.32077599163	-	5.00e-02	GO:0060369	positive regulation of Fc receptor mediated stimulatory signaling pathway	BP
1	2	3.32077599163	-	5.00e-02	GO:0045976	negative regulation of mitotic cell cycle, embryonic	BP
1	2	3.32077599163	-	5.00e-02	GO:0021623	oculomotor nerve formation	BP
1	2	3.32077599163	-	5.00e-02	GO:0003050	regulation of systemic arterial blood pressure by atrial natriuretic peptide	BP
1	2	3.32077599163	-	5.00e-02	GO:0002228	natural killer cell mediated immunity	BP
1	2	3.32077599163	-	5.00e-02	GO:0032528	microvillus organization	BP
1	2	3.32077599163	-	5.00e-02	GO:0002769	natural killer cell inhibitory signaling pathway	BP
1	2	3.32077599163	-	5.00e-02	GO:1904639	cellular response to resveratrol	BP
1	2	3.32077599163	-	5.00e-02	GO:0072166	posterior mesonephric tubule development	BP
1	2	3.32077599163	-	5.00e-02	GO:0035358	regulation of peroxisome proliferator activated receptor signaling pathway	BP
1	2	3.32077599163	-	5.00e-02	GO:0021551	central nervous system morphogenesis	BP
1	2	3.32077599163	-	5.00e-02	GO:0002720	positive regulation of cytokine production involved in immune response	BP
1	2	3.32077599163	-	5.00e-02	GO:0034165	positive regulation of toll-like receptor 9 signaling pathway	BP
1	2	3.32077599163	-	5.00e-02	GO:1903053	regulation of extracellular matrix organization	BP
1	2	3.32077599163	-	5.00e-02	GO:0042595	behavioral response to starvation	BP
1	2	3.32077599163	-	5.00e-02	GO:0051053	negative regulation of DNA metabolic process	BP
1	2	3.32077599163	-	5.00e-02	GO:0090276	regulation of peptide hormone secretion	BP
1	2	3.32077599163	-	5.00e-02	GO:1902613	negative regulation of anti-Mullerian hormone signaling pathway	BP
1	2	3.32077599163	-	5.00e-02	GO:0031658	negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle	BP
1	2	3.32077599163	-	5.00e-02	GO:0002879	positive regulation of acute inflammatory response to non-antigenic stimulus	BP
1	2	3.32077599163	-	5.00e-02	GO:0090657	telomeric loop disassembly	BP
1	2	3.32077599163	-	5.00e-02	GO:0010623	programmed cell death involved in cell development	BP
1	2	3.32077599163	-	9.76e-02	GO:1904528	positive regulation of microtubule binding	BP
1	2	3.32077599163	-	9.76e-02	GO:0016198	axon choice point recognition	BP
1	2	3.32077599163	-	9.76e-02	GO:1904956	regulation of midbrain dopaminergic neuron differentiation	BP
1	2	3.32077599163	-	9.76e-02	GO:0017055	negative regulation of RNA polymerase II transcriptional preinitiation complex assembly	BP
1	2	3.32077599163	-	9.76e-02	GO:0002378	immunoglobulin biosynthetic process	BP
1	2	3.32077599163	-	9.76e-02	GO:0001776	leukocyte homeostasis	BP
1	2	3.32077599163	-	9.76e-02	GO:0030832	regulation of actin filament length	BP
1	2	3.32077599163	-	9.76e-02	GO:0071140	resolution of mitotic recombination intermediates	BP
1	2	3.32077599163	-	9.76e-02	GO:0046636	negative regulation of alpha-beta T cell activation	BP
1	2	3.32077599163	-	9.76e-02	GO:1904527	negative regulation of microtubule binding	BP
1	2	3.32077599163	-	9.76e-02	GO:0086053	AV node cell to bundle of His cell communication by electrical coupling	BP
1	2	3.32077599163	-	9.76e-02	GO:0090260	negative regulation of retinal ganglion cell axon guidance	BP
1	2	3.32077599163	-	9.76e-02	GO:0097252	oligodendrocyte apoptotic process	BP
1	2	3.32077599163	-	9.76e-02	GO:0072182	regulation of nephron tubule epithelial cell differentiation	BP
1	2	3.32077599163	-	9.76e-02	GO:0060341	regulation of cellular localization	BP
1	2	3.32077599163	-	9.76e-02	GO:0006525	arginine metabolic process	BP
1	2	3.32077599163	-	9.76e-02	GO:0098905	regulation of bundle of His cell action potential	BP
1	2	3.32077599163	-	9.76e-02	GO:0060667	branch elongation involved in salivary gland morphogenesis	BP
1	2	3.32077599163	-	9.76e-02	GO:0071221	cellular response to bacterial lipopeptide	BP
1	2	3.32077599163	-	9.76e-02	GO:0046732	active induction of host immune response by virus	BP
1	2	3.32077599163	-	9.76e-02	GO:0036269	swimming behavior	BP
1	2	3.32077599163	-	9.76e-02	GO:0071417	cellular response to organonitrogen compound	BP
1	2	3.32077599163	-	9.76e-02	GO:0044818	mitotic G2/M transition checkpoint	BP
1	2	3.32077599163	-	9.76e-02	GO:0040013	negative regulation of locomotion	BP
1	2	3.32077599163	-	9.76e-02	GO:0043331	response to dsRNA	BP
1	2	3.32077599163	-	9.76e-02	GO:0010611	regulation of cardiac muscle hypertrophy	BP
1	2	3.32077599163	-	9.76e-02	GO:0021681	cerebellar granular layer development	BP
1	2	3.32077599163	-	9.76e-02	GO:0045728	respiratory burst after phagocytosis	BP
1	2	3.32077599163	-	9.76e-02	GO:0060595	fibroblast growth factor receptor signaling pathway involved in mammary gland specification	BP
1	2	3.32077599163	-	9.76e-02	GO:0060599	lateral sprouting involved in mammary gland duct morphogenesis	BP
1	2	3.32077599163	-	9.76e-02	GO:0060454	positive regulation of gastric acid secretion	BP
1	2	3.32077599163	-	9.76e-02	GO:0032071	regulation of endodeoxyribonuclease activity	BP
1	2	3.32077599163	-	9.76e-02	GO:0045819	positive regulation of glycogen catabolic process	BP
1	2	3.32077599163	-	9.76e-02	GO:0061035	regulation of cartilage development	BP
1	2	3.32077599163	-	9.76e-02	GO:0061032	visceral serous pericardium development	BP
1	2	3.32077599163	-	9.76e-02	GO:0009785	blue light signaling pathway	BP
1	2	3.32077599163	-	9.76e-02	GO:1902532	negative regulation of intracellular signal transduction	BP
1	2	3.32077599163	-	9.76e-02	GO:0032509	endosome transport via multivesicular body sorting pathway	BP
1	2	3.32077599163	-	9.76e-02	GO:0071389	cellular response to mineralocorticoid stimulus	BP
1	2	3.32077599163	-	9.76e-02	GO:0060557	positive regulation of vitamin D biosynthetic process	BP
1	2	3.32077599163	-	9.76e-02	GO:1900275	negative regulation of phospholipase C activity	BP
1	2	3.32077599163	-	9.76e-02	GO:0070489	T cell aggregation	BP
1	2	3.32077599163	-	9.76e-02	GO:0044236	multicellular organism metabolic process	BP
1	2	3.32077599163	-	9.76e-02	GO:2000402	negative regulation of lymphocyte migration	BP
1	2	3.32077599163	-	9.76e-02	GO:0032959	inositol trisphosphate biosynthetic process	BP
1	2	3.32077599163	-	9.76e-02	GO:0023035	CD40 signaling pathway	BP
1	2	3.32077599163	-	9.76e-02	GO:0097107	postsynaptic density assembly	BP
1	2	3.32077599163	-	9.76e-02	GO:0002283	neutrophil activation involved in immune response	BP
1	2	3.32077599163	-	9.76e-02	GO:0086021	SA node cell to atrial cardiac muscle cell communication by electrical coupling	BP
1	2	3.32077599163	-	9.76e-02	GO:0006116	NADH oxidation	BP
1	2	3.32077599163	-	9.76e-02	GO:0032912	negative regulation of transforming growth factor beta2 production	BP
1	2	3.32077599163	-	9.76e-02	GO:0031393	negative regulation of prostaglandin biosynthetic process	BP
1	2	3.32077599163	-	9.76e-02	GO:0060915	mesenchymal cell differentiation involved in lung development	BP
1	2	3.32077599163	-	9.76e-02	GO:0032425	positive regulation of mismatch repair	BP
1	2	3.32077599163	-	9.76e-02	GO:1901374	acetate ester transport	BP
1	2	3.32077599163	-	9.76e-02	GO:0030862	positive regulation of polarized epithelial cell differentiation	BP
1	2	3.32077599163	-	9.76e-02	GO:0010934	macrophage cytokine production	BP
1	2	3.32077599163	-	9.76e-02	GO:0046605	regulation of centrosome cycle	BP
1	2	3.32077599163	-	9.76e-02	GO:0048069	eye pigmentation	BP
1	2	3.32077599163	-	9.76e-02	GO:0072054	renal outer medulla development	BP
1	2	3.32077599163	-	9.76e-02	GO:0019087	transformation of host cell by virus	BP
1	2	3.32077599163	-	9.76e-02	GO:0071624	positive regulation of granulocyte chemotaxis	BP
1	2	3.32077599163	-	9.76e-02	GO:0003220	left ventricular cardiac muscle tissue morphogenesis	BP
1	2	3.32077599163	-	9.76e-02	GO:0099553	trans-synaptic signaling by endocannabinoid, modulating synaptic transmission	BP
1	2	3.32077599163	-	9.76e-02	GO:0072604	interleukin-6 secretion	BP
1	2	3.32077599163	-	9.76e-02	GO:0090045	positive regulation of deacetylase activity	BP
1	2	3.32077599163	-	9.76e-02	GO:0019049	evasion or tolerance of host defenses by virus	BP
1	2	3.32077599163	-	9.76e-02	GO:1903033	positive regulation of microtubule plus-end binding	BP
1	2	3.32077599163	-	9.76e-02	GO:0021633	optic nerve structural organization	BP
1	2	3.32077599163	-	9.76e-02	GO:0007057	spindle assembly involved in female meiosis I	BP
1	2	3.32077599163	-	9.76e-02	GO:0061104	adrenal chromaffin cell differentiation	BP
1	2	3.32077599163	-	9.76e-02	GO:0044334	canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition	BP
1	2	3.32077599163	-	9.76e-02	GO:0021849	neuroblast division in subventricular zone	BP
1	2	3.32077599163	-	9.76e-02	GO:2001045	negative regulation of integrin-mediated signaling pathway	BP
1	2	3.32077599163	-	9.76e-02	GO:0044860	protein localization to plasma membrane raft	BP
1	2	3.32077599163	-	9.76e-02	GO:2000594	positive regulation of metanephric DCT cell differentiation	BP
1	2	3.32077599163	-	9.76e-02	GO:0030997	regulation of centriole-centriole cohesion	BP
1	2	3.32077599163	-	9.76e-02	GO:0006542	glutamine biosynthetic process	BP
1	2	3.32077599163	-	9.76e-02	GO:0060443	mammary gland morphogenesis	BP
1	2	3.32077599163	-	9.76e-02	GO:0032741	positive regulation of interleukin-18 production	BP
1	2	3.32077599163	-	9.76e-02	GO:1904049	negative regulation of spontaneous neurotransmitter secretion	BP
1	2	3.32077599163	-	9.76e-02	GO:0015847	putrescine transport	BP
1	2	3.32077599163	-	9.76e-02	GO:0002673	regulation of acute inflammatory response	BP
1	2	3.32077599163	-	9.76e-02	GO:0048145	regulation of fibroblast proliferation	BP
1	2	3.32077599163	-	9.76e-02	GO:1901558	response to metformin	BP
1	2	3.32077599163	-	9.76e-02	GO:0061709	reticulophagy	BP
1	2	3.32077599163	-	9.76e-02	GO:0072305	negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis	BP
1	2	3.32077599163	-	9.76e-02	GO:0090737	telomere maintenance via telomere trimming	BP
1	2	3.32077599163	-	9.76e-02	GO:0003064	regulation of heart rate by hormone	BP
1	2	3.32077599163	-	9.76e-02	GO:1990264	peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity	BP
1	2	3.32077599163	-	9.76e-02	GO:0060032	notochord regression	BP
1	2	3.32077599163	-	9.76e-02	GO:0010643	cell communication by chemical coupling	BP
1	2	3.32077599163	-	9.76e-02	GO:2000041	negative regulation of planar cell polarity pathway involved in axis elongation	BP
1	2	3.32077599163	-	9.76e-02	GO:0032511	late endosome to vacuole transport via multivesicular body sorting pathway	BP
1	2	3.32077599163	-	9.76e-02	GO:0072738	cellular response to diamide	BP
1	2	3.32077599163	-	9.76e-02	GO:0045213	neurotransmitter receptor metabolic process	BP
1	2	3.32077599163	-	9.76e-02	GO:0033032	regulation of myeloid cell apoptotic process	BP
1	2	3.32077599163	-	9.76e-02	GO:0002431	Fc receptor mediated stimulatory signaling pathway	BP
1	2	3.32077599163	-	9.76e-02	GO:0032490	detection of molecule of bacterial origin	BP
1	2	3.32077599163	-	9.76e-02	GO:0036493	positive regulation of translation in response to endoplasmic reticulum stress	BP
1	2	3.32077599163	-	9.76e-02	GO:0045401	positive regulation of interleukin-3 biosynthetic process	BP
1	2	3.32077599163	-	9.76e-02	GO:1904782	negative regulation of NMDA glutamate receptor activity	BP
1	2	3.32077599163	-	9.76e-02	GO:0060502	epithelial cell proliferation involved in lung morphogenesis	BP
1	2	3.32077599163	-	9.76e-02	GO:0042991	transcription factor import into nucleus	BP
1	2	3.32077599163	-	9.76e-02	GO:0055025	positive regulation of cardiac muscle tissue development	BP
1	2	3.32077599163	-	9.76e-02	GO:0051252	regulation of RNA metabolic process	BP
1	2	3.32077599163	-	9.76e-02	GO:0003404	optic vesicle morphogenesis	BP
1	2	3.32077599163	-	9.76e-02	GO:0048710	regulation of astrocyte differentiation	BP
1	2	3.32077599163	-	9.76e-02	GO:0070252	actin-mediated cell contraction	BP
1	2	3.32077599163	-	9.76e-02	GO:2000620	positive regulation of histone H4-K16 acetylation	BP
1	2	3.32077599163	-	9.76e-02	GO:0035441	cell migration involved in vasculogenesis	BP
1	2	3.32077599163	-	9.76e-02	GO:0003193	pulmonary valve formation	BP
1	2	3.32077599163	-	9.76e-02	GO:0060125	negative regulation of growth hormone secretion	BP
1	2	3.32077599163	-	9.76e-02	GO:0002316	follicular B cell differentiation	BP
1	2	3.32077599163	-	9.76e-02	GO:0046619	optic placode formation involved in camera-type eye formation	BP
1	2	3.32077599163	-	9.76e-02	GO:0090071	negative regulation of ribosome biogenesis	BP
1	2	3.32077599163	-	9.76e-02	GO:0035947	regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter	BP
1	2	3.32077599163	-	9.76e-02	GO:0072053	renal inner medulla development	BP
1	2	3.32077599163	-	9.76e-02	GO:0001300	chronological cell aging	BP
1	2	3.32077599163	-	9.76e-02	GO:2000506	negative regulation of energy homeostasis	BP
1	2	3.32077599163	-	9.76e-02	GO:0061153	trachea gland development	BP
1	2	3.32077599163	-	9.76e-02	GO:0021873	forebrain neuroblast division	BP
1	2	3.32077599163	-	9.76e-02	GO:0061302	smooth muscle cell-matrix adhesion	BP
1	2	3.32077599163	-	9.76e-02	GO:0003156	regulation of animal organ formation	BP
1	2	3.32077599163	-	9.76e-02	GO:2001076	positive regulation of metanephric ureteric bud development	BP
1	2	3.32077599163	-	9.76e-02	GO:2000098	negative regulation of smooth muscle cell-matrix adhesion	BP
1	2	3.32077599163	-	9.76e-02	GO:0071670	smooth muscle cell chemotaxis	BP
1	2	3.32077599163	-	9.76e-02	GO:2000397	positive regulation of ubiquitin-dependent endocytosis	BP
1	2	3.32077599163	-	9.76e-02	GO:0060434	bronchus morphogenesis	BP
1	2	3.32077599163	-	9.76e-02	GO:0002643	regulation of tolerance induction	BP
1	2	3.32077599163	-	9.76e-02	GO:0035802	adrenal cortex formation	BP
1	2	3.32077599163	-	9.76e-02	GO:0002866	positive regulation of acute inflammatory response to antigenic stimulus	BP
1	2	3.32077599163	-	9.76e-02	GO:0001805	positive regulation of type III hypersensitivity	BP
1	2	3.32077599163	-	9.76e-02	GO:0070668	positive regulation of mast cell proliferation	BP
1	2	3.32077599163	-	9.76e-02	GO:1904059	regulation of locomotor rhythm	BP
1	2	3.32077599163	-	9.76e-02	GO:1900215	negative regulation of apoptotic process involved in metanephric collecting duct development	BP
1	2	3.32077599163	-	9.76e-02	GO:1900218	negative regulation of apoptotic process involved in metanephric nephron tubule development	BP
1	2	3.32077599163	-	9.76e-02	GO:0007525	somatic muscle development	BP
1	2	3.32077599163	-	9.76e-02	GO:0071900	regulation of protein serine/threonine kinase activity	BP
1	2	3.32077599163	-	9.76e-02	GO:2000017	positive regulation of determination of dorsal identity	BP
1	2	3.32077599163	-	9.76e-02	GO:0003057	regulation of the force of heart contraction by chemical signal	BP
1	2	3.32077599163	-	9.76e-02	GO:0019265	glycine biosynthetic process, by transamination of glyoxylate	BP
1	2	3.32077599163	-	9.76e-02	GO:0043506	regulation of JUN kinase activity	BP
1	2	3.32077599163	-	9.76e-02	GO:2000194	regulation of female gonad development	BP
1	2	3.32077599163	-	9.76e-02	GO:0051548	negative regulation of keratinocyte migration	BP
1	2	3.32077599163	-	9.76e-02	GO:0042496	detection of diacyl bacterial lipopeptide	BP
1	2	3.32077599163	-	9.76e-02	GO:0042495	detection of triacyl bacterial lipopeptide	BP
1	2	3.32077599163	-	9.76e-02	GO:1902728	positive regulation of growth factor dependent skeletal muscle satellite cell proliferation	BP
1	2	3.32077599163	-	9.76e-02	GO:1902722	positive regulation of prolactin secretion	BP
1	2	3.32077599163	-	9.76e-02	GO:2000426	negative regulation of apoptotic cell clearance	BP
1	2	3.32077599163	-	9.76e-02	GO:0033003	regulation of mast cell activation	BP
1	2	3.32077599163	-	9.76e-02	GO:0033007	negative regulation of mast cell activation involved in immune response	BP
1	2	3.32077599163	-	9.76e-02	GO:0035922	foramen ovale closure	BP
1	2	3.32077599163	-	9.76e-02	GO:0043313	regulation of neutrophil degranulation	BP
1	2	3.32077599163	-	9.76e-02	GO:0097324	melanocyte migration	BP
1	2	3.32077599163	-	9.76e-02	GO:0035566	regulation of metanephros size	BP
1	2	3.32077599163	-	9.76e-02	GO:0003430	growth plate cartilage chondrocyte growth	BP
1	2	3.32077599163	-	9.76e-02	GO:0042732	D-xylose metabolic process	BP
1	2	3.32077599163	-	9.76e-02	GO:0060390	regulation of SMAD protein import into nucleus	BP
1	2	3.32077599163	-	9.76e-02	GO:0060251	regulation of glial cell proliferation	BP
1	2	3.32077599163	-	9.76e-02	GO:1902202	regulation of hepatocyte growth factor receptor signaling pathway	BP
1	2	3.32077599163	-	9.76e-02	GO:0000720	pyrimidine dimer repair by nucleotide-excision repair	BP
1	2	3.32077599163	-	9.76e-02	GO:2000349	negative regulation of CD40 signaling pathway	BP
1	2	3.32077599163	-	9.76e-02	GO:0061647	histone H3-K9 modification	BP
1	2	3.32077599163	-	9.76e-02	GO:1900195	positive regulation of oocyte maturation	BP
1	2	3.32077599163	-	9.76e-02	GO:1902595	regulation of DNA replication origin binding	BP
1	2	3.32077599163	-	9.76e-02	GO:0042412	taurine biosynthetic process	BP
1	2	3.32077599163	-	9.76e-02	GO:2000309	positive regulation of tumor necrosis factor (ligand) superfamily member 11 production	BP
1	2	3.32077599163	-	9.76e-02	GO:0014736	negative regulation of muscle atrophy	BP
1	2	3.32077599163	-	9.76e-02	GO:1990791	dorsal root ganglion development	BP
1	2	3.32077599163	-	9.76e-02	GO:0060152	microtubule-based peroxisome localization	BP
1	2	3.32077599163	-	9.76e-02	GO:0002302	CD8-positive, alpha-beta T cell differentiation involved in immune response	BP
1	2	3.32077599163	-	9.76e-02	GO:0050867	positive regulation of cell activation	BP
1	2	3.32077599163	-	9.76e-02	GO:0043970	histone H3-K9 acetylation	BP
1	2	3.32077599163	-	9.76e-02	GO:2000538	positive regulation of B cell chemotaxis	BP
1	2	3.32077599163	-	9.76e-02	GO:0033484	nitric oxide homeostasis	BP
1	2	3.32077599163	-	9.76e-02	GO:1990619	histone H3-K9 deacetylation	BP
1	2	3.32077599163	-	9.76e-02	GO:1901255	nucleotide-excision repair involved in interstrand cross-link repair	BP
1	2	3.32077599163	-	9.76e-02	GO:1904021	negative regulation of G-protein coupled receptor internalization	BP
1	2	3.32077599163	-	9.76e-02	GO:0043006	activation of phospholipase A2 activity by calcium-mediated signaling	BP
1	2	3.32077599163	-	9.76e-02	GO:0031204	posttranslational protein targeting to membrane, translocation	BP
1	2	3.32077599163	-	9.76e-02	GO:0032834	positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response	BP
1	2	3.32077599163	-	9.76e-02	GO:0005997	xylulose metabolic process	BP
1	2	3.32077599163	-	9.76e-02	GO:0002522	leukocyte migration involved in immune response	BP
1	2	3.32077599163	-	9.76e-02	GO:0032762	mast cell cytokine production	BP
1	2	3.32077599163	-	9.76e-02	GO:0061723	glycophagy	BP
1	2	3.32077599163	-	9.76e-02	GO:0039003	pronephric field specification	BP
1	2	3.32077599163	-	9.76e-02	GO:0031247	actin rod assembly	BP
1	2	3.32077599163	-	9.76e-02	GO:0048638	regulation of developmental growth	BP
1	2	3.32077599163	-	9.76e-02	GO:0060615	mammary gland bud formation	BP
1	2	3.32077599163	-	9.76e-02	GO:0019516	lactate oxidation	BP
1	2	3.32077599163	-	9.76e-02	GO:0035022	positive regulation of Rac protein signal transduction	BP
1	2	3.32077599163	-	9.76e-02	GO:1905477	positive regulation of protein localization to membrane	BP
1	2	3.32077599163	-	9.76e-02	GO:0014057	positive regulation of acetylcholine secretion, neurotransmission	BP
1	2	3.32077599163	-	9.76e-02	GO:0044029	hypomethylation of CpG island	BP
1	2	3.32077599163	-	9.76e-02	GO:2000681	negative regulation of rubidium ion transport	BP
1	2	3.32077599163	-	9.76e-02	GO:2000473	positive regulation of hematopoietic stem cell migration	BP
1	2	3.32077599163	-	9.76e-02	GO:2000474	regulation of opioid receptor signaling pathway	BP
1	2	3.32077599163	-	9.76e-02	GO:0006043	glucosamine catabolic process	BP
1	2	3.32077599163	-	9.76e-02	GO:0072134	nephrogenic mesenchyme morphogenesis	BP
1	2	3.32077599163	-	9.76e-02	GO:0003365	establishment of cell polarity involved in ameboidal cell migration	BP
1	2	3.32077599163	-	9.76e-02	GO:0009631	cold acclimation	BP
1	2	3.32077599163	-	9.76e-02	GO:0032943	mononuclear cell proliferation	BP
1	2	3.32077599163	-	9.76e-02	GO:0031328	positive regulation of cellular biosynthetic process	BP
1	2	3.32077599163	-	9.76e-02	GO:0072179	nephric duct formation	BP
1	2	3.32077599163	-	9.76e-02	GO:0021897	forebrain astrocyte development	BP
1	2	3.32077599163	-	9.76e-02	GO:0097111	endoplasmic reticulum-Golgi intermediate compartment organization	BP
1	2	3.32077599163	-	9.76e-02	GO:0010966	regulation of phosphate transport	BP
1	2	3.32077599163	-	9.76e-02	GO:0002717	positive regulation of natural killer cell mediated immunity	BP
1	2	3.32077599163	-	9.76e-02	GO:0038194	thyroid-stimulating hormone signaling pathway	BP
1	2	3.32077599163	-	9.76e-02	GO:0060529	squamous basal epithelial stem cell differentiation involved in prostate gland acinus development	BP
1	2	3.32077599163	-	9.76e-02	GO:0072033	renal vesicle formation	BP
8	16	3.32077599163	-	1.78e-07	GO:0005159	insulin-like growth factor receptor binding	MF
3	6	3.32077599163	-	2.23e-03	GO:0043559	insulin binding	MF
3	6	3.32077599163	-	2.23e-03	GO:0071253	connexin binding	MF
2	4	3.32077599163	-	2.50e-03	GO:0004515	nicotinate-nucleotide adenylyltransferase activity	MF
2	4	3.32077599163	-	7.25e-03	GO:0001032	RNA polymerase III type 3 promoter DNA binding	MF
2	4	3.32077599163	-	1.40e-02	GO:0050815	phosphoserine residue binding	MF
2	4	3.32077599163	-	1.40e-02	GO:0038085	vascular endothelial growth factor binding	MF
1	2	3.32077599163	-	5.00e-02	GO:0051377	mannose-ethanolamine phosphotransferase activity	MF
1	2	3.32077599163	-	5.00e-02	GO:0017098	sulfonylurea receptor binding	MF
1	2	3.32077599163	-	5.00e-02	GO:0005026	transforming growth factor beta receptor activity, type II	MF
1	2	3.32077599163	-	5.00e-02	GO:0002134	UTP binding	MF
1	2	3.32077599163	-	5.00e-02	GO:0003920	GMP reductase activity	MF
1	2	3.32077599163	-	5.00e-02	GO:0016857	racemase and epimerase activity, acting on carbohydrates and derivatives	MF
1	2	3.32077599163	-	5.00e-02	GO:1903763	gap junction channel activity involved in cell communication by electrical coupling	MF
1	2	3.32077599163	-	5.00e-02	GO:0004458	D-lactate dehydrogenase (cytochrome) activity	MF
1	2	3.32077599163	-	5.00e-02	GO:0045509	interleukin-27 receptor activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0004996	thyroid-stimulating hormone receptor activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0004991	parathyroid hormone receptor activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0034736	cholesterol O-acyltransferase activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0010698	acetyltransferase activator activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0030366	molybdopterin synthase activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0004352	glutamate dehydrogenase (NAD+) activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0030984	kininogen binding	MF
1	2	3.32077599163	-	9.76e-02	GO:0061733	peptide-lysine-N-acetyltransferase activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0033883	pyridoxal phosphatase activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0052642	lysophosphatidic acid phosphatase activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0051990	(R)-2-hydroxyglutarate dehydrogenase activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0008781	N-acylneuraminate cytidylyltransferase activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0050436	microfibril binding	MF
1	2	3.32077599163	-	9.76e-02	GO:0052815	medium-chain acyl-CoA hydrolase activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0071074	eukaryotic initiation factor eIF2 binding	MF
1	2	3.32077599163	-	9.76e-02	GO:0016410	N-acyltransferase activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0000701	purine-specific mismatch base pair DNA N-glycosylase activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0030109	HLA-B specific inhibitory MHC class I receptor activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0086020	gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling	MF
1	2	3.32077599163	-	9.76e-02	GO:0019981	interleukin-6 binding	MF
1	2	3.32077599163	-	9.76e-02	GO:0051717	inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0004906	interferon-gamma receptor activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0048101	calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0019002	GMP binding	MF
1	2	3.32077599163	-	9.76e-02	GO:0004053	arginase activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0034212	peptide N-acetyltransferase activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0004915	interleukin-6 receptor activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0005163	nerve growth factor receptor binding	MF
1	2	3.32077599163	-	9.76e-02	GO:0015489	putrescine transmembrane transporter activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0001134	transcription factor activity, transcription factor recruiting	MF
1	2	3.32077599163	-	9.76e-02	GO:0042610	CD8 receptor binding	MF
1	2	3.32077599163	-	9.76e-02	GO:0086077	gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling	MF
1	2	3.32077599163	-	9.76e-02	GO:0034988	Fc-gamma receptor I complex binding	MF
1	2	3.32077599163	-	9.76e-02	GO:0097003	adipokinetic hormone receptor activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0005006	epidermal growth factor-activated receptor activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0035014	phosphatidylinositol 3-kinase regulator activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0005042	netrin receptor activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0009882	blue light photoreceptor activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0004356	glutamate-ammonia ligase activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0004353	glutamate dehydrogenase [NAD(P)+] activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0046969	NAD-dependent histone deacetylase activity (H3-K9 specific)	MF
1	2	3.32077599163	-	9.76e-02	GO:0031729	CCR4 chemokine receptor binding	MF
1	2	3.32077599163	-	9.76e-02	GO:0004923	leukemia inhibitory factor receptor activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0016780	phosphotransferase activity, for other substituted phosphate groups	MF
1	2	3.32077599163	-	9.76e-02	GO:0038062	protein tyrosine kinase collagen receptor activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0097199	cysteine-type endopeptidase activity involved in apoptotic signaling pathway	MF
1	2	3.32077599163	-	9.76e-02	GO:0008160	protein tyrosine phosphatase activator activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0051800	phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0004342	glucosamine-6-phosphate deaminase activity	MF
14	29	3.27014991856	-	1.13e-11	GO:0043552	positive regulation of phosphatidylinositol 3-kinase activity	BP
42	88	3.25366179577	-	8.48e-33	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	BP
27	57	3.24277347963	-	2.51e-21	GO:0005070	SH3/SH2 adaptor activity	MF
7	15	3.22124031808	-	3.45e-06	GO:0031929	TOR signaling	BP
7	15	3.22124031808	-	3.45e-06	GO:0048011	neurotrophin TRK receptor signaling pathway	BP
5	11	3.18327246788	-	6.31e-05	GO:0007260	tyrosine phosphorylation of STAT protein	BP
30	66	3.18327246788	-	2.77e-23	GO:0014068	positive regulation of phosphatidylinositol 3-kinase signaling	BP
4	9	3.15085099019	-	1.93e-04	GO:0010907	positive regulation of glucose metabolic process	BP
4	9	3.15085099019	-	3.70e-04	GO:0070886	positive regulation of calcineurin-NFAT signaling cascade	BP
25	57	3.13174216724	-	4.77e-19	GO:0007173	epidermal growth factor receptor signaling pathway	BP
6	14	3.0983835703	-	5.72e-06	GO:0022408	negative regulation of cell-cell adhesion	BP
6	14	3.0983835703	-	1.95e-05	GO:0001678	cellular glucose homeostasis	BP
3	7	3.0983835703	-	1.16e-03	GO:0010518	positive regulation of phospholipase activity	BP
3	7	3.0983835703	-	3.75e-03	GO:2000171	negative regulation of dendrite development	BP
3	7	3.0983835703	-	3.75e-03	GO:0034141	positive regulation of toll-like receptor 3 signaling pathway	BP
3	7	3.0983835703	-	3.75e-03	GO:2000210	positive regulation of anoikis	BP
3	7	3.0983835703	-	3.75e-03	GO:0030388	fructose 1,6-bisphosphate metabolic process	BP
3	7	3.0983835703	-	3.75e-03	GO:0044321	response to leptin	BP
3	7	3.0983835703	-	3.75e-03	GO:0010742	macrophage derived foam cell differentiation	BP
3	7	3.0983835703	-	3.75e-03	GO:0050764	regulation of phagocytosis	BP
5	12	3.0577415858	-	1.11e-04	GO:0031669	cellular response to nutrient levels	BP
5	12	3.0577415858	-	1.82e-04	GO:0048012	hepatocyte growth factor receptor signaling pathway	BP
10	24	3.0577415858	-	9.55e-08	GO:0030295	protein kinase activator activity	MF
27	66	3.03126937444	-	4.92e-20	GO:0046934	phosphatidylinositol-4,5-bisphosphate 3-kinase activity	MF
44	108	3.02532010811	-	1.87e-31	GO:0048015	phosphatidylinositol-mediated signaling	BP
6	15	2.99884789674	-	3.27e-05	GO:0005161	platelet-derived growth factor receptor binding	MF
4	10	2.99884789674	-	6.40e-04	GO:0050855	regulation of B cell receptor signaling pathway	BP
2	5	2.99884789674	-	7.25e-03	GO:0038203	TORC2 signaling	BP
2	5	2.99884789674	-	7.25e-03	GO:0003105	negative regulation of glomerular filtration	BP
2	5	2.99884789674	-	7.25e-03	GO:0006144	purine nucleobase metabolic process	BP
2	5	2.99884789674	-	7.25e-03	GO:0021879	forebrain neuron differentiation	BP
2	5	2.99884789674	-	1.40e-02	GO:0060956	endocardial cell differentiation	BP
2	5	2.99884789674	-	1.40e-02	GO:0019217	regulation of fatty acid metabolic process	BP
2	5	2.99884789674	-	1.40e-02	GO:0035630	bone mineralization involved in bone maturation	BP
2	5	2.99884789674	-	1.40e-02	GO:0010632	regulation of epithelial cell migration	BP
2	5	2.99884789674	-	1.40e-02	GO:0007406	negative regulation of neuroblast proliferation	BP
2	5	2.99884789674	-	1.40e-02	GO:0072207	metanephric epithelium development	BP
2	5	2.99884789674	-	1.40e-02	GO:0072284	metanephric S-shaped body morphogenesis	BP
2	5	2.99884789674	-	2.26e-02	GO:0010715	regulation of extracellular matrix disassembly	BP
2	5	2.99884789674	-	2.26e-02	GO:0034134	toll-like receptor 2 signaling pathway	BP
2	5	2.99884789674	-	2.26e-02	GO:0016202	regulation of striated muscle tissue development	BP
2	5	2.99884789674	-	2.26e-02	GO:0045063	T-helper 1 cell differentiation	BP
2	5	2.99884789674	-	2.26e-02	GO:0034109	homotypic cell-cell adhesion	BP
2	5	2.99884789674	-	2.26e-02	GO:0050847	progesterone receptor signaling pathway	BP
2	5	2.99884789674	-	2.26e-02	GO:0038084	vascular endothelial growth factor signaling pathway	BP
2	5	2.99884789674	-	2.26e-02	GO:1903898	negative regulation of PERK-mediated unfolded protein response	BP
2	5	2.99884789674	-	2.26e-02	GO:0038007	netrin-activated signaling pathway	BP
2	5	2.99884789674	-	2.26e-02	GO:0055062	phosphate ion homeostasis	BP
2	5	2.99884789674	-	2.26e-02	GO:0048170	positive regulation of long-term neuronal synaptic plasticity	BP
2	5	2.99884789674	-	2.26e-02	GO:0060603	mammary gland duct morphogenesis	BP
2	5	2.99884789674	-	2.26e-02	GO:0002821	positive regulation of adaptive immune response	BP
2	5	2.99884789674	-	2.26e-02	GO:0032713	negative regulation of interleukin-4 production	BP
2	5	2.99884789674	-	2.26e-02	GO:0060762	regulation of branching involved in mammary gland duct morphogenesis	BP
2	5	2.99884789674	-	2.26e-02	GO:0090330	regulation of platelet aggregation	BP
2	5	2.99884789674	-	2.26e-02	GO:0006896	Golgi to vacuole transport	BP
2	5	2.99884789674	-	2.26e-02	GO:0048639	positive regulation of developmental growth	BP
2	5	2.99884789674	-	2.26e-02	GO:0031802	type 5 metabotropic glutamate receptor binding	MF
2	5	2.99884789674	-	2.26e-02	GO:0035004	phosphatidylinositol 3-kinase activity	MF
2	5	2.99884789674	-	2.26e-02	GO:0035325	Toll-like receptor binding	MF
2	5	2.99884789674	-	2.26e-02	GO:0030284	estrogen receptor activity	MF
11	28	2.97285268821	-	4.47e-08	GO:0046875	ephrin receptor binding	MF
7	18	2.95820591225	-	9.54e-06	GO:0046579	positive regulation of Ras protein signal transduction	BP
5	13	2.94226436838	-	3.29e-05	GO:0043568	positive regulation of insulin-like growth factor receptor signaling pathway	BP
5	13	2.94226436838	-	1.11e-04	GO:0046628	positive regulation of insulin receptor signaling pathway	BP
5	13	2.94226436838	-	2.84e-04	GO:2000573	positive regulation of DNA biosynthetic process	BP
3	8	2.90573849235	-	3.75e-03	GO:0072075	metanephric mesenchyme development	BP
3	8	2.90573849235	-	3.75e-03	GO:0033629	negative regulation of cell adhesion mediated by integrin	BP
3	8	2.90573849235	-	3.75e-03	GO:0070102	interleukin-6-mediated signaling pathway	BP
3	8	2.90573849235	-	3.75e-03	GO:0007167	enzyme linked receptor protein signaling pathway	BP
3	8	2.90573849235	-	3.75e-03	GO:0016264	gap junction assembly	BP
3	8	2.90573849235	-	3.75e-03	GO:0007183	SMAD protein complex assembly	BP
3	8	2.90573849235	-	3.75e-03	GO:1902715	positive regulation of interferon-gamma secretion	BP
3	8	2.90573849235	-	5.78e-03	GO:0070307	lens fiber cell development	BP
3	8	2.90573849235	-	5.78e-03	GO:0010544	negative regulation of platelet activation	BP
3	8	2.90573849235	-	5.78e-03	GO:2000587	negative regulation of platelet-derived growth factor receptor-beta signaling pathway	BP
3	8	2.90573849235	-	5.78e-03	GO:1903800	positive regulation of production of miRNAs involved in gene silencing by miRNA	BP
3	8	2.90573849235	-	5.78e-03	GO:0014909	smooth muscle cell migration	BP
3	8	2.90573849235	-	5.78e-03	GO:2000774	positive regulation of cellular senescence	BP
3	8	2.90573849235	-	5.78e-03	GO:0004726	non-membrane spanning protein tyrosine phosphatase activity	MF
3	8	2.90573849235	-	5.78e-03	GO:0031995	insulin-like growth factor II binding	MF
11	30	2.87331701466	-	6.89e-08	GO:0046627	negative regulation of insulin receptor signaling pathway	BP
4	11	2.86134437299	-	1.02e-03	GO:0001944	vasculature development	BP
4	11	2.86134437299	-	1.02e-03	GO:0051489	regulation of filopodium assembly	BP
4	11	2.86134437299	-	1.02e-03	GO:0045945	positive regulation of transcription from RNA polymerase III promoter	BP
4	11	2.86134437299	-	1.02e-03	GO:0045792	negative regulation of cell size	BP
4	11	2.86134437299	-	1.55e-03	GO:0033628	regulation of cell adhesion mediated by integrin	BP
4	11	2.86134437299	-	1.55e-03	GO:0043276	anoikis	BP
4	11	2.86134437299	-	1.55e-03	GO:0045667	regulation of osteoblast differentiation	BP
4	11	2.86134437299	-	1.55e-03	GO:0006853	carnitine shuttle	BP
4	11	2.86134437299	-	1.55e-03	GO:0070411	I-SMAD binding	MF
37	102	2.85780401529	-	6.01e-24	GO:0038111	interleukin-7-mediated signaling pathway	BP
22	61	2.84947027271	-	1.16e-14	GO:0009967	positive regulation of signal transduction	BP
44	122	2.84947027271	-	7.07e-28	GO:0004713	protein tyrosine kinase activity	MF
10	28	2.83534916446	-	2.36e-07	GO:0048008	platelet-derived growth factor receptor signaling pathway	BP
5	14	2.83534916446	-	1.82e-04	GO:2001275	positive regulation of glucose import in response to insulin stimulus	BP
11	31	2.82601129988	-	2.84e-08	GO:0014065	phosphatidylinositol 3-kinase signaling	BP
29	82	2.82120498214	-	3.97e-19	GO:0014066	regulation of phosphatidylinositol 3-kinase signaling	BP
6	17	2.8182756511	-	7.99e-05	GO:2000249	regulation of actin cytoskeleton reorganization	BP
9	26	2.79026127493	-	8.10e-07	GO:0070372	regulation of ERK1 and ERK2 cascade	BP
5	15	2.73581349091	-	4.24e-04	GO:2000251	positive regulation of actin cytoskeleton reorganization	BP
5	15	2.73581349091	-	4.24e-04	GO:0060397	JAK-STAT cascade involved in growth hormone signaling pathway	BP
4	12	2.73581349091	-	1.02e-03	GO:0060391	positive regulation of SMAD protein import into nucleus	BP
4	12	2.73581349091	-	1.02e-03	GO:0007600	sensory perception	BP
4	12	2.73581349091	-	1.55e-03	GO:2000505	regulation of energy homeostasis	BP
4	12	2.73581349091	-	2.23e-03	GO:0033160	positive regulation of protein import into nucleus, translocation	BP
4	12	2.73581349091	-	2.23e-03	GO:0050765	negative regulation of phagocytosis	BP
2	6	2.73581349091	-	7.25e-03	GO:0048856	anatomical structure development	BP
2	6	2.73581349091	-	1.40e-02	GO:0009913	epidermal cell differentiation	BP
2	6	2.73581349091	-	1.40e-02	GO:0061000	negative regulation of dendritic spine development	BP
2	6	2.73581349091	-	2.26e-02	GO:0090344	negative regulation of cell aging	BP
2	6	2.73581349091	-	2.26e-02	GO:0003179	heart valve morphogenesis	BP
2	6	2.73581349091	-	2.26e-02	GO:0061469	regulation of type B pancreatic cell proliferation	BP
2	6	2.73581349091	-	2.26e-02	GO:0050707	regulation of cytokine secretion	BP
2	6	2.73581349091	-	2.26e-02	GO:0046850	regulation of bone remodeling	BP
2	6	2.73581349091	-	3.28e-02	GO:0046825	regulation of protein export from nucleus	BP
2	6	2.73581349091	-	3.28e-02	GO:0046632	alpha-beta T cell differentiation	BP
2	6	2.73581349091	-	3.28e-02	GO:0031584	activation of phospholipase D activity	BP
2	6	2.73581349091	-	3.28e-02	GO:0014910	regulation of smooth muscle cell migration	BP
2	6	2.73581349091	-	3.28e-02	GO:0043567	regulation of insulin-like growth factor receptor signaling pathway	BP
2	6	2.73581349091	-	3.28e-02	GO:1900272	negative regulation of long-term synaptic potentiation	BP
2	6	2.73581349091	-	3.28e-02	GO:1904798	positive regulation of core promoter binding	BP
2	6	2.73581349091	-	3.28e-02	GO:0035900	response to isolation stress	BP
2	6	2.73581349091	-	3.28e-02	GO:0036006	cellular response to macrophage colony-stimulating factor stimulus	BP
2	6	2.73581349091	-	3.28e-02	GO:0051902	negative regulation of mitochondrial depolarization	BP
2	6	2.73581349091	-	3.28e-02	GO:0003309	type B pancreatic cell differentiation	BP
2	6	2.73581349091	-	3.28e-02	GO:0032025	response to cobalt ion	BP
2	6	2.73581349091	-	3.28e-02	GO:0045639	positive regulation of myeloid cell differentiation	BP
2	6	2.73581349091	-	3.28e-02	GO:0006101	citrate metabolic process	BP
2	6	2.73581349091	-	3.28e-02	GO:0051353	positive regulation of oxidoreductase activity	BP
2	6	2.73581349091	-	3.28e-02	GO:1901016	regulation of potassium ion transmembrane transporter activity	BP
2	6	2.73581349091	-	3.28e-02	GO:0007182	common-partner SMAD protein phosphorylation	BP
2	6	2.73581349091	-	3.28e-02	GO:0007185	transmembrane receptor protein tyrosine phosphatase signaling pathway	BP
2	6	2.73581349091	-	3.28e-02	GO:0051964	negative regulation of synapse assembly	BP
2	6	2.73581349091	-	3.28e-02	GO:0060789	hair follicle placode formation	BP
2	6	2.73581349091	-	3.28e-02	GO:0035020	regulation of Rac protein signal transduction	BP
2	6	2.73581349091	-	3.28e-02	GO:0060561	apoptotic process involved in morphogenesis	BP
2	6	2.73581349091	-	3.28e-02	GO:0007435	salivary gland morphogenesis	BP
2	6	2.73581349091	-	3.28e-02	GO:0060527	prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis	BP
1	3	2.73581349091	-	5.00e-02	GO:0070172	positive regulation of tooth mineralization	BP
1	3	2.73581349091	-	5.00e-02	GO:0042269	regulation of natural killer cell mediated cytotoxicity	BP
1	3	2.73581349091	-	5.00e-02	GO:0038093	Fc receptor signaling pathway	BP
1	3	2.73581349091	-	5.00e-02	GO:0060914	heart formation	BP
1	3	2.73581349091	-	5.00e-02	GO:0034628	'de novo' NAD biosynthetic process from aspartate	BP
1	3	2.73581349091	-	5.00e-02	GO:1905913	negative regulation of calcium ion export from cell	BP
1	3	2.73581349091	-	5.00e-02	GO:0038171	cannabinoid signaling pathway	BP
1	3	2.73581349091	-	5.00e-02	GO:0061044	negative regulation of vascular wound healing	BP
1	3	2.73581349091	-	9.76e-02	GO:0002554	serotonin secretion by platelet	BP
1	3	2.73581349091	-	9.76e-02	GO:1990418	response to insulin-like growth factor stimulus	BP
1	3	2.73581349091	-	9.76e-02	GO:0002374	cytokine secretion involved in immune response	BP
1	3	2.73581349091	-	9.76e-02	GO:0048732	gland development	BP
1	3	2.73581349091	-	9.76e-02	GO:0061368	behavioral response to formalin induced pain	BP
1	3	2.73581349091	-	9.76e-02	GO:1904693	midbrain morphogenesis	BP
1	3	2.73581349091	-	9.76e-02	GO:0060066	oviduct development	BP
1	3	2.73581349091	-	9.76e-02	GO:0032289	central nervous system myelin formation	BP
1	3	2.73581349091	-	9.76e-02	GO:0001828	inner cell mass cellular morphogenesis	BP
1	3	2.73581349091	-	9.76e-02	GO:0045726	positive regulation of integrin biosynthetic process	BP
1	3	2.73581349091	-	9.76e-02	GO:0072278	metanephric comma-shaped body morphogenesis	BP
1	3	2.73581349091	-	9.76e-02	GO:0032732	positive regulation of interleukin-1 production	BP
1	3	2.73581349091	-	9.76e-02	GO:0001781	neutrophil apoptotic process	BP
1	3	2.73581349091	-	9.76e-02	GO:0001787	natural killer cell proliferation	BP
1	3	2.73581349091	-	9.76e-02	GO:0009436	glyoxylate catabolic process	BP
1	3	2.73581349091	-	9.76e-02	GO:0051797	regulation of hair follicle development	BP
1	3	2.73581349091	-	9.76e-02	GO:0044336	canonical Wnt signaling pathway involved in negative regulation of apoptotic process	BP
1	3	2.73581349091	-	9.76e-02	GO:1904000	positive regulation of eating behavior	BP
1	3	2.73581349091	-	9.76e-02	GO:0051490	negative regulation of filopodium assembly	BP
1	3	2.73581349091	-	9.76e-02	GO:0030718	germ-line stem cell population maintenance	BP
1	3	2.73581349091	-	9.76e-02	GO:0035701	hematopoietic stem cell migration	BP
1	3	2.73581349091	-	9.76e-02	GO:0070634	transepithelial ammonium transport	BP
1	3	2.73581349091	-	9.76e-02	GO:0002774	Fc receptor mediated inhibitory signaling pathway	BP
1	3	2.73581349091	-	9.76e-02	GO:1903691	positive regulation of wound healing, spreading of epidermal cells	BP
1	3	2.73581349091	-	9.76e-02	GO:0042997	negative regulation of Golgi to plasma membrane protein transport	BP
1	3	2.73581349091	-	9.76e-02	GO:0007418	ventral midline development	BP
1	3	2.73581349091	-	9.76e-02	GO:0010909	positive regulation of heparan sulfate proteoglycan biosynthetic process	BP
1	3	2.73581349091	-	9.76e-02	GO:0048382	mesendoderm development	BP
1	3	2.73581349091	-	9.76e-02	GO:0051668	localization within membrane	BP
1	3	2.73581349091	-	9.76e-02	GO:0032696	negative regulation of interleukin-13 production	BP
1	3	2.73581349091	-	9.76e-02	GO:0010866	regulation of triglyceride biosynthetic process	BP
1	3	2.73581349091	-	9.76e-02	GO:0048302	regulation of isotype switching to IgG isotypes	BP
1	3	2.73581349091	-	9.76e-02	GO:1900042	positive regulation of interleukin-2 secretion	BP
1	3	2.73581349091	-	9.76e-02	GO:0010823	negative regulation of mitochondrion organization	BP
1	3	2.73581349091	-	9.76e-02	GO:0072350	tricarboxylic acid metabolic process	BP
1	3	2.73581349091	-	9.76e-02	GO:1904349	positive regulation of small intestine smooth muscle contraction	BP
1	3	2.73581349091	-	9.76e-02	GO:0003358	noradrenergic neuron development	BP
1	3	2.73581349091	-	9.76e-02	GO:0019062	virion attachment to host cell	BP
1	3	2.73581349091	-	9.76e-02	GO:0015742	alpha-ketoglutarate transport	BP
1	3	2.73581349091	-	9.76e-02	GO:0035411	catenin import into nucleus	BP
1	3	2.73581349091	-	9.76e-02	GO:0036023	embryonic skeletal limb joint morphogenesis	BP
1	3	2.73581349091	-	9.76e-02	GO:1902617	response to fluoride	BP
1	3	2.73581349091	-	9.76e-02	GO:0061762	CAMKK-AMPK signaling cascade	BP
1	3	2.73581349091	-	9.76e-02	GO:1903215	negative regulation of protein targeting to mitochondrion	BP
1	3	2.73581349091	-	9.76e-02	GO:0043369	CD4-positive or CD8-positive, alpha-beta T cell lineage commitment	BP
1	3	2.73581349091	-	9.76e-02	GO:0071393	cellular response to progesterone stimulus	BP
1	3	2.73581349091	-	9.76e-02	GO:1903445	protein transport from ciliary membrane to plasma membrane	BP
1	3	2.73581349091	-	9.76e-02	GO:2000479	regulation of cAMP-dependent protein kinase activity	BP
1	3	2.73581349091	-	9.76e-02	GO:0072133	metanephric mesenchyme morphogenesis	BP
1	3	2.73581349091	-	9.76e-02	GO:0010454	negative regulation of cell fate commitment	BP
1	3	2.73581349091	-	9.76e-02	GO:0050954	sensory perception of mechanical stimulus	BP
1	3	2.73581349091	-	9.76e-02	GO:1902093	positive regulation of flagellated sperm motility	BP
1	3	2.73581349091	-	9.76e-02	GO:0060523	prostate epithelial cord elongation	BP
1	3	2.73581349091	-	1.43e-01	GO:0033387	putrescine biosynthetic process from ornithine	BP
1	3	2.73581349091	-	1.43e-01	GO:2000819	regulation of nucleotide-excision repair	BP
1	3	2.73581349091	-	1.43e-01	GO:1903984	positive regulation of TRAIL-activated apoptotic signaling pathway	BP
1	3	2.73581349091	-	1.43e-01	GO:0002924	negative regulation of humoral immune response mediated by circulating immunoglobulin	BP
1	3	2.73581349091	-	1.43e-01	GO:0043415	positive regulation of skeletal muscle tissue regeneration	BP
1	3	2.73581349091	-	1.43e-01	GO:0070562	regulation of vitamin D receptor signaling pathway	BP
1	3	2.73581349091	-	1.43e-01	GO:0072125	negative regulation of glomerular mesangial cell proliferation	BP
1	3	2.73581349091	-	1.43e-01	GO:0060923	cardiac muscle cell fate commitment	BP
1	3	2.73581349091	-	1.43e-01	GO:0060492	lung induction	BP
1	3	2.73581349091	-	1.43e-01	GO:0060491	regulation of cell projection assembly	BP
1	3	2.73581349091	-	1.43e-01	GO:0001773	myeloid dendritic cell activation	BP
1	3	2.73581349091	-	1.43e-01	GO:1905098	negative regulation of guanyl-nucleotide exchange factor activity	BP
1	3	2.73581349091	-	1.43e-01	GO:0008218	bioluminescence	BP
1	3	2.73581349091	-	1.43e-01	GO:0035793	positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway	BP
1	3	2.73581349091	-	1.43e-01	GO:0016052	carbohydrate catabolic process	BP
1	3	2.73581349091	-	1.43e-01	GO:0031937	positive regulation of chromatin silencing	BP
1	3	2.73581349091	-	1.43e-01	GO:1900451	positive regulation of glutamate receptor signaling pathway	BP
1	3	2.73581349091	-	1.43e-01	GO:0046209	nitric oxide metabolic process	BP
1	3	2.73581349091	-	1.43e-01	GO:0098904	regulation of AV node cell action potential	BP
1	3	2.73581349091	-	1.43e-01	GO:0098903	regulation of membrane repolarization during action potential	BP
1	3	2.73581349091	-	1.43e-01	GO:0098908	regulation of neuronal action potential	BP
1	3	2.73581349091	-	1.43e-01	GO:0010560	positive regulation of glycoprotein biosynthetic process	BP
1	3	2.73581349091	-	1.43e-01	GO:0015874	norepinephrine transport	BP
1	3	2.73581349091	-	1.43e-01	GO:0014005	microglia development	BP
1	3	2.73581349091	-	1.43e-01	GO:0072331	signal transduction by p53 class mediator	BP
1	3	2.73581349091	-	1.43e-01	GO:0008298	intracellular mRNA localization	BP
1	3	2.73581349091	-	1.43e-01	GO:0030001	metal ion transport	BP
1	3	2.73581349091	-	1.43e-01	GO:0060024	rhythmic synaptic transmission	BP
1	3	2.73581349091	-	1.43e-01	GO:0033590	response to cobalamin	BP
1	3	2.73581349091	-	1.43e-01	GO:1903660	negative regulation of complement-dependent cytotoxicity	BP
1	3	2.73581349091	-	1.43e-01	GO:0060559	positive regulation of calcidiol 1-monooxygenase activity	BP
1	3	2.73581349091	-	1.43e-01	GO:0055096	low-density lipoprotein particle mediated signaling	BP
1	3	2.73581349091	-	1.43e-01	GO:0046320	regulation of fatty acid oxidation	BP
1	3	2.73581349091	-	1.43e-01	GO:0060743	epithelial cell maturation involved in prostate gland development	BP
1	3	2.73581349091	-	1.43e-01	GO:0060748	tertiary branching involved in mammary gland duct morphogenesis	BP
1	3	2.73581349091	-	1.43e-01	GO:0021885	forebrain cell migration	BP
1	3	2.73581349091	-	1.43e-01	GO:0010766	negative regulation of sodium ion transport	BP
1	3	2.73581349091	-	1.43e-01	GO:0071899	negative regulation of estrogen receptor binding	BP
1	3	2.73581349091	-	1.43e-01	GO:0071895	odontoblast differentiation	BP
1	3	2.73581349091	-	1.43e-01	GO:2000286	receptor internalization involved in canonical Wnt signaling pathway	BP
1	3	2.73581349091	-	1.43e-01	GO:0021965	spinal cord ventral commissure morphogenesis	BP
1	3	2.73581349091	-	1.43e-01	GO:0035583	sequestering of TGFbeta in extracellular matrix	BP
1	3	2.73581349091	-	1.43e-01	GO:0036462	TRAIL-activated apoptotic signaling pathway	BP
1	3	2.73581349091	-	1.43e-01	GO:2000619	negative regulation of histone H4-K16 acetylation	BP
1	3	2.73581349091	-	1.43e-01	GO:0006114	glycerol biosynthetic process	BP
1	3	2.73581349091	-	1.43e-01	GO:0003274	endocardial cushion fusion	BP
1	3	2.73581349091	-	1.43e-01	GO:0022898	regulation of transmembrane transporter activity	BP
1	3	2.73581349091	-	1.43e-01	GO:1902268	negative regulation of polyamine transmembrane transport	BP
1	3	2.73581349091	-	1.43e-01	GO:0071173	spindle assembly checkpoint	BP
1	3	2.73581349091	-	1.43e-01	GO:2001212	regulation of vasculogenesis	BP
1	3	2.73581349091	-	1.43e-01	GO:0038123	toll-like receptor TLR1:TLR2 signaling pathway	BP
1	3	2.73581349091	-	1.43e-01	GO:0090258	negative regulation of mitochondrial fission	BP
1	3	2.73581349091	-	1.43e-01	GO:0048294	negative regulation of isotype switching to IgE isotypes	BP
1	3	2.73581349091	-	1.43e-01	GO:0035986	senescence-associated heterochromatin focus assembly	BP
1	3	2.73581349091	-	1.43e-01	GO:0014719	skeletal muscle satellite cell activation	BP
1	3	2.73581349091	-	1.43e-01	GO:0072300	positive regulation of metanephric glomerulus development	BP
1	3	2.73581349091	-	1.43e-01	GO:0090043	regulation of tubulin deacetylation	BP
1	3	2.73581349091	-	1.43e-01	GO:0060379	cardiac muscle cell myoblast differentiation	BP
1	3	2.73581349091	-	1.43e-01	GO:0060374	mast cell differentiation	BP
1	3	2.73581349091	-	1.43e-01	GO:0051280	negative regulation of release of sequestered calcium ion into cytosol	BP
1	3	2.73581349091	-	1.43e-01	GO:1902186	regulation of viral release from host cell	BP
1	3	2.73581349091	-	1.43e-01	GO:1902309	negative regulation of peptidyl-serine dephosphorylation	BP
1	3	2.73581349091	-	1.43e-01	GO:0098910	regulation of atrial cardiac muscle cell action potential	BP
1	3	2.73581349091	-	1.43e-01	GO:0001812	positive regulation of type I hypersensitivity	BP
1	3	2.73581349091	-	1.43e-01	GO:0031063	regulation of histone deacetylation	BP
1	3	2.73581349091	-	1.43e-01	GO:0070671	response to interleukin-12	BP
1	3	2.73581349091	-	1.43e-01	GO:0070433	negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway	BP
1	3	2.73581349091	-	1.43e-01	GO:0000350	generation of catalytic spliceosome for second transesterification step	BP
1	3	2.73581349091	-	1.43e-01	GO:0019724	B cell mediated immunity	BP
1	3	2.73581349091	-	1.43e-01	GO:0002638	negative regulation of immunoglobulin production	BP
1	3	2.73581349091	-	1.43e-01	GO:1902108	regulation of mitochondrial membrane permeability involved in apoptotic process	BP
1	3	2.73581349091	-	1.43e-01	GO:1990535	neuron projection maintenance	BP
1	3	2.73581349091	-	1.43e-01	GO:1902523	positive regulation of protein K63-linked ubiquitination	BP
1	3	2.73581349091	-	1.43e-01	GO:0010641	positive regulation of platelet-derived growth factor receptor signaling pathway	BP
1	3	2.73581349091	-	1.43e-01	GO:0021587	cerebellum morphogenesis	BP
1	3	2.73581349091	-	1.43e-01	GO:0045217	cell-cell junction maintenance	BP
1	3	2.73581349091	-	1.43e-01	GO:0003340	negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis	BP
1	3	2.73581349091	-	1.43e-01	GO:1900126	negative regulation of hyaluronan biosynthetic process	BP
1	3	2.73581349091	-	1.43e-01	GO:0021545	cranial nerve development	BP
1	3	2.73581349091	-	1.43e-01	GO:1904783	positive regulation of NMDA glutamate receptor activity	BP
1	3	2.73581349091	-	1.43e-01	GO:0034435	cholesterol esterification	BP
1	3	2.73581349091	-	1.43e-01	GO:0060242	contact inhibition	BP
1	3	2.73581349091	-	1.43e-01	GO:0023021	termination of signal transduction	BP
1	3	2.73581349091	-	1.43e-01	GO:0051250	negative regulation of lymphocyte activation	BP
1	3	2.73581349091	-	1.43e-01	GO:0021747	cochlear nucleus development	BP
1	3	2.73581349091	-	1.43e-01	GO:0001922	B-1 B cell homeostasis	BP
1	3	2.73581349091	-	1.43e-01	GO:1903551	regulation of extracellular exosome assembly	BP
1	3	2.73581349091	-	1.43e-01	GO:2001170	negative regulation of ATP biosynthetic process	BP
1	3	2.73581349091	-	1.43e-01	GO:0048385	regulation of retinoic acid receptor signaling pathway	BP
1	3	2.73581349091	-	1.43e-01	GO:0002904	positive regulation of B cell apoptotic process	BP
1	3	2.73581349091	-	1.43e-01	GO:0090135	actin filament branching	BP
1	3	2.73581349091	-	1.43e-01	GO:0021781	glial cell fate commitment	BP
1	3	2.73581349091	-	1.43e-01	GO:0003190	atrioventricular valve formation	BP
1	3	2.73581349091	-	1.43e-01	GO:2000669	negative regulation of dendritic cell apoptotic process	BP
1	3	2.73581349091	-	1.43e-01	GO:1903721	positive regulation of I-kappaB phosphorylation	BP
1	3	2.73581349091	-	1.43e-01	GO:0019448	L-cysteine catabolic process	BP
1	3	2.73581349091	-	1.43e-01	GO:0034112	positive regulation of homotypic cell-cell adhesion	BP
1	3	2.73581349091	-	1.43e-01	GO:0051707	response to other organism	BP
1	3	2.73581349091	-	1.43e-01	GO:0060368	regulation of Fc receptor mediated stimulatory signaling pathway	BP
1	3	2.73581349091	-	1.43e-01	GO:0060437	lung growth	BP
1	3	2.73581349091	-	1.43e-01	GO:1902174	positive regulation of keratinocyte apoptotic process	BP
1	3	2.73581349091	-	1.43e-01	GO:1903598	positive regulation of gap junction assembly	BP
1	3	2.73581349091	-	1.43e-01	GO:0000819	sister chromatid segregation	BP
1	3	2.73581349091	-	1.43e-01	GO:0070093	negative regulation of glucagon secretion	BP
1	3	2.73581349091	-	1.43e-01	GO:0007176	regulation of epidermal growth factor-activated receptor activity	BP
1	3	2.73581349091	-	1.43e-01	GO:1900212	negative regulation of mesenchymal cell apoptotic process involved in metanephros development	BP
1	3	2.73581349091	-	1.43e-01	GO:0033602	negative regulation of dopamine secretion	BP
1	3	2.73581349091	-	1.43e-01	GO:0050904	diapedesis	BP
1	3	2.73581349091	-	1.43e-01	GO:0031998	regulation of fatty acid beta-oxidation	BP
1	3	2.73581349091	-	1.43e-01	GO:0045163	clustering of voltage-gated potassium channels	BP
1	3	2.73581349091	-	1.43e-01	GO:2000195	negative regulation of female gonad development	BP
1	3	2.73581349091	-	1.43e-01	GO:0001555	oocyte growth	BP
1	3	2.73581349091	-	1.43e-01	GO:2000051	negative regulation of non-canonical Wnt signaling pathway	BP
1	3	2.73581349091	-	1.43e-01	GO:0002762	negative regulation of myeloid leukocyte differentiation	BP
1	3	2.73581349091	-	1.43e-01	GO:0060688	regulation of morphogenesis of a branching structure	BP
1	3	2.73581349091	-	1.43e-01	GO:1902723	negative regulation of skeletal muscle satellite cell proliferation	BP
1	3	2.73581349091	-	1.43e-01	GO:1902725	negative regulation of satellite cell differentiation	BP
1	3	2.73581349091	-	1.43e-01	GO:0045200	establishment of neuroblast polarity	BP
1	3	2.73581349091	-	1.43e-01	GO:0033688	regulation of osteoblast proliferation	BP
1	3	2.73581349091	-	1.43e-01	GO:0021553	olfactory nerve development	BP
1	3	2.73581349091	-	1.43e-01	GO:0001936	regulation of endothelial cell proliferation	BP
1	3	2.73581349091	-	1.43e-01	GO:2000630	positive regulation of miRNA metabolic process	BP
1	3	2.73581349091	-	1.43e-01	GO:0045007	depurination	BP
1	3	2.73581349091	-	1.43e-01	GO:2000301	negative regulation of synaptic vesicle exocytosis	BP
1	3	2.73581349091	-	1.43e-01	GO:0097286	iron ion import	BP
1	3	2.73581349091	-	1.43e-01	GO:0060480	lung goblet cell differentiation	BP
1	3	2.73581349091	-	1.43e-01	GO:0051882	mitochondrial depolarization	BP
1	3	2.73581349091	-	1.43e-01	GO:0019065	receptor-mediated endocytosis of virus by host cell	BP
1	3	2.73581349091	-	1.43e-01	GO:2000670	positive regulation of dendritic cell apoptotic process	BP
1	3	2.73581349091	-	1.43e-01	GO:0090272	negative regulation of fibroblast growth factor production	BP
1	3	2.73581349091	-	1.43e-01	GO:0018076	N-terminal peptidyl-lysine acetylation	BP
1	3	2.73581349091	-	1.43e-01	GO:1903378	positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway	BP
1	3	2.73581349091	-	1.43e-01	GO:0032310	prostaglandin secretion	BP
1	3	2.73581349091	-	1.43e-01	GO:1903774	positive regulation of viral budding via host ESCRT complex	BP
1	3	2.73581349091	-	1.43e-01	GO:1903772	regulation of viral budding via host ESCRT complex	BP
1	3	2.73581349091	-	1.43e-01	GO:0071871	response to epinephrine	BP
1	3	2.73581349091	-	1.43e-01	GO:0046890	regulation of lipid biosynthetic process	BP
1	3	2.73581349091	-	1.43e-01	GO:0031281	positive regulation of cyclase activity	BP
1	3	2.73581349091	-	1.43e-01	GO:2000278	regulation of DNA biosynthetic process	BP
1	3	2.73581349091	-	1.43e-01	GO:1903679	positive regulation of cap-independent translational initiation	BP
1	3	2.73581349091	-	1.43e-01	GO:0001560	regulation of cell growth by extracellular stimulus	BP
1	3	2.73581349091	-	1.43e-01	GO:2000687	negative regulation of rubidium ion transmembrane transporter activity	BP
1	3	2.73581349091	-	1.43e-01	GO:0045588	positive regulation of gamma-delta T cell differentiation	BP
1	3	2.73581349091	-	1.43e-01	GO:0070495	negative regulation of thrombin-activated receptor signaling pathway	BP
1	3	2.73581349091	-	1.43e-01	GO:0051572	negative regulation of histone H3-K4 methylation	BP
1	3	2.73581349091	-	1.43e-01	GO:0071727	cellular response to triacyl bacterial lipopeptide	BP
1	3	2.73581349091	-	1.43e-01	GO:0072717	cellular response to actinomycin D	BP
1	3	2.73581349091	-	1.43e-01	GO:1904640	response to methionine	BP
1	3	2.73581349091	-	1.43e-01	GO:0021769	orbitofrontal cortex development	BP
1	3	2.73581349091	-	1.43e-01	GO:0033563	dorsal/ventral axon guidance	BP
1	3	2.73581349091	-	1.43e-01	GO:0060715	syncytiotrophoblast cell differentiation involved in labyrinthine layer development	BP
1	3	2.73581349091	-	1.43e-01	GO:0002277	myeloid dendritic cell activation involved in immune response	BP
1	3	2.73581349091	-	1.43e-01	GO:0048014	Tie signaling pathway	BP
1	3	2.73581349091	-	1.43e-01	GO:0045425	positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process	BP
4	12	2.73581349091	-	1.55e-03	GO:0050321	tau-protein kinase activity	MF
4	12	2.73581349091	-	2.23e-03	GO:0031994	insulin-like growth factor I binding	MF
2	6	2.73581349091	-	2.50e-03	GO:0003828	alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity	MF
2	6	2.73581349091	-	1.40e-02	GO:0070097	delta-catenin binding	MF
2	6	2.73581349091	-	3.28e-02	GO:0005024	transforming growth factor beta-activated receptor activity	MF
2	6	2.73581349091	-	3.28e-02	GO:0048406	nerve growth factor binding	MF
2	6	2.73581349091	-	3.28e-02	GO:0016004	phospholipase activator activity	MF
2	6	2.73581349091	-	3.28e-02	GO:0030275	LRR domain binding	MF
2	6	2.73581349091	-	3.28e-02	GO:0031730	CCR5 chemokine receptor binding	MF
2	6	2.73581349091	-	3.28e-02	GO:0010997	anaphase-promoting complex binding	MF
1	3	2.73581349091	-	5.00e-02	GO:0004949	cannabinoid receptor activity	MF
1	3	2.73581349091	-	5.00e-02	GO:0000309	nicotinamide-nucleotide adenylyltransferase activity	MF
1	3	2.73581349091	-	5.00e-02	GO:0030298	receptor signaling protein tyrosine kinase activator activity	MF
1	3	2.73581349091	-	9.76e-02	GO:0019958	C-X-C chemokine binding	MF
1	3	2.73581349091	-	9.76e-02	GO:0048403	brain-derived neurotrophic factor binding	MF
1	3	2.73581349091	-	9.76e-02	GO:0052812	phosphatidylinositol-3,4-bisphosphate 5-kinase activity	MF
1	3	2.73581349091	-	9.76e-02	GO:0004117	calmodulin-dependent cyclic-nucleotide phosphodiesterase activity	MF
1	3	2.73581349091	-	9.76e-02	GO:0023024	MHC class I protein complex binding	MF
1	3	2.73581349091	-	9.76e-02	GO:0005277	acetylcholine transmembrane transporter activity	MF
1	3	2.73581349091	-	9.76e-02	GO:0060002	plus-end directed microfilament motor activity	MF
1	3	2.73581349091	-	9.76e-02	GO:0008321	Ral guanyl-nucleotide exchange factor activity	MF
1	3	2.73581349091	-	1.43e-01	GO:0102148	N-acetyl-beta-D-galactosaminidase activity	MF
1	3	2.73581349091	-	1.43e-01	GO:0035614	snRNA stem-loop binding	MF
1	3	2.73581349091	-	1.43e-01	GO:0001093	TFIIB-class transcription factor binding	MF
1	3	2.73581349091	-	1.43e-01	GO:0001159	core promoter proximal region DNA binding	MF
1	3	2.73581349091	-	1.43e-01	GO:0004911	interleukin-2 receptor activity	MF
1	3	2.73581349091	-	1.43e-01	GO:0045309	protein phosphorylated amino acid binding	MF
1	3	2.73581349091	-	1.43e-01	GO:0004705	JUN kinase activity	MF
1	3	2.73581349091	-	1.43e-01	GO:0004332	fructose-bisphosphate aldolase activity	MF
1	3	2.73581349091	-	1.43e-01	GO:0044729	hemi-methylated DNA-binding	MF
1	3	2.73581349091	-	1.43e-01	GO:0016278	lysine N-methyltransferase activity	MF
1	3	2.73581349091	-	1.43e-01	GO:0005010	insulin-like growth factor-activated receptor activity	MF
1	3	2.73581349091	-	1.43e-01	GO:0019211	phosphatase activator activity	MF
1	3	2.73581349091	-	1.43e-01	GO:0005166	neurotrophin p75 receptor binding	MF
1	3	2.73581349091	-	1.43e-01	GO:0034714	type III transforming growth factor beta receptor binding	MF
1	3	2.73581349091	-	1.43e-01	GO:0005333	norepinephrine transmembrane transporter activity	MF
1	3	2.73581349091	-	1.43e-01	GO:0047045	testosterone 17-beta-dehydrogenase (NADP+) activity	MF
1	3	2.73581349091	-	1.43e-01	GO:0004396	hexokinase activity	MF
1	3	2.73581349091	-	1.43e-01	GO:0004563	beta-N-acetylhexosaminidase activity	MF
1	3	2.73581349091	-	1.43e-01	GO:0008073	ornithine decarboxylase inhibitor activity	MF
1	3	2.73581349091	-	1.43e-01	GO:0019976	interleukin-2 binding	MF
1	3	2.73581349091	-	1.43e-01	GO:0004060	arylamine N-acetyltransferase activity	MF
1	3	2.73581349091	-	1.43e-01	GO:0004882	androgen receptor activity	MF
1	3	2.73581349091	-	1.43e-01	GO:0016314	phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity	MF
1	3	2.73581349091	-	1.43e-01	GO:0008513	secondary active organic cation transmembrane transporter activity	MF
1	3	2.73581349091	-	1.43e-01	GO:0004699	calcium-independent protein kinase C activity	MF
1	3	2.73581349091	-	1.43e-01	GO:0004711	ribosomal protein S6 kinase activity	MF
1	3	2.73581349091	-	1.43e-01	GO:0005220	inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity	MF
3	9	2.73581349091	-	2.23e-03	GO:0051896	regulation of protein kinase B signaling	BP
3	9	2.73581349091	-	2.23e-03	GO:0042058	regulation of epidermal growth factor receptor signaling pathway	BP
3	9	2.73581349091	-	3.75e-03	GO:0002281	macrophage activation involved in immune response	BP
3	9	2.73581349091	-	5.78e-03	GO:0045591	positive regulation of regulatory T cell differentiation	BP
3	9	2.73581349091	-	5.78e-03	GO:0010762	regulation of fibroblast migration	BP
3	9	2.73581349091	-	5.78e-03	GO:1990314	cellular response to insulin-like growth factor stimulus	BP
3	9	2.73581349091	-	5.78e-03	GO:0032835	glomerulus development	BP
3	9	2.73581349091	-	8.35e-03	GO:0034405	response to fluid shear stress	BP
3	9	2.73581349091	-	8.35e-03	GO:0008354	germ cell migration	BP
3	9	2.73581349091	-	8.35e-03	GO:0046641	positive regulation of alpha-beta T cell proliferation	BP
3	9	2.73581349091	-	8.35e-03	GO:0060670	branching involved in labyrinthine layer morphogenesis	BP
3	9	2.73581349091	-	8.35e-03	GO:0006000	fructose metabolic process	BP
14	43	2.70186615899	-	1.71e-09	GO:0016303	1-phosphatidylinositol-3-kinase activity	MF
10	31	2.68850777613	-	1.11e-06	GO:0042169	SH2 domain binding	MF
48	152	2.65781097891	-	2.60e-27	GO:0018108	peptidyl-tyrosine phosphorylation	BP
6	19	2.65781097891	-	1.18e-04	GO:0014911	positive regulation of smooth muscle cell migration	BP
6	19	2.65781097891	-	1.18e-04	GO:0042246	tissue regeneration	BP
6	19	2.65781097891	-	2.38e-04	GO:0070064	proline-rich region binding	MF
5	16	2.64270408652	-	6.10e-04	GO:2000811	negative regulation of anoikis	BP
5	16	2.64270408652	-	6.10e-04	GO:0060749	mammary gland alveolus development	BP
5	16	2.64270408652	-	8.51e-04	GO:0045725	positive regulation of glycogen biosynthetic process	BP
14	45	2.63627781736	-	5.42e-09	GO:0030971	receptor tyrosine kinase binding	MF
8	26	2.62033627349	-	9.47e-06	GO:0045840	positive regulation of mitotic nuclear division	BP
4	13	2.62033627349	-	6.40e-04	GO:0001775	cell activation	BP
4	13	2.62033627349	-	6.40e-04	GO:0031643	positive regulation of myelination	BP
4	13	2.62033627349	-	1.55e-03	GO:0061029	eyelid development in camera-type eye	BP
4	13	2.62033627349	-	3.09e-03	GO:0070306	lens fiber cell differentiation	BP
21	69	2.60456895763	-	5.29e-12	GO:0007265	Ras protein signal transduction	BP
10	33	2.59830996716	-	2.18e-06	GO:0043491	protein kinase B signaling	BP
12	40	2.58381039747	-	1.82e-07	GO:0071364	cellular response to epidermal growth factor stimulus	BP
6	20	2.58381039747	-	3.26e-04	GO:1902895	positive regulation of pri-miRNA transcription from RNA polymerase II promoter	BP
3	10	2.58381039747	-	3.75e-03	GO:0043304	regulation of mast cell degranulation	BP
3	10	2.58381039747	-	8.35e-03	GO:0042532	negative regulation of tyrosine phosphorylation of STAT protein	BP
3	10	2.58381039747	-	8.35e-03	GO:0051901	positive regulation of mitochondrial depolarization	BP
3	10	2.58381039747	-	8.35e-03	GO:0010469	regulation of receptor activity	BP
3	10	2.58381039747	-	8.35e-03	GO:0060484	lung-associated mesenchyme development	BP
3	10	2.58381039747	-	8.35e-03	GO:0042770	signal transduction in response to DNA damage	BP
3	10	2.58381039747	-	1.15e-02	GO:0051918	negative regulation of fibrinolysis	BP
3	10	2.58381039747	-	1.15e-02	GO:0034145	positive regulation of toll-like receptor 4 signaling pathway	BP
3	10	2.58381039747	-	1.15e-02	GO:0033327	Leydig cell differentiation	BP
3	10	2.58381039747	-	1.15e-02	GO:0060252	positive regulation of glial cell proliferation	BP
3	10	2.58381039747	-	1.15e-02	GO:0031000	response to caffeine	BP
3	10	2.58381039747	-	8.35e-03	GO:0051428	peptide hormone receptor binding	MF
19	64	2.56870350508	-	8.54e-11	GO:0019903	protein phosphatase binding	MF
5	17	2.55524124527	-	2.84e-04	GO:0048514	blood vessel morphogenesis	BP
29	99	2.54940036668	-	3.37e-17	GO:0046854	phosphatidylinositol phosphorylation	BP
18	62	2.53650468269	-	7.84e-11	GO:0042531	positive regulation of tyrosine phosphorylation of STAT protein	BP
9	31	2.53650468269	-	5.46e-06	GO:0034614	cellular response to reactive oxygen species	BP
4	14	2.51342106957	-	3.09e-03	GO:0014912	negative regulation of smooth muscle cell migration	BP
4	14	2.51342106957	-	3.09e-03	GO:2000060	positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process	BP
2	7	2.51342106957	-	7.25e-03	GO:2000272	negative regulation of receptor activity	BP
2	7	2.51342106957	-	2.26e-02	GO:0033135	regulation of peptidyl-serine phosphorylation	BP
2	7	2.51342106957	-	2.26e-02	GO:0060463	lung lobe morphogenesis	BP
2	7	2.51342106957	-	2.26e-02	GO:0009950	dorsal/ventral axis specification	BP
2	7	2.51342106957	-	2.26e-02	GO:0036302	atrioventricular canal development	BP
2	7	2.51342106957	-	3.28e-02	GO:0071455	cellular response to hyperoxia	BP
2	7	2.51342106957	-	3.28e-02	GO:0045722	positive regulation of gluconeogenesis	BP
2	7	2.51342106957	-	3.28e-02	GO:2000617	positive regulation of histone H3-K9 acetylation	BP
2	7	2.51342106957	-	3.28e-02	GO:1903077	negative regulation of protein localization to plasma membrane	BP
2	7	2.51342106957	-	3.28e-02	GO:0072112	glomerular visceral epithelial cell differentiation	BP
2	7	2.51342106957	-	3.28e-02	GO:0051001	negative regulation of nitric-oxide synthase activity	BP
2	7	2.51342106957	-	3.28e-02	GO:0051057	positive regulation of small GTPase mediated signal transduction	BP
2	7	2.51342106957	-	3.28e-02	GO:0061298	retina vasculature development in camera-type eye	BP
2	7	2.51342106957	-	3.28e-02	GO:0048671	negative regulation of collateral sprouting	BP
2	7	2.51342106957	-	3.28e-02	GO:0051574	positive regulation of histone H3-K9 methylation	BP
2	7	2.51342106957	-	3.28e-02	GO:0042129	regulation of T cell proliferation	BP
2	7	2.51342106957	-	3.28e-02	GO:0043457	regulation of cellular respiration	BP
2	7	2.51342106957	-	4.44e-02	GO:0006595	polyamine metabolic process	BP
2	7	2.51342106957	-	4.44e-02	GO:0050810	regulation of steroid biosynthetic process	BP
2	7	2.51342106957	-	4.44e-02	GO:2000641	regulation of early endosome to late endosome transport	BP
2	7	2.51342106957	-	4.44e-02	GO:0014049	positive regulation of glutamate secretion	BP
2	7	2.51342106957	-	4.44e-02	GO:0030948	negative regulation of vascular endothelial growth factor receptor signaling pathway	BP
2	7	2.51342106957	-	4.44e-02	GO:0043486	histone exchange	BP
2	7	2.51342106957	-	4.44e-02	GO:0043405	regulation of MAP kinase activity	BP
2	7	2.51342106957	-	4.44e-02	GO:0071233	cellular response to leucine	BP
2	7	2.51342106957	-	4.44e-02	GO:0071474	cellular hyperosmotic response	BP
2	7	2.51342106957	-	4.44e-02	GO:0031642	negative regulation of myelination	BP
2	7	2.51342106957	-	4.44e-02	GO:0033601	positive regulation of mammary gland epithelial cell proliferation	BP
2	7	2.51342106957	-	4.44e-02	GO:0031659	positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle	BP
4	14	2.51342106957	-	6.40e-04	GO:0070403	NAD+ binding	MF
2	7	2.51342106957	-	3.28e-02	GO:0035005	1-phosphatidylinositol-4-phosphate 3-kinase activity	MF
2	7	2.51342106957	-	3.28e-02	GO:0001848	complement binding	MF
2	7	2.51342106957	-	3.28e-02	GO:0005004	GPI-linked ephrin receptor activity	MF
2	7	2.51342106957	-	4.44e-02	GO:0004675	transmembrane receptor protein serine/threonine kinase activity	MF
2	7	2.51342106957	-	4.44e-02	GO:0008603	cAMP-dependent protein kinase regulator activity	MF
2	7	2.51342106957	-	4.44e-02	GO:0004691	cAMP-dependent protein kinase activity	MF
2	7	2.51342106957	-	4.44e-02	GO:0008329	signaling pattern recognition receptor activity	MF
14	50	2.48427472391	-	1.54e-08	GO:0036092	phosphatidylinositol-3-phosphate biosynthetic process	BP
7	25	2.48427472391	-	3.33e-05	GO:0019838	growth factor binding	MF
46	166	2.46929851634	-	2.23e-22	GO:0046777	protein autophosphorylation	BP
8	29	2.4627949965	-	1.91e-05	GO:2000145	regulation of cell motility	BP
3	11	2.44630687372	-	5.78e-03	GO:0002089	lens morphogenesis in camera-type eye	BP
3	11	2.44630687372	-	5.78e-03	GO:0030857	negative regulation of epithelial cell differentiation	BP
3	11	2.44630687372	-	5.78e-03	GO:0043586	tongue development	BP
3	11	2.44630687372	-	8.35e-03	GO:0045745	positive regulation of G-protein coupled receptor protein signaling pathway	BP
3	11	2.44630687372	-	1.15e-02	GO:0050732	negative regulation of peptidyl-tyrosine phosphorylation	BP
3	11	2.44630687372	-	1.15e-02	GO:0042445	hormone metabolic process	BP
3	11	2.44630687372	-	1.15e-02	GO:0032930	positive regulation of superoxide anion generation	BP
3	11	2.44630687372	-	1.52e-02	GO:0051279	regulation of release of sequestered calcium ion into cytosol	BP
3	11	2.44630687372	-	1.52e-02	GO:0050927	positive regulation of positive chemotaxis	BP
3	11	2.44630687372	-	1.52e-02	GO:0032516	positive regulation of phosphoprotein phosphatase activity	BP
3	11	2.44630687372	-	1.52e-02	GO:0043306	positive regulation of mast cell degranulation	BP
3	11	2.44630687372	-	1.52e-02	GO:0090136	epithelial cell-cell adhesion	BP
3	11	2.44630687372	-	8.35e-03	GO:0004629	phospholipase C activity	MF
3	11	2.44630687372	-	1.52e-02	GO:0016208	AMP binding	MF
4	15	2.41388539602	-	5.45e-03	GO:0051895	negative regulation of focal adhesion assembly	BP
4	15	2.41388539602	-	5.45e-03	GO:0051571	positive regulation of histone H3-K4 methylation	BP
4	15	2.41388539602	-	3.09e-03	GO:0017016	Ras GTPase binding	MF
6	23	2.3821765363	-	4.37e-04	GO:0034394	protein localization to cell surface	BP
7	27	2.37324341153	-	1.66e-04	GO:0040014	regulation of multicellular organism growth	BP
8	31	2.36657968124	-	4.80e-05	GO:0030217	T cell differentiation	BP
29	115	2.33326693582	-	1.08e-14	GO:0005088	Ras guanyl-nucleotide exchange factor activity	MF
10	40	2.32077599163	-	7.17e-06	GO:0071902	positive regulation of protein serine/threonine kinase activity	BP
8	32	2.32077599163	-	1.91e-05	GO:0007498	mesoderm development	BP
7	28	2.32077599163	-	1.66e-04	GO:0030010	establishment of cell polarity	BP
5	20	2.32077599163	-	2.56e-03	GO:0008361	regulation of cell size	BP
4	16	2.32077599163	-	3.09e-03	GO:0032012	regulation of ARF protein signal transduction	BP
4	16	2.32077599163	-	4.16e-03	GO:0035855	megakaryocyte development	BP
4	16	2.32077599163	-	5.45e-03	GO:0035162	embryonic hemopoiesis	BP
4	16	2.32077599163	-	6.98e-03	GO:0006978	DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator	BP
3	12	2.32077599163	-	1.15e-02	GO:0097028	dendritic cell differentiation	BP
3	12	2.32077599163	-	1.15e-02	GO:0050868	negative regulation of T cell activation	BP
3	12	2.32077599163	-	1.15e-02	GO:0090399	replicative senescence	BP
2	8	2.32077599163	-	1.40e-02	GO:0050863	regulation of T cell activation	BP
3	12	2.32077599163	-	1.52e-02	GO:0030833	regulation of actin filament polymerization	BP
3	12	2.32077599163	-	1.52e-02	GO:0030212	hyaluronan metabolic process	BP
3	12	2.32077599163	-	1.96e-02	GO:2000146	negative regulation of cell motility	BP
2	8	2.32077599163	-	3.28e-02	GO:0046324	regulation of glucose import	BP
2	8	2.32077599163	-	3.28e-02	GO:0035137	hindlimb morphogenesis	BP
2	8	2.32077599163	-	3.28e-02	GO:0060736	prostate gland growth	BP
2	8	2.32077599163	-	3.28e-02	GO:0042698	ovulation cycle	BP
2	8	2.32077599163	-	3.28e-02	GO:2000427	positive regulation of apoptotic cell clearance	BP
2	8	2.32077599163	-	3.28e-02	GO:0060259	regulation of feeding behavior	BP
2	8	2.32077599163	-	3.28e-02	GO:0051152	positive regulation of smooth muscle cell differentiation	BP
2	8	2.32077599163	-	4.44e-02	GO:0035265	organ growth	BP
2	8	2.32077599163	-	4.44e-02	GO:0098909	regulation of cardiac muscle cell action potential involved in regulation of contraction	BP
2	8	2.32077599163	-	4.44e-02	GO:0034393	positive regulation of smooth muscle cell apoptotic process	BP
2	8	2.32077599163	-	4.44e-02	GO:0005979	regulation of glycogen biosynthetic process	BP
2	8	2.32077599163	-	4.44e-02	GO:1901380	negative regulation of potassium ion transmembrane transport	BP
2	8	2.32077599163	-	4.44e-02	GO:0001542	ovulation from ovarian follicle	BP
2	8	2.32077599163	-	4.44e-02	GO:0045059	positive thymic T cell selection	BP
2	8	2.32077599163	-	4.44e-02	GO:1901017	negative regulation of potassium ion transmembrane transporter activity	BP
1	4	2.32077599163	-	5.00e-02	GO:1903609	negative regulation of inward rectifier potassium channel activity	BP
1	4	2.32077599163	-	5.00e-02	GO:0048859	formation of anatomical boundary	BP
2	8	2.32077599163	-	5.73e-02	GO:0045348	positive regulation of MHC class II biosynthetic process	BP
2	8	2.32077599163	-	5.73e-02	GO:0070723	response to cholesterol	BP
2	8	2.32077599163	-	5.73e-02	GO:0048762	mesenchymal cell differentiation	BP
2	8	2.32077599163	-	5.73e-02	GO:0070262	peptidyl-serine dephosphorylation	BP
2	8	2.32077599163	-	5.73e-02	GO:0001955	blood vessel maturation	BP
2	8	2.32077599163	-	5.73e-02	GO:0048143	astrocyte activation	BP
2	8	2.32077599163	-	5.73e-02	GO:0006975	DNA damage induced protein phosphorylation	BP
2	8	2.32077599163	-	5.73e-02	GO:0002903	negative regulation of B cell apoptotic process	BP
2	8	2.32077599163	-	5.73e-02	GO:0001960	negative regulation of cytokine-mediated signaling pathway	BP
2	8	2.32077599163	-	5.73e-02	GO:1900119	positive regulation of execution phase of apoptosis	BP
2	8	2.32077599163	-	5.73e-02	GO:0038180	nerve growth factor signaling pathway	BP
2	8	2.32077599163	-	5.73e-02	GO:0021795	cerebral cortex cell migration	BP
2	8	2.32077599163	-	5.73e-02	GO:0014732	skeletal muscle atrophy	BP
2	8	2.32077599163	-	5.73e-02	GO:0006002	fructose 6-phosphate metabolic process	BP
2	8	2.32077599163	-	5.73e-02	GO:0060711	labyrinthine layer development	BP
1	4	2.32077599163	-	9.76e-02	GO:1904954	canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation	BP
1	4	2.32077599163	-	9.76e-02	GO:2000724	positive regulation of cardiac vascular smooth muscle cell differentiation	BP
1	4	2.32077599163	-	9.76e-02	GO:0048609	multicellular organismal reproductive process	BP
1	4	2.32077599163	-	9.76e-02	GO:0021575	hindbrain morphogenesis	BP
1	4	2.32077599163	-	9.76e-02	GO:0090403	oxidative stress-induced premature senescence	BP
1	4	2.32077599163	-	9.76e-02	GO:0006772	thiamine metabolic process	BP
1	4	2.32077599163	-	9.76e-02	GO:0006651	diacylglycerol biosynthetic process	BP
1	4	2.32077599163	-	9.76e-02	GO:0042662	negative regulation of mesodermal cell fate specification	BP
1	4	2.32077599163	-	1.43e-01	GO:0034136	negative regulation of toll-like receptor 2 signaling pathway	BP
1	4	2.32077599163	-	1.43e-01	GO:0045918	negative regulation of cytolysis	BP
1	4	2.32077599163	-	1.43e-01	GO:0031547	brain-derived neurotrophic factor receptor signaling pathway	BP
1	4	2.32077599163	-	1.43e-01	GO:0060965	negative regulation of gene silencing by miRNA	BP
1	4	2.32077599163	-	1.43e-01	GO:1903243	negative regulation of cardiac muscle hypertrophy in response to stress	BP
1	4	2.32077599163	-	1.43e-01	GO:0072189	ureter development	BP
1	4	2.32077599163	-	1.43e-01	GO:0002666	positive regulation of T cell tolerance induction	BP
1	4	2.32077599163	-	1.43e-01	GO:0048368	lateral mesoderm development	BP
1	4	2.32077599163	-	1.43e-01	GO:0032286	central nervous system myelin maintenance	BP
1	4	2.32077599163	-	1.43e-01	GO:0048608	reproductive structure development	BP
1	4	2.32077599163	-	1.43e-01	GO:1902806	regulation of cell cycle G1/S phase transition	BP
1	4	2.32077599163	-	1.43e-01	GO:0003338	metanephros morphogenesis	BP
1	4	2.32077599163	-	1.43e-01	GO:0006054	N-acetylneuraminate metabolic process	BP
1	4	2.32077599163	-	1.43e-01	GO:0060510	Type II pneumocyte differentiation	BP
1	4	2.32077599163	-	1.43e-01	GO:0003272	endocardial cushion formation	BP
1	4	2.32077599163	-	1.43e-01	GO:0050672	negative regulation of lymphocyte proliferation	BP
1	4	2.32077599163	-	1.43e-01	GO:2000653	regulation of genetic imprinting	BP
1	4	2.32077599163	-	1.43e-01	GO:0072606	interleukin-8 secretion	BP
1	4	2.32077599163	-	1.43e-01	GO:0072600	establishment of protein localization to Golgi	BP
1	4	2.32077599163	-	1.43e-01	GO:0034103	regulation of tissue remodeling	BP
1	4	2.32077599163	-	1.43e-01	GO:0044331	cell-cell adhesion mediated by cadherin	BP
1	4	2.32077599163	-	1.43e-01	GO:0072221	metanephric distal convoluted tubule development	BP
1	4	2.32077599163	-	1.43e-01	GO:0048808	male genitalia morphogenesis	BP
1	4	2.32077599163	-	1.43e-01	GO:1900738	positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway	BP
1	4	2.32077599163	-	1.43e-01	GO:1900245	positive regulation of MDA-5 signaling pathway	BP
1	4	2.32077599163	-	1.43e-01	GO:0010644	cell communication by electrical coupling	BP
1	4	2.32077599163	-	1.43e-01	GO:0033031	positive regulation of neutrophil apoptotic process	BP
1	4	2.32077599163	-	1.43e-01	GO:0021938	smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation	BP
1	4	2.32077599163	-	1.43e-01	GO:0048550	negative regulation of pinocytosis	BP
1	4	2.32077599163	-	1.43e-01	GO:0045759	negative regulation of action potential	BP
1	4	2.32077599163	-	1.43e-01	GO:0048070	regulation of developmental pigmentation	BP
1	4	2.32077599163	-	1.43e-01	GO:0048133	male germ-line stem cell asymmetric division	BP
1	4	2.32077599163	-	1.43e-01	GO:2000546	positive regulation of endothelial cell chemotaxis to fibroblast growth factor	BP
1	4	2.32077599163	-	1.43e-01	GO:0032348	negative regulation of aldosterone biosynthetic process	BP
1	4	2.32077599163	-	1.43e-01	GO:0033088	negative regulation of immature T cell proliferation in thymus	BP
1	4	2.32077599163	-	1.43e-01	GO:0014061	regulation of norepinephrine secretion	BP
1	4	2.32077599163	-	1.43e-01	GO:0043549	regulation of kinase activity	BP
1	4	2.32077599163	-	1.43e-01	GO:0060043	regulation of cardiac muscle cell proliferation	BP
1	4	2.32077599163	-	1.43e-01	GO:0001880	Mullerian duct regression	BP
1	4	2.32077599163	-	1.43e-01	GO:1901097	negative regulation of autophagosome maturation	BP
1	4	2.32077599163	-	1.43e-01	GO:0035112	genitalia morphogenesis	BP
1	4	2.32077599163	-	1.43e-01	GO:0032392	DNA geometric change	BP
1	4	2.32077599163	-	1.43e-01	GO:0046596	regulation of viral entry into host cell	BP
1	4	2.32077599163	-	1.43e-01	GO:2001274	negative regulation of glucose import in response to insulin stimulus	BP
1	4	2.32077599163	-	1.43e-01	GO:2000065	negative regulation of cortisol biosynthetic process	BP
1	4	2.32077599163	-	1.43e-01	GO:0070945	neutrophil mediated killing of gram-negative bacterium	BP
1	4	2.32077599163	-	1.43e-01	GO:0010453	regulation of cell fate commitment	BP
1	4	2.32077599163	-	1.43e-01	GO:0070236	negative regulation of activation-induced cell death of T cells	BP
1	4	2.32077599163	-	1.86e-01	GO:0090400	stress-induced premature senescence	BP
1	4	2.32077599163	-	1.86e-01	GO:0010716	negative regulation of extracellular matrix disassembly	BP
1	4	2.32077599163	-	1.86e-01	GO:0050859	negative regulation of B cell receptor signaling pathway	BP
1	4	2.32077599163	-	1.86e-01	GO:0035799	ureter maturation	BP
1	4	2.32077599163	-	1.86e-01	GO:0035426	extracellular matrix-cell signaling	BP
1	4	2.32077599163	-	1.86e-01	GO:0035655	interleukin-18-mediated signaling pathway	BP
1	4	2.32077599163	-	1.86e-01	GO:0008588	release of cytoplasmic sequestered NF-kappaB	BP
1	4	2.32077599163	-	1.86e-01	GO:1900454	positive regulation of long term synaptic depression	BP
1	4	2.32077599163	-	1.86e-01	GO:0009048	dosage compensation by inactivation of X chromosome	BP
1	4	2.32077599163	-	1.86e-01	GO:0070445	regulation of oligodendrocyte progenitor proliferation	BP
1	4	2.32077599163	-	1.86e-01	GO:1900024	regulation of substrate adhesion-dependent cell spreading	BP
1	4	2.32077599163	-	1.86e-01	GO:2000563	positive regulation of CD4-positive, alpha-beta T cell proliferation	BP
1	4	2.32077599163	-	1.86e-01	GO:0016240	autophagosome membrane docking	BP
1	4	2.32077599163	-	1.86e-01	GO:0002074	extraocular skeletal muscle development	BP
1	4	2.32077599163	-	1.86e-01	GO:0051106	positive regulation of DNA ligation	BP
1	4	2.32077599163	-	1.86e-01	GO:1901203	positive regulation of extracellular matrix assembly	BP
1	4	2.32077599163	-	1.86e-01	GO:0030043	actin filament fragmentation	BP
1	4	2.32077599163	-	1.86e-01	GO:0008356	asymmetric cell division	BP
1	4	2.32077599163	-	1.86e-01	GO:0014042	positive regulation of neuron maturation	BP
1	4	2.32077599163	-	1.86e-01	GO:0072108	positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis	BP
1	4	2.32077599163	-	1.86e-01	GO:0033625	positive regulation of integrin activation	BP
1	4	2.32077599163	-	1.86e-01	GO:0032507	maintenance of protein location in cell	BP
1	4	2.32077599163	-	1.86e-01	GO:1990966	ATP generation from poly-ADP-D-ribose	BP
1	4	2.32077599163	-	1.86e-01	GO:1901020	negative regulation of calcium ion transmembrane transporter activity	BP
1	4	2.32077599163	-	1.86e-01	GO:0070836	caveola assembly	BP
1	4	2.32077599163	-	1.86e-01	GO:0002248	connective tissue replacement involved in inflammatory response wound healing	BP
1	4	2.32077599163	-	1.86e-01	GO:0090168	Golgi reassembly	BP
1	4	2.32077599163	-	1.86e-01	GO:0090312	positive regulation of protein deacetylation	BP
1	4	2.32077599163	-	1.86e-01	GO:0016080	synaptic vesicle targeting	BP
1	4	2.32077599163	-	1.86e-01	GO:0071896	protein localization to adherens junction	BP
1	4	2.32077599163	-	1.86e-01	GO:0003413	chondrocyte differentiation involved in endochondral bone morphogenesis	BP
1	4	2.32077599163	-	1.86e-01	GO:0060708	spongiotrophoblast differentiation	BP
1	4	2.32077599163	-	1.86e-01	GO:1903377	negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway	BP
1	4	2.32077599163	-	1.86e-01	GO:0048023	positive regulation of melanin biosynthetic process	BP
1	4	2.32077599163	-	1.86e-01	GO:0002328	pro-B cell differentiation	BP
1	4	2.32077599163	-	1.86e-01	GO:0038124	toll-like receptor TLR6:TLR2 signaling pathway	BP
1	4	2.32077599163	-	1.86e-01	GO:0007258	JUN phosphorylation	BP
1	4	2.32077599163	-	1.86e-01	GO:0035089	establishment of apical/basal cell polarity	BP
1	4	2.32077599163	-	1.86e-01	GO:0051712	positive regulation of killing of cells of other organism	BP
1	4	2.32077599163	-	1.86e-01	GO:0007296	vitellogenesis	BP
1	4	2.32077599163	-	1.86e-01	GO:0003104	positive regulation of glomerular filtration	BP
1	4	2.32077599163	-	1.86e-01	GO:0060421	positive regulation of heart growth	BP
1	4	2.32077599163	-	1.86e-01	GO:1905323	telomerase holoenzyme complex assembly	BP
1	4	2.32077599163	-	1.86e-01	GO:0051138	positive regulation of NK T cell differentiation	BP
1	4	2.32077599163	-	1.86e-01	GO:2000002	negative regulation of DNA damage checkpoint	BP
1	4	2.32077599163	-	1.86e-01	GO:1905867	epididymis development	BP
1	4	2.32077599163	-	1.86e-01	GO:0030035	microspike assembly	BP
1	4	2.32077599163	-	1.86e-01	GO:0043570	maintenance of DNA repeat elements	BP
1	4	2.32077599163	-	1.86e-01	GO:0060033	anatomical structure regression	BP
1	4	2.32077599163	-	1.86e-01	GO:0018393	internal peptidyl-lysine acetylation	BP
1	4	2.32077599163	-	1.86e-01	GO:0018394	peptidyl-lysine acetylation	BP
1	4	2.32077599163	-	1.86e-01	GO:0033634	positive regulation of cell-cell adhesion mediated by integrin	BP
1	4	2.32077599163	-	1.86e-01	GO:1990182	exosomal secretion	BP
1	4	2.32077599163	-	1.86e-01	GO:0042482	positive regulation of odontogenesis	BP
1	4	2.32077599163	-	1.86e-01	GO:0051414	response to cortisol	BP
1	4	2.32077599163	-	1.86e-01	GO:1900825	regulation of membrane depolarization during cardiac muscle cell action potential	BP
1	4	2.32077599163	-	1.86e-01	GO:0051599	response to hydrostatic pressure	BP
1	4	2.32077599163	-	1.86e-01	GO:1903690	negative regulation of wound healing, spreading of epidermal cells	BP
1	4	2.32077599163	-	1.86e-01	GO:1904781	positive regulation of protein localization to centrosome	BP
1	4	2.32077599163	-	1.86e-01	GO:0008105	asymmetric protein localization	BP
1	4	2.32077599163	-	1.86e-01	GO:0090170	regulation of Golgi inheritance	BP
1	4	2.32077599163	-	1.86e-01	GO:0072012	glomerulus vasculature development	BP
1	4	2.32077599163	-	1.86e-01	GO:1905244	regulation of modification of synaptic structure	BP
1	4	2.32077599163	-	1.86e-01	GO:0003266	regulation of secondary heart field cardioblast proliferation	BP
1	4	2.32077599163	-	1.86e-01	GO:0006642	triglyceride mobilization	BP
1	4	2.32077599163	-	1.86e-01	GO:2001200	positive regulation of dendritic cell differentiation	BP
1	4	2.32077599163	-	1.86e-01	GO:0006933	negative regulation of cell adhesion involved in substrate-bound cell migration	BP
1	4	2.32077599163	-	1.86e-01	GO:0090244	Wnt signaling pathway involved in somitogenesis	BP
1	4	2.32077599163	-	1.86e-01	GO:0032455	nerve growth factor processing	BP
1	4	2.32077599163	-	1.86e-01	GO:0060364	frontal suture morphogenesis	BP
1	4	2.32077599163	-	1.86e-01	GO:0071677	positive regulation of mononuclear cell migration	BP
1	4	2.32077599163	-	1.86e-01	GO:0006534	cysteine metabolic process	BP
1	4	2.32077599163	-	1.86e-01	GO:0006538	glutamate catabolic process	BP
1	4	2.32077599163	-	1.86e-01	GO:0071866	negative regulation of apoptotic process in bone marrow	BP
1	4	2.32077599163	-	1.86e-01	GO:0002051	osteoblast fate commitment	BP
1	4	2.32077599163	-	1.86e-01	GO:1902459	positive regulation of stem cell population maintenance	BP
1	4	2.32077599163	-	1.86e-01	GO:0008038	neuron recognition	BP
1	4	2.32077599163	-	1.86e-01	GO:0061056	sclerotome development	BP
1	4	2.32077599163	-	1.86e-01	GO:0030223	neutrophil differentiation	BP
1	4	2.32077599163	-	1.86e-01	GO:0034698	response to gonadotropin	BP
1	4	2.32077599163	-	1.86e-01	GO:0034205	amyloid-beta formation	BP
1	4	2.32077599163	-	1.86e-01	GO:0022009	central nervous system vasculogenesis	BP
1	4	2.32077599163	-	1.86e-01	GO:0014834	skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration	BP
1	4	2.32077599163	-	1.86e-01	GO:1904637	cellular response to ionomycin	BP
1	4	2.32077599163	-	1.86e-01	GO:0090559	regulation of membrane permeability	BP
1	4	2.32077599163	-	1.86e-01	GO:0021943	formation of radial glial scaffolds	BP
1	4	2.32077599163	-	1.86e-01	GO:2000346	negative regulation of hepatocyte proliferation	BP
1	4	2.32077599163	-	1.86e-01	GO:0042089	cytokine biosynthetic process	BP
1	4	2.32077599163	-	1.86e-01	GO:0050798	activated T cell proliferation	BP
1	4	2.32077599163	-	1.86e-01	GO:0043932	ossification involved in bone remodeling	BP
1	4	2.32077599163	-	1.86e-01	GO:0048549	positive regulation of pinocytosis	BP
1	4	2.32077599163	-	1.86e-01	GO:0032640	tumor necrosis factor production	BP
1	4	2.32077599163	-	1.86e-01	GO:0032095	regulation of response to food	BP
1	4	2.32077599163	-	1.86e-01	GO:0060159	regulation of dopamine receptor signaling pathway	BP
1	4	2.32077599163	-	1.86e-01	GO:0034123	positive regulation of toll-like receptor signaling pathway	BP
1	4	2.32077599163	-	1.86e-01	GO:0006924	activation-induced cell death of T cells	BP
1	4	2.32077599163	-	1.86e-01	GO:0038108	negative regulation of appetite by leptin-mediated signaling pathway	BP
1	4	2.32077599163	-	1.86e-01	GO:0045906	negative regulation of vasoconstriction	BP
1	4	2.32077599163	-	1.86e-01	GO:0033158	regulation of protein import into nucleus, translocation	BP
1	4	2.32077599163	-	1.86e-01	GO:1903936	cellular response to sodium arsenite	BP
1	4	2.32077599163	-	1.86e-01	GO:1901984	negative regulation of protein acetylation	BP
1	4	2.32077599163	-	1.86e-01	GO:0060355	positive regulation of cell adhesion molecule production	BP
1	4	2.32077599163	-	1.86e-01	GO:0014904	myotube cell development	BP
1	4	2.32077599163	-	1.86e-01	GO:0048633	positive regulation of skeletal muscle tissue growth	BP
1	4	2.32077599163	-	1.86e-01	GO:0022405	hair cycle process	BP
1	4	2.32077599163	-	1.86e-01	GO:0045716	positive regulation of low-density lipoprotein particle receptor biosynthetic process	BP
1	4	2.32077599163	-	1.86e-01	GO:0035021	negative regulation of Rac protein signal transduction	BP
1	4	2.32077599163	-	1.86e-01	GO:0061041	regulation of wound healing	BP
1	4	2.32077599163	-	1.86e-01	GO:1990086	lens fiber cell apoptotic process	BP
1	4	2.32077599163	-	1.86e-01	GO:0072289	metanephric nephron tubule formation	BP
1	4	2.32077599163	-	1.86e-01	GO:0048861	leukemia inhibitory factor signaling pathway	BP
1	4	2.32077599163	-	1.86e-01	GO:1902714	negative regulation of interferon-gamma secretion	BP
1	4	2.32077599163	-	1.86e-01	GO:0071726	cellular response to diacyl bacterial lipopeptide	BP
1	4	2.32077599163	-	1.86e-01	GO:0006990	positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response	BP
1	4	2.32077599163	-	1.86e-01	GO:0000904	cell morphogenesis involved in differentiation	BP
1	4	2.32077599163	-	1.86e-01	GO:0045619	regulation of lymphocyte differentiation	BP
1	4	2.32077599163	-	1.86e-01	GO:0071315	cellular response to morphine	BP
1	4	2.32077599163	-	1.86e-01	GO:0046425	regulation of JAK-STAT cascade	BP
1	4	2.32077599163	-	1.86e-01	GO:0051645	Golgi localization	BP
1	4	2.32077599163	-	1.86e-01	GO:0032909	regulation of transforming growth factor beta2 production	BP
5	20	2.32077599163	-	1.16e-03	GO:0005086	ARF guanyl-nucleotide exchange factor activity	MF
2	8	2.32077599163	-	2.26e-02	GO:0019213	deacetylase activity	MF
2	8	2.32077599163	-	4.44e-02	GO:0042379	chemokine receptor binding	MF
2	8	2.32077599163	-	4.44e-02	GO:0102991	myristoyl-CoA hydrolase activity	MF
2	8	2.32077599163	-	5.73e-02	GO:0097027	ubiquitin-protein transferase activator activity	MF
2	8	2.32077599163	-	5.73e-02	GO:0008140	cAMP response element binding protein binding	MF
2	8	2.32077599163	-	5.73e-02	GO:0035591	signaling adaptor activity	MF
1	4	2.32077599163	-	9.76e-02	GO:0031628	opioid receptor binding	MF
1	4	2.32077599163	-	9.76e-02	GO:0016286	small conductance calcium-activated potassium channel activity	MF
1	4	2.32077599163	-	9.76e-02	GO:0005332	gamma-aminobutyric acid:sodium symporter activity	MF
1	4	2.32077599163	-	9.76e-02	GO:0055077	gap junction hemi-channel activity	MF
1	4	2.32077599163	-	1.43e-01	GO:0008509	anion transmembrane transporter activity	MF
1	4	2.32077599163	-	1.43e-01	GO:0090722	receptor-receptor interaction	MF
1	4	2.32077599163	-	1.43e-01	GO:0004647	phosphoserine phosphatase activity	MF
1	4	2.32077599163	-	1.43e-01	GO:0042030	ATPase inhibitor activity	MF
1	4	2.32077599163	-	1.43e-01	GO:0008453	alanine-glyoxylate transaminase activity	MF
1	4	2.32077599163	-	1.43e-01	GO:0005176	ErbB-2 class receptor binding	MF
1	4	2.32077599163	-	1.43e-01	GO:0001515	opioid peptide activity	MF
1	4	2.32077599163	-	1.86e-01	GO:0043208	glycosphingolipid binding	MF
1	4	2.32077599163	-	1.86e-01	GO:0001012	RNA polymerase II regulatory region DNA binding	MF
1	4	2.32077599163	-	1.86e-01	GO:0070851	growth factor receptor binding	MF
1	4	2.32077599163	-	1.86e-01	GO:0005329	dopamine transmembrane transporter activity	MF
1	4	2.32077599163	-	1.86e-01	GO:0003696	satellite DNA binding	MF
1	4	2.32077599163	-	1.86e-01	GO:0035877	death effector domain binding	MF
1	4	2.32077599163	-	1.86e-01	GO:0045159	myosin II binding	MF
1	4	2.32077599163	-	1.86e-01	GO:0019158	mannokinase activity	MF
1	4	2.32077599163	-	1.86e-01	GO:0043199	sulfate binding	MF
1	4	2.32077599163	-	1.86e-01	GO:0017136	NAD-dependent histone deacetylase activity	MF
1	4	2.32077599163	-	1.86e-01	GO:0008607	phosphorylase kinase regulator activity	MF
1	4	2.32077599163	-	1.86e-01	GO:0015085	calcium ion transmembrane transporter activity	MF
1	4	2.32077599163	-	1.86e-01	GO:0051425	PTB domain binding	MF
1	4	2.32077599163	-	1.86e-01	GO:0008865	fructokinase activity	MF
1	4	2.32077599163	-	1.86e-01	GO:0071535	RING-like zinc finger domain binding	MF
1	4	2.32077599163	-	1.86e-01	GO:0005497	androgen binding	MF
1	4	2.32077599163	-	1.86e-01	GO:0070053	thrombospondin receptor activity	MF
1	4	2.32077599163	-	1.86e-01	GO:0032564	dATP binding	MF
1	4	2.32077599163	-	1.86e-01	GO:0004897	ciliary neurotrophic factor receptor activity	MF
1	4	2.32077599163	-	1.86e-01	GO:0031698	beta-2 adrenergic receptor binding	MF
13	53	2.29329525521	-	3.20e-07	GO:0043406	positive regulation of MAP kinase activity	BP
19	78	2.28330128621	-	1.13e-09	GO:0008286	insulin receptor signaling pathway	BP
9	37	2.28124762745	-	1.85e-05	GO:0034332	adherens junction organization	BP
7	29	2.27014991856	-	1.66e-04	GO:0007205	protein kinase C-activating G-protein coupled receptor signaling pathway	BP
7	29	2.27014991856	-	3.59e-04	GO:0030032	lamellipodium assembly	BP
19	79	2.2649227569	-	2.13e-10	GO:0031295	T cell costimulation	BP
6	25	2.26188230258	-	7.45e-04	GO:0002053	positive regulation of mesenchymal cell proliferation	BP
6	25	2.26188230258	-	1.20e-03	GO:0045742	positive regulation of epidermal growth factor receptor signaling pathway	BP
17	71	2.25849171338	-	4.15e-08	GO:0048010	vascular endothelial growth factor receptor signaling pathway	BP
5	21	2.25038666374	-	2.56e-03	GO:0030879	mammary gland development	BP
5	21	2.25038666374	-	1.54e-03	GO:0043539	protein serine/threonine kinase activator activity	MF
5	21	2.25038666374	-	3.22e-03	GO:0051019	mitogen-activated protein kinase binding	MF
18	76	2.24277347963	-	7.95e-09	GO:0043410	positive regulation of MAPK cascade	BP
4	17	2.23331315038	-	4.16e-03	GO:0010975	regulation of neuron projection development	BP
4	17	2.23331315038	-	5.45e-03	GO:0001702	gastrulation with mouth forming second	BP
4	17	2.23331315038	-	5.45e-03	GO:0071375	cellular response to peptide hormone stimulus	BP
4	17	2.23331315038	-	8.78e-03	GO:0031668	cellular response to extracellular stimulus	BP
7	30	2.22124031808	-	2.81e-04	GO:0007259	JAK-STAT cascade	BP
32	138	2.21225153485	-	4.18e-15	GO:0001934	positive regulation of protein phosphorylation	BP
3	13	2.20529877421	-	1.52e-02	GO:0010763	positive regulation of fibroblast migration	BP
3	13	2.20529877421	-	1.52e-02	GO:0032228	regulation of synaptic transmission, GABAergic	BP
3	13	2.20529877421	-	1.52e-02	GO:0048546	digestive tract morphogenesis	BP
3	13	2.20529877421	-	1.52e-02	GO:0055089	fatty acid homeostasis	BP
3	13	2.20529877421	-	1.96e-02	GO:0019395	fatty acid oxidation	BP
3	13	2.20529877421	-	1.96e-02	GO:2000010	positive regulation of protein localization to cell surface	BP
3	13	2.20529877421	-	1.96e-02	GO:0035810	positive regulation of urine volume	BP
3	13	2.20529877421	-	2.45e-02	GO:0016242	negative regulation of macroautophagy	BP
3	13	2.20529877421	-	2.45e-02	GO:0033630	positive regulation of cell adhesion mediated by integrin	BP
3	13	2.20529877421	-	2.45e-02	GO:1904668	positive regulation of ubiquitin protein ligase activity	BP
5	22	2.18327246788	-	1.54e-03	GO:0097755	positive regulation of blood vessel diameter	BP
5	22	2.18327246788	-	2.56e-03	GO:0043536	positive regulation of blood vessel endothelial cell migration	BP
5	22	2.18327246788	-	4.00e-03	GO:0035257	nuclear hormone receptor binding	MF
25	110	2.18327246788	-	8.45e-12	GO:0030168	platelet activation	BP
7	31	2.1739346033	-	6.99e-04	GO:0031663	lipopolysaccharide-mediated signaling pathway	BP
10	45	2.15085099019	-	1.99e-05	GO:0030838	positive regulation of actin filament polymerization	BP
6	27	2.15085099019	-	9.52e-04	GO:2000352	negative regulation of endothelial cell apoptotic process	BP
4	18	2.15085099019	-	1.55e-03	GO:0030539	male genitalia development	BP
4	18	2.15085099019	-	5.45e-03	GO:0090026	positive regulation of monocyte chemotaxis	BP
4	18	2.15085099019	-	5.45e-03	GO:0046427	positive regulation of JAK-STAT cascade	BP
2	9	2.15085099019	-	7.25e-03	GO:0016051	carbohydrate biosynthetic process	BP
4	18	2.15085099019	-	8.78e-03	GO:0030325	adrenal gland development	BP
4	18	2.15085099019	-	8.78e-03	GO:0035024	negative regulation of Rho protein signal transduction	BP
4	18	2.15085099019	-	8.78e-03	GO:0030225	macrophage differentiation	BP
4	18	2.15085099019	-	8.78e-03	GO:2000114	regulation of establishment of cell polarity	BP
4	18	2.15085099019	-	8.78e-03	GO:0050860	negative regulation of T cell receptor signaling pathway	BP
4	18	2.15085099019	-	1.08e-02	GO:0045821	positive regulation of glycolytic process	BP
2	9	2.15085099019	-	3.28e-02	GO:0002315	marginal zone B cell differentiation	BP
2	9	2.15085099019	-	3.28e-02	GO:0032099	negative regulation of appetite	BP
2	9	2.15085099019	-	4.44e-02	GO:2001223	negative regulation of neuron migration	BP
2	9	2.15085099019	-	4.44e-02	GO:0006518	peptide metabolic process	BP
2	9	2.15085099019	-	4.44e-02	GO:0048643	positive regulation of skeletal muscle tissue development	BP
2	9	2.15085099019	-	4.44e-02	GO:0061549	sympathetic ganglion development	BP
2	9	2.15085099019	-	4.44e-02	GO:0010579	positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway	BP
2	9	2.15085099019	-	4.44e-02	GO:0045124	regulation of bone resorption	BP
2	9	2.15085099019	-	4.44e-02	GO:0035767	endothelial cell chemotaxis	BP
2	9	2.15085099019	-	5.73e-02	GO:0030836	positive regulation of actin filament depolymerization	BP
2	9	2.15085099019	-	5.73e-02	GO:0019953	sexual reproduction	BP
2	9	2.15085099019	-	5.73e-02	GO:0042119	neutrophil activation	BP
2	9	2.15085099019	-	5.73e-02	GO:0060231	mesenchymal to epithelial transition	BP
2	9	2.15085099019	-	5.73e-02	GO:0006111	regulation of gluconeogenesis	BP
2	9	2.15085099019	-	5.73e-02	GO:0001818	negative regulation of cytokine production	BP
2	9	2.15085099019	-	5.73e-02	GO:0006105	succinate metabolic process	BP
2	9	2.15085099019	-	5.73e-02	GO:0003197	endocardial cushion development	BP
2	9	2.15085099019	-	5.73e-02	GO:0032886	regulation of microtubule-based process	BP
2	9	2.15085099019	-	5.73e-02	GO:0051974	negative regulation of telomerase activity	BP
2	9	2.15085099019	-	5.73e-02	GO:0048660	regulation of smooth muscle cell proliferation	BP
2	9	2.15085099019	-	7.13e-02	GO:0051146	striated muscle cell differentiation	BP
2	9	2.15085099019	-	7.13e-02	GO:0050807	regulation of synapse organization	BP
2	9	2.15085099019	-	7.13e-02	GO:0003149	membranous septum morphogenesis	BP
2	9	2.15085099019	-	7.13e-02	GO:0043068	positive regulation of programmed cell death	BP
2	9	2.15085099019	-	7.13e-02	GO:0043534	blood vessel endothelial cell migration	BP
2	9	2.15085099019	-	7.13e-02	GO:0010944	negative regulation of transcription by competitive promoter binding	BP
2	9	2.15085099019	-	7.13e-02	GO:0043589	skin morphogenesis	BP
2	9	2.15085099019	-	7.13e-02	GO:0033762	response to glucagon	BP
2	9	2.15085099019	-	7.13e-02	GO:0031497	chromatin assembly	BP
2	9	2.15085099019	-	7.13e-02	GO:0046621	negative regulation of organ growth	BP
2	9	2.15085099019	-	7.13e-02	GO:0034333	adherens junction assembly	BP
2	9	2.15085099019	-	7.13e-02	GO:0022407	regulation of cell-cell adhesion	BP
2	9	2.15085099019	-	7.13e-02	GO:0038063	collagen-activated tyrosine kinase receptor signaling pathway	BP
2	9	2.15085099019	-	7.13e-02	GO:0032000	positive regulation of fatty acid beta-oxidation	BP
6	27	2.15085099019	-	4.37e-04	GO:0004435	phosphatidylinositol phospholipase C activity	MF
4	18	2.15085099019	-	1.02e-03	GO:0005520	insulin-like growth factor binding	MF
2	9	2.15085099019	-	4.44e-02	GO:0031404	chloride ion binding	MF
2	9	2.15085099019	-	7.13e-02	GO:0034713	type I transforming growth factor beta receptor binding	MF
2	9	2.15085099019	-	7.13e-02	GO:0008821	crossover junction endodeoxyribonuclease activity	MF
2	9	2.15085099019	-	7.13e-02	GO:0019887	protein kinase regulator activity	MF
9	41	2.13314898846	-	1.02e-04	GO:0045740	positive regulation of DNA replication	BP
7	32	2.12813091369	-	2.81e-04	GO:0032007	negative regulation of TOR signaling	BP
7	32	2.12813091369	-	5.65e-04	GO:0001932	regulation of protein phosphorylation	BP
8	37	2.111322626	-	1.72e-04	GO:0010507	negative regulation of autophagy	BP
8	37	2.111322626	-	1.72e-04	GO:0005547	phosphatidylinositol-3,4,5-trisphosphate binding	MF
15	70	2.0983835703	-	1.46e-06	GO:0016241	regulation of macroautophagy	BP
9	42	2.0983835703	-	1.54e-04	GO:0045429	positive regulation of nitric oxide biosynthetic process	BP
6	28	2.0983835703	-	9.52e-04	GO:0032148	activation of protein kinase B activity	BP
3	14	2.0983835703	-	1.52e-02	GO:0043303	mast cell degranulation	BP
3	14	2.0983835703	-	1.52e-02	GO:0061045	negative regulation of wound healing	BP
3	14	2.0983835703	-	1.96e-02	GO:0060065	uterus development	BP
3	14	2.0983835703	-	1.96e-02	GO:0045721	negative regulation of gluconeogenesis	BP
3	14	2.0983835703	-	1.96e-02	GO:0031641	regulation of myelination	BP
3	14	2.0983835703	-	3.00e-02	GO:0043069	negative regulation of programmed cell death	BP
3	14	2.0983835703	-	3.00e-02	GO:0008631	intrinsic apoptotic signaling pathway in response to oxidative stress	BP
3	14	2.0983835703	-	3.00e-02	GO:0042993	positive regulation of transcription factor import into nucleus	BP
3	14	2.0983835703	-	3.00e-02	GO:0031529	ruffle organization	BP
3	14	2.0983835703	-	3.00e-02	GO:0060644	mammary gland epithelial cell differentiation	BP
3	14	2.0983835703	-	3.00e-02	GO:0007175	negative regulation of epidermal growth factor-activated receptor activity	BP
3	14	2.0983835703	-	3.00e-02	GO:0032006	regulation of TOR signaling	BP
14	66	2.08373679433	-	2.52e-06	GO:0032147	activation of protein kinase activity	BP
7	33	2.08373679433	-	6.99e-04	GO:0005154	epidermal growth factor receptor binding	MF
4	19	2.07284847819	-	8.78e-03	GO:0036120	cellular response to platelet-derived growth factor stimulus	BP
4	19	2.07284847819	-	8.78e-03	GO:0051968	positive regulation of synaptic transmission, glutamatergic	BP
4	19	2.07284847819	-	1.32e-02	GO:1900182	positive regulation of protein localization to nucleus	BP
4	19	2.07284847819	-	8.78e-03	GO:0030506	ankyrin binding	MF
4	19	2.07284847819	-	1.08e-02	GO:0008157	protein phosphatase 1 binding	MF
9	43	2.06443623837	-	8.22e-05	GO:0042110	T cell activation	BP
5	24	2.0577415858	-	4.90e-03	GO:0048041	focal adhesion assembly	BP
5	24	2.0577415858	-	5.94e-03	GO:1901216	positive regulation of neuron death	BP
16	77	2.05398945094	-	1.67e-07	GO:0042060	wound healing	BP
6	29	2.04775749723	-	1.20e-03	GO:2000379	positive regulation of reactive oxygen species metabolic process	BP
7	34	2.04066807244	-	1.04e-03	GO:0097194	execution phase of apoptosis	BP
8	39	2.03537377277	-	1.36e-04	GO:0006633	fatty acid biosynthetic process	BP
9	44	2.03126937444	-	7.57e-06	GO:0046426	negative regulation of JAK-STAT cascade	BP
20	98	2.0279942424	-	9.13e-09	GO:0035335	peptidyl-tyrosine dephosphorylation	BP
17	84	2.0159214101	-	4.03e-07	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	BP
18	89	2.01496756211	-	5.95e-08	GO:0004725	protein tyrosine phosphatase activity	MF
6	30	1.99884789674	-	1.84e-03	GO:0007281	germ cell development	BP
5	25	1.99884789674	-	2.00e-03	GO:0060349	bone morphogenesis	BP
5	25	1.99884789674	-	4.00e-03	GO:0050772	positive regulation of axonogenesis	BP
5	25	1.99884789674	-	4.00e-03	GO:0048709	oligodendrocyte differentiation	BP
5	25	1.99884789674	-	4.90e-03	GO:0030511	positive regulation of transforming growth factor beta receptor signaling pathway	BP
5	25	1.99884789674	-	7.13e-03	GO:0071353	cellular response to interleukin-4	BP
3	15	1.99884789674	-	1.52e-02	GO:0006112	energy reserve metabolic process	BP
3	15	1.99884789674	-	3.00e-02	GO:0097067	cellular response to thyroid hormone stimulus	BP
3	15	1.99884789674	-	3.00e-02	GO:0051412	response to corticosterone	BP
3	15	1.99884789674	-	3.00e-02	GO:0043254	regulation of protein complex assembly	BP
3	15	1.99884789674	-	3.62e-02	GO:2000484	positive regulation of interleukin-8 secretion	BP
3	15	1.99884789674	-	3.62e-02	GO:0043923	positive regulation by host of viral transcription	BP
3	15	1.99884789674	-	3.62e-02	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	BP
7	35	1.99884789674	-	1.25e-03	GO:0005057	signal transducer activity, downstream of receptor	MF
5	25	1.99884789674	-	5.94e-03	GO:0071889	14-3-3 protein binding	MF
25	125	1.99884789674	-	2.36e-10	GO:0006470	protein dephosphorylation	BP
2	10	1.99884789674	-	3.28e-02	GO:0002021	response to dietary excess	BP
2	10	1.99884789674	-	4.44e-02	GO:0048935	peripheral nervous system neuron development	BP
2	10	1.99884789674	-	4.44e-02	GO:0009100	glycoprotein metabolic process	BP
2	10	1.99884789674	-	5.73e-02	GO:0046325	negative regulation of glucose import	BP
2	10	1.99884789674	-	5.73e-02	GO:0048681	negative regulation of axon regeneration	BP
2	10	1.99884789674	-	5.73e-02	GO:0003300	cardiac muscle hypertrophy	BP
2	10	1.99884789674	-	7.13e-02	GO:0046638	positive regulation of alpha-beta T cell differentiation	BP
2	10	1.99884789674	-	7.13e-02	GO:0060674	placenta blood vessel development	BP
2	10	1.99884789674	-	7.13e-02	GO:0033673	negative regulation of kinase activity	BP
2	10	1.99884789674	-	7.13e-02	GO:0061564	axon development	BP
2	10	1.99884789674	-	7.13e-02	GO:0010954	positive regulation of protein processing	BP
2	10	1.99884789674	-	7.13e-02	GO:0003214	cardiac left ventricle morphogenesis	BP
2	10	1.99884789674	-	7.13e-02	GO:0045793	positive regulation of cell size	BP
2	10	1.99884789674	-	8.62e-02	GO:0031115	negative regulation of microtubule polymerization	BP
2	10	1.99884789674	-	8.62e-02	GO:0050678	regulation of epithelial cell proliferation	BP
2	10	1.99884789674	-	8.62e-02	GO:0031571	mitotic G1 DNA damage checkpoint	BP
2	10	1.99884789674	-	8.62e-02	GO:1902237	positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway	BP
2	10	1.99884789674	-	8.62e-02	GO:0001759	organ induction	BP
2	10	1.99884789674	-	8.62e-02	GO:0048304	positive regulation of isotype switching to IgG isotypes	BP
2	10	1.99884789674	-	8.62e-02	GO:0044320	cellular response to leptin stimulus	BP
2	10	1.99884789674	-	8.62e-02	GO:0006884	cell volume homeostasis	BP
2	10	1.99884789674	-	8.62e-02	GO:1901522	positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus	BP
2	10	1.99884789674	-	8.62e-02	GO:0016572	histone phosphorylation	BP
2	10	1.99884789674	-	8.62e-02	GO:0042982	amyloid precursor protein metabolic process	BP
2	10	1.99884789674	-	8.62e-02	GO:0043114	regulation of vascular permeability	BP
1	5	1.99884789674	-	9.76e-02	GO:0000320	re-entry into mitotic cell cycle	BP
1	5	1.99884789674	-	9.76e-02	GO:0043270	positive regulation of ion transport	BP
1	5	1.99884789674	-	9.76e-02	GO:0006873	cellular ion homeostasis	BP
1	5	1.99884789674	-	9.76e-02	GO:0050878	regulation of body fluid levels	BP
1	5	1.99884789674	-	9.76e-02	GO:0015812	gamma-aminobutyric acid transport	BP
1	5	1.99884789674	-	9.76e-02	GO:1905065	positive regulation of vascular smooth muscle cell differentiation	BP
1	5	1.99884789674	-	9.76e-02	GO:0042743	hydrogen peroxide metabolic process	BP
1	5	1.99884789674	-	1.43e-01	GO:0002385	mucosal immune response	BP
1	5	1.99884789674	-	1.43e-01	GO:0048645	animal organ formation	BP
1	5	1.99884789674	-	1.43e-01	GO:0021889	olfactory bulb interneuron differentiation	BP
1	5	1.99884789674	-	1.43e-01	GO:0002322	B cell proliferation involved in immune response	BP
1	5	1.99884789674	-	1.43e-01	GO:0060335	positive regulation of interferon-gamma-mediated signaling pathway	BP
1	5	1.99884789674	-	1.43e-01	GO:0061370	testosterone biosynthetic process	BP
1	5	1.99884789674	-	1.43e-01	GO:0046486	glycerolipid metabolic process	BP
1	5	1.99884789674	-	1.43e-01	GO:0048513	animal organ development	BP
1	5	1.99884789674	-	1.43e-01	GO:0002829	negative regulation of type 2 immune response	BP
1	5	1.99884789674	-	1.43e-01	GO:0032714	negative regulation of interleukin-5 production	BP
1	5	1.99884789674	-	1.43e-01	GO:0033004	negative regulation of mast cell activation	BP
1	5	1.99884789674	-	1.43e-01	GO:0060117	auditory receptor cell development	BP
1	5	1.99884789674	-	1.43e-01	GO:0060312	regulation of blood vessel remodeling	BP
1	5	1.99884789674	-	1.86e-01	GO:0048730	epidermis morphogenesis	BP
1	5	1.99884789674	-	1.86e-01	GO:0048733	sebaceous gland development	BP
1	5	1.99884789674	-	1.86e-01	GO:1900180	regulation of protein localization to nucleus	BP
1	5	1.99884789674	-	1.86e-01	GO:0045347	negative regulation of MHC class II biosynthetic process	BP
1	5	1.99884789674	-	1.86e-01	GO:0050851	antigen receptor-mediated signaling pathway	BP
1	5	1.99884789674	-	1.86e-01	GO:0046541	saliva secretion	BP
1	5	1.99884789674	-	1.86e-01	GO:1900020	positive regulation of protein kinase C activity	BP
1	5	1.99884789674	-	1.86e-01	GO:0003283	atrial septum development	BP
1	5	1.99884789674	-	1.86e-01	GO:0060666	dichotomous subdivision of terminal units involved in salivary gland branching	BP
1	5	1.99884789674	-	1.86e-01	GO:0075044	autophagy of host cells involved in interaction with symbiont	BP
1	5	1.99884789674	-	1.86e-01	GO:2000035	regulation of stem cell division	BP
1	5	1.99884789674	-	1.86e-01	GO:1904179	positive regulation of adipose tissue development	BP
1	5	1.99884789674	-	1.86e-01	GO:0031113	regulation of microtubule polymerization	BP
1	5	1.99884789674	-	1.86e-01	GO:0048562	embryonic organ morphogenesis	BP
1	5	1.99884789674	-	1.86e-01	GO:0046600	negative regulation of centriole replication	BP
1	5	1.99884789674	-	1.86e-01	GO:0007356	thorax and anterior abdomen determination	BP
1	5	1.99884789674	-	1.86e-01	GO:0070100	negative regulation of chemokine-mediated signaling pathway	BP
1	5	1.99884789674	-	1.86e-01	GO:0051754	meiotic sister chromatid cohesion, centromeric	BP
1	5	1.99884789674	-	1.86e-01	GO:0097500	receptor localization to non-motile cilium	BP
1	5	1.99884789674	-	1.86e-01	GO:0090080	positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway	BP
1	5	1.99884789674	-	1.86e-01	GO:2000987	positive regulation of behavioral fear response	BP
1	5	1.99884789674	-	1.86e-01	GO:0032237	activation of store-operated calcium channel activity	BP
1	5	1.99884789674	-	1.86e-01	GO:0032962	positive regulation of inositol trisphosphate biosynthetic process	BP
1	5	1.99884789674	-	1.86e-01	GO:1903142	positive regulation of establishment of endothelial barrier	BP
1	5	1.99884789674	-	1.86e-01	GO:0015696	ammonium transport	BP
1	5	1.99884789674	-	1.86e-01	GO:1901844	regulation of cell communication by electrical coupling involved in cardiac conduction	BP
1	5	1.99884789674	-	1.86e-01	GO:0001302	replicative cell aging	BP
1	5	1.99884789674	-	1.86e-01	GO:0010989	negative regulation of low-density lipoprotein particle clearance	BP
1	5	1.99884789674	-	1.86e-01	GO:0030300	regulation of intestinal cholesterol absorption	BP
1	5	1.99884789674	-	1.86e-01	GO:0031914	negative regulation of synaptic plasticity	BP
1	5	1.99884789674	-	1.86e-01	GO:0071205	protein localization to juxtaparanode region of axon	BP
1	5	1.99884789674	-	1.86e-01	GO:0016101	diterpenoid metabolic process	BP
1	5	1.99884789674	-	1.86e-01	GO:0050716	positive regulation of interleukin-1 secretion	BP
1	5	1.99884789674	-	1.86e-01	GO:0072162	metanephric mesenchymal cell differentiation	BP
1	5	1.99884789674	-	1.86e-01	GO:0032224	positive regulation of synaptic transmission, cholinergic	BP
1	5	1.99884789674	-	1.86e-01	GO:2000110	negative regulation of macrophage apoptotic process	BP
1	5	1.99884789674	-	1.86e-01	GO:1904888	cranial skeletal system development	BP
1	5	1.99884789674	-	1.86e-01	GO:0021650	vestibulocochlear nerve formation	BP
1	5	1.99884789674	-	1.86e-01	GO:0045542	positive regulation of cholesterol biosynthetic process	BP
1	5	1.99884789674	-	1.86e-01	GO:0021696	cerebellar cortex morphogenesis	BP
1	5	1.99884789674	-	1.86e-01	GO:0043367	CD4-positive, alpha-beta T cell differentiation	BP
1	5	1.99884789674	-	1.86e-01	GO:0090650	cellular response to oxygen-glucose deprivation	BP
1	5	1.99884789674	-	1.86e-01	GO:0048864	stem cell development	BP
1	5	1.99884789674	-	1.86e-01	GO:0031427	response to methotrexate	BP
1	5	1.99884789674	-	1.86e-01	GO:0010668	ectodermal cell differentiation	BP
1	5	1.99884789674	-	2.26e-01	GO:0006623	protein targeting to vacuole	BP
1	5	1.99884789674	-	2.26e-01	GO:0072656	maintenance of protein location in mitochondrion	BP
1	5	1.99884789674	-	2.26e-01	GO:0072655	establishment of protein localization to mitochondrion	BP
1	5	1.99884789674	-	2.26e-01	GO:0002551	mast cell chemotaxis	BP
1	5	1.99884789674	-	2.26e-01	GO:0010656	negative regulation of muscle cell apoptotic process	BP
1	5	1.99884789674	-	2.26e-01	GO:0034137	positive regulation of toll-like receptor 2 signaling pathway	BP
1	5	1.99884789674	-	2.26e-01	GO:0007262	STAT protein import into nucleus	BP
1	5	1.99884789674	-	2.26e-01	GO:0071225	cellular response to muramyl dipeptide	BP
1	5	1.99884789674	-	2.26e-01	GO:0031622	positive regulation of fever generation	BP
1	5	1.99884789674	-	2.26e-01	GO:0007501	mesodermal cell fate specification	BP
1	5	1.99884789674	-	2.26e-01	GO:2000481	positive regulation of cAMP-dependent protein kinase activity	BP
1	5	1.99884789674	-	2.26e-01	GO:0060028	convergent extension involved in axis elongation	BP
1	5	1.99884789674	-	2.26e-01	GO:0030242	autophagy of peroxisome	BP
1	5	1.99884789674	-	2.26e-01	GO:0050920	regulation of chemotaxis	BP
1	5	1.99884789674	-	2.26e-01	GO:0065004	protein-DNA complex assembly	BP
1	5	1.99884789674	-	2.26e-01	GO:0042306	regulation of protein import into nucleus	BP
1	5	1.99884789674	-	2.26e-01	GO:0060744	mammary gland branching involved in thelarche	BP
1	5	1.99884789674	-	2.26e-01	GO:0051823	regulation of synapse structural plasticity	BP
1	5	1.99884789674	-	2.26e-01	GO:1902749	regulation of cell cycle G2/M phase transition	BP
1	5	1.99884789674	-	2.26e-01	GO:1902961	positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process	BP
1	5	1.99884789674	-	2.26e-01	GO:0000707	meiotic DNA recombinase assembly	BP
1	5	1.99884789674	-	2.26e-01	GO:0061624	fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate	BP
1	5	1.99884789674	-	2.26e-01	GO:1905007	positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation	BP
1	5	1.99884789674	-	2.26e-01	GO:0046085	adenosine metabolic process	BP
1	5	1.99884789674	-	2.26e-01	GO:1902262	apoptotic process involved in blood vessel morphogenesis	BP
1	5	1.99884789674	-	2.26e-01	GO:0031536	positive regulation of exit from mitosis	BP
1	5	1.99884789674	-	2.26e-01	GO:0019640	glucuronate catabolic process to xylulose 5-phosphate	BP
1	5	1.99884789674	-	2.26e-01	GO:0001915	negative regulation of T cell mediated cytotoxicity	BP
1	5	1.99884789674	-	2.26e-01	GO:1990441	negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress	BP
1	5	1.99884789674	-	2.26e-01	GO:0045646	regulation of erythrocyte differentiation	BP
1	5	1.99884789674	-	2.26e-01	GO:0010936	negative regulation of macrophage cytokine production	BP
1	5	1.99884789674	-	2.26e-01	GO:1904714	regulation of chaperone-mediated autophagy	BP
1	5	1.99884789674	-	2.26e-01	GO:0048298	positive regulation of isotype switching to IgA isotypes	BP
1	5	1.99884789674	-	2.26e-01	GO:0060179	male mating behavior	BP
1	5	1.99884789674	-	2.26e-01	GO:1903753	negative regulation of p38MAPK cascade	BP
1	5	1.99884789674	-	2.26e-01	GO:0010830	regulation of myotube differentiation	BP
1	5	1.99884789674	-	2.26e-01	GO:0008063	Toll signaling pathway	BP
1	5	1.99884789674	-	2.26e-01	GO:0046578	regulation of Ras protein signal transduction	BP
1	5	1.99884789674	-	2.26e-01	GO:1903912	negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation	BP
1	5	1.99884789674	-	2.26e-01	GO:0001661	conditioned taste aversion	BP
1	5	1.99884789674	-	2.26e-01	GO:0032747	positive regulation of interleukin-23 production	BP
1	5	1.99884789674	-	2.26e-01	GO:0045843	negative regulation of striated muscle tissue development	BP
1	5	1.99884789674	-	2.26e-01	GO:0040020	regulation of meiotic nuclear division	BP
1	5	1.99884789674	-	2.26e-01	GO:0048841	regulation of axon extension involved in axon guidance	BP
1	5	1.99884789674	-	2.26e-01	GO:0048755	branching morphogenesis of a nerve	BP
1	5	1.99884789674	-	2.26e-01	GO:0002082	regulation of oxidative phosphorylation	BP
1	5	1.99884789674	-	2.26e-01	GO:0015697	quaternary ammonium group transport	BP
1	5	1.99884789674	-	2.26e-01	GO:0030854	positive regulation of granulocyte differentiation	BP
1	5	1.99884789674	-	2.26e-01	GO:0046651	lymphocyte proliferation	BP
1	5	1.99884789674	-	2.26e-01	GO:0071332	cellular response to fructose stimulus	BP
1	5	1.99884789674	-	2.26e-01	GO:0032410	negative regulation of transporter activity	BP
1	5	1.99884789674	-	2.26e-01	GO:0072584	caveolin-mediated endocytosis	BP
1	5	1.99884789674	-	2.26e-01	GO:0071376	cellular response to corticotropin-releasing hormone stimulus	BP
1	5	1.99884789674	-	2.26e-01	GO:1900086	positive regulation of peptidyl-tyrosine autophosphorylation	BP
1	5	1.99884789674	-	2.26e-01	GO:0090240	positive regulation of histone H4 acetylation	BP
1	5	1.99884789674	-	2.26e-01	GO:0036035	osteoclast development	BP
1	5	1.99884789674	-	2.26e-01	GO:0006537	glutamate biosynthetic process	BP
1	5	1.99884789674	-	2.26e-01	GO:0071864	positive regulation of cell proliferation in bone marrow	BP
1	5	1.99884789674	-	2.26e-01	GO:0048341	paraxial mesoderm formation	BP
1	5	1.99884789674	-	2.26e-01	GO:1903416	response to glycoside	BP
1	5	1.99884789674	-	2.26e-01	GO:0046883	regulation of hormone secretion	BP
1	5	1.99884789674	-	2.26e-01	GO:0033081	regulation of T cell differentiation in thymus	BP
1	5	1.99884789674	-	2.26e-01	GO:0030263	apoptotic chromosome condensation	BP
1	5	1.99884789674	-	2.26e-01	GO:0038033	positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway	BP
1	5	1.99884789674	-	2.26e-01	GO:0060761	negative regulation of response to cytokine stimulus	BP
1	5	1.99884789674	-	2.26e-01	GO:0031133	regulation of axon diameter	BP
1	5	1.99884789674	-	2.26e-01	GO:0002260	lymphocyte homeostasis	BP
1	5	1.99884789674	-	2.26e-01	GO:0002725	negative regulation of T cell cytokine production	BP
1	5	1.99884789674	-	2.26e-01	GO:0070245	positive regulation of thymocyte apoptotic process	BP
1	5	1.99884789674	-	2.26e-01	GO:1904885	beta-catenin destruction complex assembly	BP
1	5	1.99884789674	-	2.26e-01	GO:0051220	cytoplasmic sequestering of protein	BP
1	5	1.99884789674	-	2.26e-01	GO:0051224	negative regulation of protein transport	BP
1	5	1.99884789674	-	2.26e-01	GO:0098887	neurotransmitter receptor transport, endosome to postsynaptic membrane	BP
1	5	1.99884789674	-	2.26e-01	GO:0032876	negative regulation of DNA endoreduplication	BP
1	5	1.99884789674	-	2.26e-01	GO:2000535	regulation of entry of bacterium into host cell	BP
1	5	1.99884789674	-	2.26e-01	GO:0033153	T cell receptor V(D)J recombination	BP
1	5	1.99884789674	-	2.26e-01	GO:0070120	ciliary neurotrophic factor-mediated signaling pathway	BP
1	5	1.99884789674	-	2.26e-01	GO:0021861	forebrain radial glial cell differentiation	BP
1	5	1.99884789674	-	2.26e-01	GO:0045541	negative regulation of cholesterol biosynthetic process	BP
1	5	1.99884789674	-	2.26e-01	GO:1900015	regulation of cytokine production involved in inflammatory response	BP
1	5	1.99884789674	-	2.26e-01	GO:0051534	negative regulation of NFAT protein import into nucleus	BP
1	5	1.99884789674	-	2.26e-01	GO:0051573	negative regulation of histone H3-K9 methylation	BP
1	5	1.99884789674	-	2.26e-01	GO:1900103	positive regulation of endoplasmic reticulum unfolded protein response	BP
1	5	1.99884789674	-	2.26e-01	GO:0042501	serine phosphorylation of STAT protein	BP
1	5	1.99884789674	-	2.26e-01	GO:0033564	anterior/posterior axon guidance	BP
1	5	1.99884789674	-	2.26e-01	GO:0021952	central nervous system projection neuron axonogenesis	BP
1	5	1.99884789674	-	2.26e-01	GO:1903361	protein localization to basolateral plasma membrane	BP
1	5	1.99884789674	-	2.26e-01	GO:0060385	axonogenesis involved in innervation	BP
2	10	1.99884789674	-	7.13e-02	GO:0036312	phosphatidylinositol 3-kinase regulatory subunit binding	MF
2	10	1.99884789674	-	7.13e-02	GO:0030296	protein tyrosine kinase activator activity	MF
2	10	1.99884789674	-	8.62e-02	GO:0033558	protein deacetylase activity	MF
2	10	1.99884789674	-	8.62e-02	GO:0031702	type 1 angiotensin receptor binding	MF
2	10	1.99884789674	-	8.62e-02	GO:0045294	alpha-catenin binding	MF
2	10	1.99884789674	-	8.62e-02	GO:1990782	protein tyrosine kinase binding	MF
1	5	1.99884789674	-	1.43e-01	GO:0042392	sphingosine-1-phosphate phosphatase activity	MF
1	5	1.99884789674	-	1.43e-01	GO:0005280	hydrogen:amino acid symporter activity	MF
1	5	1.99884789674	-	1.43e-01	GO:0017176	phosphatidylinositol N-acetylglucosaminyltransferase activity	MF
1	5	1.99884789674	-	1.43e-01	GO:0008175	tRNA methyltransferase activity	MF
1	5	1.99884789674	-	1.43e-01	GO:0001609	G-protein coupled adenosine receptor activity	MF
1	5	1.99884789674	-	1.86e-01	GO:0052811	1-phosphatidylinositol-3-phosphate 4-kinase activity	MF
1	5	1.99884789674	-	1.86e-01	GO:0034979	NAD-dependent protein deacetylase activity	MF
1	5	1.99884789674	-	1.86e-01	GO:0071813	lipoprotein particle binding	MF
1	5	1.99884789674	-	1.86e-01	GO:0019871	sodium channel inhibitor activity	MF
1	5	1.99884789674	-	1.86e-01	GO:0005127	ciliary neurotrophic factor receptor binding	MF
1	5	1.99884789674	-	1.86e-01	GO:0070290	N-acylphosphatidylethanolamine-specific phospholipase D activity	MF
1	5	1.99884789674	-	1.86e-01	GO:0098519	nucleotide phosphatase activity, acting on free nucleotides	MF
1	5	1.99884789674	-	1.86e-01	GO:1990254	keratin filament binding	MF
1	5	1.99884789674	-	1.86e-01	GO:0031726	CCR1 chemokine receptor binding	MF
1	5	1.99884789674	-	1.86e-01	GO:1990405	protein antigen binding	MF
1	5	1.99884789674	-	1.86e-01	GO:0004556	alpha-amylase activity	MF
1	5	1.99884789674	-	1.86e-01	GO:0035727	lysophosphatidic acid binding	MF
1	5	1.99884789674	-	2.26e-01	GO:0051373	FATZ binding	MF
1	5	1.99884789674	-	2.26e-01	GO:0044388	small protein activating enzyme binding	MF
1	5	1.99884789674	-	2.26e-01	GO:0010385	double-stranded methylated DNA binding	MF
1	5	1.99884789674	-	2.26e-01	GO:0097100	supercoiled DNA binding	MF
1	5	1.99884789674	-	2.26e-01	GO:0048029	monosaccharide binding	MF
1	5	1.99884789674	-	2.26e-01	GO:0019210	kinase inhibitor activity	MF
1	5	1.99884789674	-	2.26e-01	GO:0015651	quaternary ammonium group transmembrane transporter activity	MF
1	5	1.99884789674	-	2.26e-01	GO:0030618	transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity	MF
1	5	1.99884789674	-	2.26e-01	GO:0070061	fructose binding	MF
1	5	1.99884789674	-	2.26e-01	GO:0005134	interleukin-2 receptor binding	MF
1	5	1.99884789674	-	2.26e-01	GO:0038132	neuregulin binding	MF
1	5	1.99884789674	-	2.26e-01	GO:0032407	MutSalpha complex binding	MF
1	5	1.99884789674	-	2.26e-01	GO:0008046	axon guidance receptor activity	MF
1	5	1.99884789674	-	2.26e-01	GO:0001875	lipopolysaccharide receptor activity	MF
1	5	1.99884789674	-	2.26e-01	GO:0000988	transcription factor activity, protein binding	MF
1	5	1.99884789674	-	2.26e-01	GO:0004340	glucokinase activity	MF
1	5	1.99884789674	-	2.26e-01	GO:0005143	interleukin-12 receptor binding	MF
8	41	1.96322398701	-	4.00e-04	GO:0010718	positive regulation of epithelial to mesenchymal transition	BP
8	41	1.96322398701	-	6.98e-04	GO:0010508	positive regulation of autophagy	BP
6	31	1.95154218197	-	9.52e-04	GO:0048565	digestive tract development	BP
6	31	1.95154218197	-	2.25e-03	GO:0046326	positive regulation of glucose import	BP
6	31	1.95154218197	-	2.72e-03	GO:0071276	cellular response to cadmium ion	BP
6	31	1.95154218197	-	3.87e-03	GO:0042059	negative regulation of epidermal growth factor receptor signaling pathway	BP
6	31	1.95154218197	-	3.87e-03	GO:0097421	liver regeneration	BP
11	57	1.9473175961	-	6.06e-05	GO:0048661	positive regulation of smooth muscle cell proliferation	BP
27	140	1.94638047685	-	9.81e-11	GO:0007050	cell cycle arrest	BP
36	187	1.94380653319	-	1.78e-14	GO:0030335	positive regulation of cell migration	BP
10	52	1.94226436838	-	7.30e-05	GO:0060326	cell chemotaxis	BP
5	26	1.94226436838	-	8.47e-03	GO:0016239	positive regulation of macroautophagy	BP
9	47	1.9361121414	-	4.59e-04	GO:0000186	activation of MAPKK activity	BP
4	21	1.92845856885	-	1.08e-02	GO:0035902	response to immobilization stress	BP
4	21	1.92845856885	-	1.08e-02	GO:0046697	decidualization	BP
4	21	1.92845856885	-	1.32e-02	GO:0042730	fibrinolysis	BP
4	21	1.92845856885	-	1.59e-02	GO:0003148	outflow tract septum morphogenesis	BP
18	96	1.90573849235	-	1.32e-07	GO:0042593	glucose homeostasis	BP
6	32	1.90573849235	-	3.25e-03	GO:0032008	positive regulation of TOR signaling	BP
6	32	1.90573849235	-	3.87e-03	GO:0046677	response to antibiotic	BP
6	32	1.90573849235	-	4.56e-03	GO:1990090	cellular response to nerve growth factor stimulus	BP
3	16	1.90573849235	-	2.45e-02	GO:0048714	positive regulation of oligodendrocyte differentiation	BP
3	16	1.90573849235	-	3.62e-02	GO:0010633	negative regulation of epithelial cell migration	BP
3	16	1.90573849235	-	4.29e-02	GO:0046328	regulation of JNK cascade	BP
3	16	1.90573849235	-	4.29e-02	GO:0001935	endothelial cell proliferation	BP
15	80	1.90573849235	-	3.07e-06	GO:0008013	beta-catenin binding	MF
5	27	1.88781658436	-	5.94e-03	GO:0046580	negative regulation of Ras protein signal transduction	BP
5	27	1.88781658436	-	7.13e-03	GO:0051281	positive regulation of release of sequestered calcium ion into cytosol	BP
5	27	1.88781658436	-	9.98e-03	GO:0051721	protein phosphatase 2A binding	MF
20	109	1.87451976174	-	1.51e-07	GO:0000187	activation of MAPK activity	BP
15	82	1.87011458262	-	2.14e-06	GO:0007229	integrin-mediated signaling pathway	BP
4	22	1.86134437299	-	1.08e-02	GO:0071157	negative regulation of cell cycle arrest	BP
4	22	1.86134437299	-	1.59e-02	GO:0035924	cellular response to vascular endothelial growth factor stimulus	BP
4	22	1.86134437299	-	1.59e-02	GO:1904886	beta-catenin destruction complex disassembly	BP
4	22	1.86134437299	-	1.88e-02	GO:0045453	bone resorption	BP
4	22	1.86134437299	-	2.21e-02	GO:0048568	embryonic organ development	BP
2	11	1.86134437299	-	4.44e-02	GO:0006702	androgen biosynthetic process	BP
2	11	1.86134437299	-	4.44e-02	GO:0015867	ATP transport	BP
2	11	1.86134437299	-	4.44e-02	GO:1903672	positive regulation of sprouting angiogenesis	BP
2	11	1.86134437299	-	5.73e-02	GO:0031639	plasminogen activation	BP
2	11	1.86134437299	-	5.73e-02	GO:0003323	type B pancreatic cell development	BP
2	11	1.86134437299	-	5.73e-02	GO:0048016	inositol phosphate-mediated signaling	BP
2	11	1.86134437299	-	7.13e-02	GO:0070997	neuron death	BP
2	11	1.86134437299	-	7.13e-02	GO:0002675	positive regulation of acute inflammatory response	BP
2	11	1.86134437299	-	7.13e-02	GO:0046488	phosphatidylinositol metabolic process	BP
2	11	1.86134437299	-	7.13e-02	GO:0035414	negative regulation of catenin import into nucleus	BP
2	11	1.86134437299	-	8.62e-02	GO:0001952	regulation of cell-matrix adhesion	BP
2	11	1.86134437299	-	8.62e-02	GO:0006473	protein acetylation	BP
2	11	1.86134437299	-	8.62e-02	GO:0043116	negative regulation of vascular permeability	BP
2	11	1.86134437299	-	8.62e-02	GO:0030850	prostate gland development	BP
2	11	1.86134437299	-	8.62e-02	GO:0050862	positive regulation of T cell receptor signaling pathway	BP
2	11	1.86134437299	-	8.62e-02	GO:0035413	positive regulation of catenin import into nucleus	BP
2	11	1.86134437299	-	8.62e-02	GO:0060445	branching involved in salivary gland morphogenesis	BP
2	11	1.86134437299	-	1.02e-01	GO:0071803	positive regulation of podosome assembly	BP
2	11	1.86134437299	-	1.02e-01	GO:0071383	cellular response to steroid hormone stimulus	BP
2	11	1.86134437299	-	1.02e-01	GO:0070914	UV-damage excision repair	BP
2	11	1.86134437299	-	1.02e-01	GO:0031065	positive regulation of histone deacetylation	BP
2	11	1.86134437299	-	1.02e-01	GO:0032700	negative regulation of interleukin-17 production	BP
2	11	1.86134437299	-	1.02e-01	GO:0006600	creatine metabolic process	BP
2	11	1.86134437299	-	1.02e-01	GO:0048712	negative regulation of astrocyte differentiation	BP
2	11	1.86134437299	-	1.02e-01	GO:0033197	response to vitamin E	BP
2	11	1.86134437299	-	1.02e-01	GO:0016064	immunoglobulin mediated immune response	BP
2	11	1.86134437299	-	1.02e-01	GO:0060444	branching involved in mammary gland duct morphogenesis	BP
2	11	1.86134437299	-	4.44e-02	GO:0015078	hydrogen ion transmembrane transporter activity	MF
2	11	1.86134437299	-	8.62e-02	GO:0048407	platelet-derived growth factor binding	MF
2	11	1.86134437299	-	8.62e-02	GO:0016290	palmitoyl-CoA hydrolase activity	MF
2	11	1.86134437299	-	1.02e-01	GO:0008093	cytoskeletal adaptor activity	MF
31	172	1.84870754732	-	7.47e-12	GO:0042127	regulation of cell proliferation	BP
7	39	1.84272869483	-	1.25e-03	GO:0050918	positive chemotaxis	BP
7	39	1.84272869483	-	2.47e-03	GO:0030155	regulation of cell adhesion	BP
5	28	1.83534916446	-	3.22e-03	GO:0060338	regulation of type I interferon-mediated signaling pathway	BP
10	56	1.83534916446	-	1.54e-04	GO:0004722	protein serine/threonine phosphatase activity	MF
5	28	1.83534916446	-	1.17e-02	GO:0097718	disordered domain specific binding	MF
8	45	1.8289228953	-	6.98e-04	GO:0032956	regulation of actin cytoskeleton organization	BP
9	51	1.8182756511	-	3.88e-04	GO:0045860	positive regulation of protein kinase activity	BP
3	17	1.8182756511	-	2.45e-02	GO:0009948	anterior/posterior axis specification	BP
3	17	1.8182756511	-	2.45e-02	GO:0001953	negative regulation of cell-matrix adhesion	BP
3	17	1.8182756511	-	3.00e-02	GO:0007043	cell-cell junction assembly	BP
3	17	1.8182756511	-	3.62e-02	GO:0006103	2-oxoglutarate metabolic process	BP
3	17	1.8182756511	-	3.62e-02	GO:0071380	cellular response to prostaglandin E stimulus	BP
3	17	1.8182756511	-	4.29e-02	GO:1990138	neuron projection extension	BP
3	17	1.8182756511	-	4.29e-02	GO:0090201	negative regulation of release of cytochrome c from mitochondria	BP
3	17	1.8182756511	-	3.62e-02	GO:0000987	core promoter proximal region sequence-specific DNA binding	MF
26	148	1.81176234414	-	2.95e-09	GO:0050852	T cell receptor signaling pathway	BP
14	80	1.8062028188	-	2.08e-05	GO:0033138	positive regulation of peptidyl-serine phosphorylation	BP
7	40	1.8062028188	-	1.50e-03	GO:0009968	negative regulation of signal transduction	BP
14	80	1.8062028188	-	9.17e-06	GO:0016301	kinase activity	MF
4	23	1.79721403557	-	1.59e-02	GO:0031018	endocrine pancreas development	BP
4	23	1.79721403557	-	2.21e-02	GO:0090398	cellular senescence	BP
4	23	1.79721403557	-	2.21e-02	GO:0007422	peripheral nervous system development	BP
4	23	1.79721403557	-	2.21e-02	GO:0050999	regulation of nitric-oxide synthase activity	BP
5	29	1.78472309139	-	5.94e-03	GO:0001569	branching involved in blood vessel morphogenesis	BP
5	29	1.78472309139	-	9.98e-03	GO:0045765	regulation of angiogenesis	BP
5	29	1.78472309139	-	1.35e-02	GO:1900740	positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway	BP
5	29	1.78472309139	-	1.35e-02	GO:0042771	intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	BP
5	29	1.78472309139	-	1.17e-02	GO:0004712	protein serine/threonine/tyrosine kinase activity	MF
6	35	1.77645547541	-	5.34e-03	GO:1902042	negative regulation of extrinsic apoptotic signaling pathway via death domain receptors	BP
7	41	1.77057890907	-	2.47e-03	GO:0007595	lactation	BP
45	266	1.75734665246	-	6.12e-14	GO:0000165	MAPK cascade	BP
12	71	1.75599137285	-	1.64e-05	GO:0071300	cellular response to retinoic acid	BP
31	185	1.7435908415	-	3.74e-11	GO:0007411	axon guidance	BP
5	30	1.73581349091	-	3.22e-03	GO:0045930	negative regulation of mitotic cell cycle	BP
4	24	1.73581349091	-	1.32e-02	GO:0032967	positive regulation of collagen biosynthetic process	BP
4	24	1.73581349091	-	1.59e-02	GO:0032733	positive regulation of interleukin-10 production	BP
4	24	1.73581349091	-	2.21e-02	GO:0002040	sprouting angiogenesis	BP
2	12	1.73581349091	-	4.44e-02	GO:0046323	glucose import	BP
2	12	1.73581349091	-	5.73e-02	GO:2000727	positive regulation of cardiac muscle cell differentiation	BP
2	12	1.73581349091	-	5.73e-02	GO:0046889	positive regulation of lipid biosynthetic process	BP
2	12	1.73581349091	-	7.13e-02	GO:0001655	urogenital system development	BP
2	12	1.73581349091	-	7.13e-02	GO:0009395	phospholipid catabolic process	BP
2	12	1.73581349091	-	7.13e-02	GO:0034122	negative regulation of toll-like receptor signaling pathway	BP
2	12	1.73581349091	-	7.13e-02	GO:0007041	lysosomal transport	BP
2	12	1.73581349091	-	8.62e-02	GO:0001779	natural killer cell differentiation	BP
2	12	1.73581349091	-	8.62e-02	GO:0030239	myofibril assembly	BP
2	12	1.73581349091	-	8.62e-02	GO:0009888	tissue development	BP
2	12	1.73581349091	-	8.62e-02	GO:0008206	bile acid metabolic process	BP
2	12	1.73581349091	-	8.62e-02	GO:0030195	negative regulation of blood coagulation	BP
2	12	1.73581349091	-	8.62e-02	GO:0072520	seminiferous tubule development	BP
1	6	1.73581349091	-	9.76e-02	GO:0097211	cellular response to gonadotropin-releasing hormone	BP
2	12	1.73581349091	-	1.02e-01	GO:0071498	cellular response to fluid shear stress	BP
2	12	1.73581349091	-	1.02e-01	GO:0050921	positive regulation of chemotaxis	BP
2	12	1.73581349091	-	1.02e-01	GO:0045060	negative thymic T cell selection	BP
2	12	1.73581349091	-	1.02e-01	GO:0006107	oxaloacetate metabolic process	BP
2	12	1.73581349091	-	1.18e-01	GO:0055003	cardiac myofibril assembly	BP
2	12	1.73581349091	-	1.18e-01	GO:0010801	negative regulation of peptidyl-threonine phosphorylation	BP
2	12	1.73581349091	-	1.18e-01	GO:0055093	response to hyperoxia	BP
2	12	1.73581349091	-	1.18e-01	GO:0043149	stress fiber assembly	BP
2	12	1.73581349091	-	1.18e-01	GO:0035970	peptidyl-threonine dephosphorylation	BP
2	12	1.73581349091	-	1.18e-01	GO:0032801	receptor catabolic process	BP
2	12	1.73581349091	-	1.18e-01	GO:0045820	negative regulation of glycolytic process	BP
2	12	1.73581349091	-	1.18e-01	GO:0021954	central nervous system neuron development	BP
1	6	1.73581349091	-	1.43e-01	GO:0050819	negative regulation of coagulation	BP
1	6	1.73581349091	-	1.43e-01	GO:0051552	flavone metabolic process	BP
1	6	1.73581349091	-	1.43e-01	GO:0044245	polysaccharide digestion	BP
1	6	1.73581349091	-	1.43e-01	GO:0001696	gastric acid secretion	BP
1	6	1.73581349091	-	1.43e-01	GO:0048512	circadian behavior	BP
1	6	1.73581349091	-	1.43e-01	GO:0035524	proline transmembrane transport	BP
1	6	1.73581349091	-	1.43e-01	GO:0071286	cellular response to magnesium ion	BP
1	6	1.73581349091	-	1.43e-01	GO:0051155	positive regulation of striated muscle cell differentiation	BP
1	6	1.73581349091	-	1.86e-01	GO:0060267	positive regulation of respiratory burst	BP
1	6	1.73581349091	-	1.86e-01	GO:0086015	SA node cell action potential	BP
1	6	1.73581349091	-	1.86e-01	GO:0021853	cerebral cortex GABAergic interneuron migration	BP
1	6	1.73581349091	-	1.86e-01	GO:0060426	lung vasculature development	BP
1	6	1.73581349091	-	1.86e-01	GO:1990845	adaptive thermogenesis	BP
1	6	1.73581349091	-	1.86e-01	GO:0048793	pronephros development	BP
1	6	1.73581349091	-	1.86e-01	GO:0046487	glyoxylate metabolic process	BP
1	6	1.73581349091	-	1.86e-01	GO:0051005	negative regulation of lipoprotein lipase activity	BP
1	6	1.73581349091	-	1.86e-01	GO:2000507	positive regulation of energy homeostasis	BP
1	6	1.73581349091	-	1.86e-01	GO:0045743	positive regulation of fibroblast growth factor receptor signaling pathway	BP
1	6	1.73581349091	-	1.86e-01	GO:0019800	peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan	BP
1	6	1.73581349091	-	1.86e-01	GO:0055123	digestive system development	BP
1	6	1.73581349091	-	1.86e-01	GO:0007144	female meiosis I	BP
1	6	1.73581349091	-	2.26e-01	GO:0006596	polyamine biosynthetic process	BP
1	6	1.73581349091	-	2.26e-01	GO:0045953	negative regulation of natural killer cell mediated cytotoxicity	BP
1	6	1.73581349091	-	2.26e-01	GO:0060664	epithelial cell proliferation involved in salivary gland morphogenesis	BP
1	6	1.73581349091	-	2.26e-01	GO:0035864	response to potassium ion	BP
1	6	1.73581349091	-	2.26e-01	GO:0061037	negative regulation of cartilage development	BP
1	6	1.73581349091	-	2.26e-01	GO:0033555	multicellular organismal response to stress	BP
1	6	1.73581349091	-	2.26e-01	GO:0042536	negative regulation of tumor necrosis factor biosynthetic process	BP
1	6	1.73581349091	-	2.26e-01	GO:0001913	T cell mediated cytotoxicity	BP
1	6	1.73581349091	-	2.26e-01	GO:0002320	lymphoid progenitor cell differentiation	BP
1	6	1.73581349091	-	2.26e-01	GO:0048524	positive regulation of viral process	BP
1	6	1.73581349091	-	2.26e-01	GO:0001957	intramembranous ossification	BP
1	6	1.73581349091	-	2.26e-01	GO:0060074	synapse maturation	BP
1	6	1.73581349091	-	2.26e-01	GO:0060428	lung epithelium development	BP
1	6	1.73581349091	-	2.26e-01	GO:0061180	mammary gland epithelium development	BP
1	6	1.73581349091	-	2.26e-01	GO:0003406	retinal pigment epithelium development	BP
1	6	1.73581349091	-	2.26e-01	GO:0032792	negative regulation of CREB transcription factor activity	BP
1	6	1.73581349091	-	2.26e-01	GO:0032808	lacrimal gland development	BP
1	6	1.73581349091	-	2.26e-01	GO:0035315	hair cell differentiation	BP
1	6	1.73581349091	-	2.26e-01	GO:0021902	commitment of neuronal cell to specific neuron type in forebrain	BP
1	6	1.73581349091	-	2.26e-01	GO:0033211	adiponectin-activated signaling pathway	BP
1	6	1.73581349091	-	2.26e-01	GO:1904385	cellular response to angiotensin	BP
1	6	1.73581349091	-	2.26e-01	GO:0006929	substrate-dependent cell migration	BP
1	6	1.73581349091	-	2.26e-01	GO:0033157	regulation of intracellular protein transport	BP
1	6	1.73581349091	-	2.26e-01	GO:0051150	regulation of smooth muscle cell differentiation	BP
1	6	1.73581349091	-	2.26e-01	GO:0001878	response to yeast	BP
1	6	1.73581349091	-	2.26e-01	GO:0060056	mammary gland involution	BP
1	6	1.73581349091	-	2.26e-01	GO:0051438	regulation of ubiquitin-protein transferase activity	BP
1	6	1.73581349091	-	2.26e-01	GO:0010960	magnesium ion homeostasis	BP
1	6	1.73581349091	-	2.26e-01	GO:0042421	norepinephrine biosynthetic process	BP
1	6	1.73581349091	-	2.65e-01	GO:0010757	negative regulation of plasminogen activation	BP
1	6	1.73581349091	-	2.65e-01	GO:0010756	positive regulation of plasminogen activation	BP
1	6	1.73581349091	-	2.65e-01	GO:0051101	regulation of DNA binding	BP
1	6	1.73581349091	-	2.65e-01	GO:0071559	response to transforming growth factor beta	BP
1	6	1.73581349091	-	2.65e-01	GO:1900744	regulation of p38MAPK cascade	BP
1	6	1.73581349091	-	2.65e-01	GO:0051444	negative regulation of ubiquitin-protein transferase activity	BP
1	6	1.73581349091	-	2.65e-01	GO:0048642	negative regulation of skeletal muscle tissue development	BP
1	6	1.73581349091	-	2.65e-01	GO:1902533	positive regulation of intracellular signal transduction	BP
1	6	1.73581349091	-	2.65e-01	GO:0046321	positive regulation of fatty acid oxidation	BP
1	6	1.73581349091	-	2.65e-01	GO:0055013	cardiac muscle cell development	BP
1	6	1.73581349091	-	2.65e-01	GO:2000323	negative regulation of glucocorticoid receptor signaling pathway	BP
1	6	1.73581349091	-	2.65e-01	GO:0001956	positive regulation of neurotransmitter secretion	BP
1	6	1.73581349091	-	2.65e-01	GO:0034105	positive regulation of tissue remodeling	BP
1	6	1.73581349091	-	2.65e-01	GO:0010536	positive regulation of activation of Janus kinase activity	BP
1	6	1.73581349091	-	2.65e-01	GO:0036003	positive regulation of transcription from RNA polymerase II promoter in response to stress	BP
1	6	1.73581349091	-	2.65e-01	GO:0010835	regulation of protein ADP-ribosylation	BP
1	6	1.73581349091	-	2.65e-01	GO:2001046	positive regulation of integrin-mediated signaling pathway	BP
1	6	1.73581349091	-	2.65e-01	GO:0014033	neural crest cell differentiation	BP
1	6	1.73581349091	-	2.65e-01	GO:0034620	cellular response to unfolded protein	BP
1	6	1.73581349091	-	2.65e-01	GO:0006777	Mo-molybdopterin cofactor biosynthetic process	BP
1	6	1.73581349091	-	2.65e-01	GO:1903799	negative regulation of production of miRNAs involved in gene silencing by miRNA	BP
1	6	1.73581349091	-	2.65e-01	GO:0072307	regulation of metanephric nephron tubule epithelial cell differentiation	BP
1	6	1.73581349091	-	2.65e-01	GO:0031023	microtubule organizing center organization	BP
1	6	1.73581349091	-	2.65e-01	GO:0060770	negative regulation of epithelial cell proliferation involved in prostate gland development	BP
1	6	1.73581349091	-	2.65e-01	GO:0060501	positive regulation of epithelial cell proliferation involved in lung morphogenesis	BP
1	6	1.73581349091	-	2.65e-01	GO:0048598	embryonic morphogenesis	BP
1	6	1.73581349091	-	2.65e-01	GO:0007044	cell-substrate junction assembly	BP
1	6	1.73581349091	-	2.65e-01	GO:0001711	endodermal cell fate commitment	BP
1	6	1.73581349091	-	2.65e-01	GO:0071371	cellular response to gonadotropin stimulus	BP
1	6	1.73581349091	-	2.65e-01	GO:0003223	ventricular compact myocardium morphogenesis	BP
1	6	1.73581349091	-	2.65e-01	GO:2000503	positive regulation of natural killer cell chemotaxis	BP
1	6	1.73581349091	-	2.65e-01	GO:0010042	response to manganese ion	BP
1	6	1.73581349091	-	2.65e-01	GO:0046755	viral budding	BP
1	6	1.73581349091	-	2.65e-01	GO:0071470	cellular response to osmotic stress	BP
1	6	1.73581349091	-	2.65e-01	GO:0071476	cellular hypotonic response	BP
1	6	1.73581349091	-	2.65e-01	GO:1901222	regulation of NIK/NF-kappaB signaling	BP
1	6	1.73581349091	-	2.65e-01	GO:0048668	collateral sprouting	BP
1	6	1.73581349091	-	2.65e-01	GO:0043615	astrocyte cell migration	BP
1	6	1.73581349091	-	2.65e-01	GO:1900113	negative regulation of histone H3-K9 trimethylation	BP
1	6	1.73581349091	-	2.65e-01	GO:0001553	luteinization	BP
1	6	1.73581349091	-	2.65e-01	GO:0006616	SRP-dependent cotranslational protein targeting to membrane, translocation	BP
1	6	1.73581349091	-	2.65e-01	GO:0032933	SREBP signaling pathway	BP
1	6	1.73581349091	-	2.65e-01	GO:0001765	membrane raft assembly	BP
1	6	1.73581349091	-	2.65e-01	GO:0090279	regulation of calcium ion import	BP
1	6	1.73581349091	-	2.65e-01	GO:0032680	regulation of tumor necrosis factor production	BP
1	6	1.73581349091	-	2.65e-01	GO:0061312	BMP signaling pathway involved in heart development	BP
1	6	1.73581349091	-	2.65e-01	GO:0007100	mitotic centrosome separation	BP
1	6	1.73581349091	-	2.65e-01	GO:0051346	negative regulation of hydrolase activity	BP
1	6	1.73581349091	-	2.65e-01	GO:0033194	response to hydroperoxide	BP
1	6	1.73581349091	-	2.65e-01	GO:0045084	positive regulation of interleukin-12 biosynthetic process	BP
1	6	1.73581349091	-	2.65e-01	GO:0010035	response to inorganic substance	BP
1	6	1.73581349091	-	2.65e-01	GO:0042045	epithelial fluid transport	BP
1	6	1.73581349091	-	2.65e-01	GO:0035897	proteolysis in other organism	BP
1	6	1.73581349091	-	2.65e-01	GO:0006207	'de novo' pyrimidine nucleobase biosynthetic process	BP
4	24	1.73581349091	-	2.58e-02	GO:0043325	phosphatidylinositol-3,4-bisphosphate binding	MF
2	12	1.73581349091	-	3.28e-02	GO:0008373	sialyltransferase activity	MF
1	6	1.73581349091	-	9.76e-02	GO:0015193	L-proline transmembrane transporter activity	MF
2	12	1.73581349091	-	1.18e-01	GO:0051010	microtubule plus-end binding	MF
2	12	1.73581349091	-	1.18e-01	GO:0000989	transcription factor activity, transcription factor binding	MF
1	6	1.73581349091	-	1.43e-01	GO:0015187	glycine transmembrane transporter activity	MF
1	6	1.73581349091	-	1.43e-01	GO:0005347	ATP transmembrane transporter activity	MF
1	6	1.73581349091	-	1.43e-01	GO:0045545	syndecan binding	MF
1	6	1.73581349091	-	1.43e-01	GO:0047035	testosterone dehydrogenase (NAD+) activity	MF
1	6	1.73581349091	-	1.43e-01	GO:0015217	ADP transmembrane transporter activity	MF
1	6	1.73581349091	-	1.86e-01	GO:0004630	phospholipase D activity	MF
1	6	1.73581349091	-	1.86e-01	GO:0004024	alcohol dehydrogenase activity, zinc-dependent	MF
1	6	1.73581349091	-	1.86e-01	GO:0003836	beta-galactoside (CMP) alpha-2,3-sialyltransferase activity	MF
1	6	1.73581349091	-	2.26e-01	GO:0004468	lysine N-acetyltransferase activity, acting on acetyl phosphate as donor	MF
1	6	1.73581349091	-	2.26e-01	GO:0070728	leucine binding	MF
1	6	1.73581349091	-	2.26e-01	GO:0098821	BMP receptor activity	MF
1	6	1.73581349091	-	2.26e-01	GO:1990226	histone methyltransferase binding	MF
1	6	1.73581349091	-	2.26e-01	GO:0004430	1-phosphatidylinositol 4-kinase activity	MF
1	6	1.73581349091	-	2.26e-01	GO:0001042	RNA polymerase I core binding	MF
1	6	1.73581349091	-	2.26e-01	GO:0030020	extracellular matrix structural constituent conferring tensile strength	MF
1	6	1.73581349091	-	2.65e-01	GO:0004704	NF-kappaB-inducing kinase activity	MF
1	6	1.73581349091	-	2.65e-01	GO:0061133	endopeptidase activator activity	MF
1	6	1.73581349091	-	2.65e-01	GO:0019870	potassium channel inhibitor activity	MF
1	6	1.73581349091	-	2.65e-01	GO:0030911	TPR domain binding	MF
1	6	1.73581349091	-	2.65e-01	GO:1990239	steroid hormone binding	MF
1	6	1.73581349091	-	2.65e-01	GO:0035254	glutamate receptor binding	MF
1	6	1.73581349091	-	2.65e-01	GO:0019237	centromeric DNA binding	MF
30	180	1.73581349091	-	2.51e-10	GO:0016477	cell migration	BP
3	18	1.73581349091	-	1.52e-02	GO:0060044	negative regulation of cardiac muscle cell proliferation	BP
3	18	1.73581349091	-	3.62e-02	GO:1901214	regulation of neuron death	BP
3	18	1.73581349091	-	4.29e-02	GO:0017015	regulation of transforming growth factor beta receptor signaling pathway	BP
3	18	1.73581349091	-	5.02e-02	GO:0051000	positive regulation of nitric-oxide synthase activity	BP
3	18	1.73581349091	-	5.02e-02	GO:0035066	positive regulation of histone acetylation	BP
3	18	1.73581349091	-	5.02e-02	GO:0035307	positive regulation of protein dephosphorylation	BP
3	18	1.73581349091	-	5.02e-02	GO:0048854	brain morphogenesis	BP
3	18	1.73581349091	-	5.81e-02	GO:0030705	cytoskeleton-dependent intracellular transport	BP
3	18	1.73581349091	-	5.81e-02	GO:0043523	regulation of neuron apoptotic process	BP
3	18	1.73581349091	-	1.96e-02	GO:0016746	transferase activity, transferring acyl groups	MF
3	18	1.73581349091	-	5.02e-02	GO:0019955	cytokine binding	MF
13	79	1.7174349616	-	5.90e-05	GO:0032869	cellular response to insulin stimulus	BP
9	55	1.70934127955	-	4.59e-04	GO:0001570	vasculogenesis	BP
14	86	1.70186615899	-	5.78e-05	GO:0048013	ephrin receptor signaling pathway	BP
6	37	1.69628512672	-	7.20e-03	GO:0048469	cell maturation	BP
6	37	1.69628512672	-	8.28e-03	GO:2001237	negative regulation of extrinsic apoptotic signaling pathway	BP
21	130	1.69072560138	-	4.43e-11	GO:0038096	Fc-gamma receptor signaling pathway involved in phagocytosis	BP
5	31	1.68850777613	-	5.94e-03	GO:0045907	positive regulation of vasoconstriction	BP
5	31	1.68850777613	-	1.17e-02	GO:0061098	positive regulation of protein tyrosine kinase activity	BP
4	25	1.67691980186	-	1.59e-02	GO:0050715	positive regulation of cytokine secretion	BP
4	25	1.67691980186	-	2.58e-02	GO:0043542	endothelial cell migration	BP
15	94	1.67307773556	-	4.36e-06	GO:0051897	positive regulation of protein kinase B signaling	BP
11	69	1.67168315349	-	2.99e-04	GO:0018107	peptidyl-threonine phosphorylation	BP
28	176	1.66869929505	-	9.44e-12	GO:0038095	Fc-epsilon receptor signaling pathway	BP
10	63	1.66542416302	-	6.26e-04	GO:0001933	negative regulation of protein phosphorylation	BP
9	57	1.65781097891	-	5.41e-04	GO:0043087	regulation of GTPase activity	BP
6	38	1.65781097891	-	3.87e-03	GO:0001657	ureteric bud development	BP
6	38	1.65781097891	-	4.56e-03	GO:0045597	positive regulation of cell differentiation	BP
3	19	1.65781097891	-	3.62e-02	GO:0050850	positive regulation of calcium-mediated signaling	BP
3	19	1.65781097891	-	4.29e-02	GO:0030220	platelet formation	BP
3	19	1.65781097891	-	4.29e-02	GO:0007413	axonal fasciculation	BP
3	19	1.65781097891	-	5.81e-02	GO:0046827	positive regulation of protein export from nucleus	BP
3	19	1.65781097891	-	5.81e-02	GO:0010906	regulation of glucose metabolic process	BP
3	19	1.65781097891	-	5.81e-02	GO:0043153	entrainment of circadian clock by photoperiod	BP
3	19	1.65781097891	-	5.81e-02	GO:0031954	positive regulation of protein autophosphorylation	BP
3	19	1.65781097891	-	6.65e-02	GO:0031572	G2 DNA damage checkpoint	BP
8	51	1.64835064966	-	1.57e-03	GO:0010506	regulation of autophagy	BP
10	64	1.64270408652	-	3.49e-04	GO:0032868	response to insulin	BP
10	64	1.64270408652	-	3.49e-04	GO:0070373	negative regulation of ERK1 and ERK2 cascade	BP
5	32	1.64270408652	-	1.35e-02	GO:0042220	response to cocaine	BP
5	32	1.64270408652	-	1.78e-02	GO:0071549	cellular response to dexamethasone stimulus	BP
5	32	1.64270408652	-	1.78e-02	GO:0042594	response to starvation	BP
9	58	1.63271999795	-	5.41e-04	GO:0050679	positive regulation of epithelial cell proliferation	BP
4	26	1.62033627349	-	6.98e-03	GO:0009880	embryonic pattern specification	BP
4	26	1.62033627349	-	8.78e-03	GO:0042755	eating behavior	BP
4	26	1.62033627349	-	1.88e-02	GO:0007202	activation of phospholipase C activity	BP
4	26	1.62033627349	-	2.58e-02	GO:0015758	glucose transport	BP
4	26	1.62033627349	-	2.97e-02	GO:0010800	positive regulation of peptidyl-threonine phosphorylation	BP
2	13	1.62033627349	-	4.44e-02	GO:0061051	positive regulation of cell growth involved in cardiac muscle cell development	BP
2	13	1.62033627349	-	7.13e-02	GO:0072488	ammonium transmembrane transport	BP
2	13	1.62033627349	-	7.13e-02	GO:0010001	glial cell differentiation	BP
2	13	1.62033627349	-	8.62e-02	GO:0007398	ectoderm development	BP
2	13	1.62033627349	-	8.62e-02	GO:2000773	negative regulation of cellular senescence	BP
2	13	1.62033627349	-	8.62e-02	GO:0060389	pathway-restricted SMAD protein phosphorylation	BP
2	13	1.62033627349	-	1.02e-01	GO:0007171	activation of transmembrane receptor protein tyrosine kinase activity	BP
2	13	1.62033627349	-	1.02e-01	GO:0008610	lipid biosynthetic process	BP
2	13	1.62033627349	-	1.02e-01	GO:0045995	regulation of embryonic development	BP
2	13	1.62033627349	-	1.18e-01	GO:1900181	negative regulation of protein localization to nucleus	BP
2	13	1.62033627349	-	1.18e-01	GO:0007096	regulation of exit from mitosis	BP
2	13	1.62033627349	-	1.18e-01	GO:0060413	atrial septum morphogenesis	BP
2	13	1.62033627349	-	1.18e-01	GO:0090162	establishment of epithelial cell polarity	BP
2	13	1.62033627349	-	1.18e-01	GO:0032740	positive regulation of interleukin-17 production	BP
2	13	1.62033627349	-	1.18e-01	GO:0031274	positive regulation of pseudopodium assembly	BP
2	13	1.62033627349	-	1.18e-01	GO:0045780	positive regulation of bone resorption	BP
2	13	1.62033627349	-	1.18e-01	GO:0071361	cellular response to ethanol	BP
2	13	1.62033627349	-	1.18e-01	GO:1902166	negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	BP
2	13	1.62033627349	-	1.18e-01	GO:0030194	positive regulation of blood coagulation	BP
2	13	1.62033627349	-	1.36e-01	GO:0097296	activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway	BP
2	13	1.62033627349	-	1.36e-01	GO:0060134	prepulse inhibition	BP
2	13	1.62033627349	-	1.36e-01	GO:0086064	cell communication by electrical coupling involved in cardiac conduction	BP
2	13	1.62033627349	-	1.36e-01	GO:0045197	establishment or maintenance of epithelial cell apical/basal polarity	BP
2	13	1.62033627349	-	1.36e-01	GO:0045579	positive regulation of B cell differentiation	BP
2	13	1.62033627349	-	1.36e-01	GO:0061099	negative regulation of protein tyrosine kinase activity	BP
2	13	1.62033627349	-	1.36e-01	GO:1902176	negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway	BP
2	13	1.62033627349	-	1.36e-01	GO:0042176	regulation of protein catabolic process	BP
2	13	1.62033627349	-	1.36e-01	GO:0006809	nitric oxide biosynthetic process	BP
2	13	1.62033627349	-	1.36e-01	GO:1904264	ubiquitin protein ligase activity involved in ERAD pathway	MF
15	98	1.61295674313	-	1.57e-05	GO:0001764	neuron migration	BP
13	85	1.61182477364	-	1.20e-04	GO:0019900	kinase binding	MF
29	190	1.60890137843	-	6.15e-10	GO:0070374	positive regulation of ERK1 and ERK2 cascade	BP
9	59	1.60805794371	-	8.58e-04	GO:0042102	positive regulation of T cell proliferation	BP
6	40	1.58381039747	-	9.47e-03	GO:0032024	positive regulation of insulin secretion	BP
3	20	1.58381039747	-	1.52e-02	GO:0097503	sialylation	BP
3	20	1.58381039747	-	5.02e-02	GO:0042267	natural killer cell mediated cytotoxicity	BP
3	20	1.58381039747	-	5.81e-02	GO:0050771	negative regulation of axonogenesis	BP
3	20	1.58381039747	-	5.81e-02	GO:0045862	positive regulation of proteolysis	BP
3	20	1.58381039747	-	6.65e-02	GO:0032465	regulation of cytokinesis	BP
3	20	1.58381039747	-	6.65e-02	GO:0045861	negative regulation of proteolysis	BP
3	20	1.58381039747	-	7.55e-02	GO:0042326	negative regulation of phosphorylation	BP
3	20	1.58381039747	-	7.55e-02	GO:0070932	histone H3 deacetylation	BP
3	20	1.58381039747	-	2.45e-02	GO:0005539	glycosaminoglycan binding	MF
3	20	1.58381039747	-	7.55e-02	GO:0004896	cytokine receptor activity	MF
7	47	1.57354206201	-	1.50e-03	GO:0019722	calcium-mediated signaling	BP
7	47	1.57354206201	-	3.87e-03	GO:0023014	signal transduction by protein phosphorylation	BP
7	47	1.57354206201	-	5.80e-03	GO:0032760	positive regulation of tumor necrosis factor production	BP
11	74	1.57075424464	-	1.18e-06	GO:0050853	B cell receptor signaling pathway	BP
4	27	1.56588848947	-	1.32e-02	GO:0009755	hormone-mediated signaling pathway	BP
4	27	1.56588848947	-	3.40e-02	GO:0006754	ATP biosynthetic process	BP
4	27	1.56588848947	-	3.87e-02	GO:0035329	hippo signaling	BP
4	27	1.56588848947	-	4.37e-02	GO:0050690	regulation of defense response to virus by virus	BP
5	34	1.55524124527	-	1.35e-02	GO:0042130	negative regulation of T cell proliferation	BP
6	41	1.54818648773	-	1.22e-02	GO:0030331	estrogen receptor binding	MF
8	55	1.53941627811	-	2.76e-03	GO:0006950	response to stress	BP
10	69	1.53417962974	-	9.36e-04	GO:0001938	positive regulation of endothelial cell proliferation	BP
12	83	1.53069906101	-	1.23e-04	GO:0009887	animal organ morphogenesis	BP
13	90	1.52936261344	-	1.37e-04	GO:0010976	positive regulation of neuron projection development	BP
17	119	1.51342106957	-	3.12e-05	GO:0030308	negative regulation of cell growth	BP
5	35	1.51342106957	-	1.17e-02	GO:0002062	chondrocyte differentiation	BP
5	35	1.51342106957	-	2.03e-02	GO:0051219	phosphoprotein binding	MF
13	91	1.51342106957	-	2.58e-04	GO:0007179	transforming growth factor beta receptor signaling pathway	BP
8	56	1.51342106957	-	3.56e-03	GO:0009267	cellular response to starvation	BP
7	49	1.51342106957	-	5.80e-03	GO:0071230	cellular response to amino acid stimulus	BP
7	49	1.51342106957	-	9.38e-03	GO:0042542	response to hydrogen peroxide	BP
6	42	1.51342106957	-	1.22e-02	GO:0014823	response to activity	BP
4	28	1.51342106957	-	1.59e-02	GO:0007131	reciprocal meiotic recombination	BP
4	28	1.51342106957	-	2.97e-02	GO:0045595	regulation of cell differentiation	BP
4	28	1.51342106957	-	2.97e-02	GO:0071158	positive regulation of cell cycle arrest	BP
4	28	1.51342106957	-	2.97e-02	GO:0048863	stem cell differentiation	BP
4	28	1.51342106957	-	3.87e-02	GO:0051090	regulation of sequence-specific DNA binding transcription factor activity	BP
4	28	1.51342106957	-	4.37e-02	GO:0000060	protein import into nucleus, translocation	BP
3	21	1.51342106957	-	5.81e-02	GO:0051497	negative regulation of stress fiber assembly	BP
3	21	1.51342106957	-	7.55e-02	GO:0071901	negative regulation of protein serine/threonine kinase activity	BP
2	14	1.51342106957	-	8.62e-02	GO:0031103	axon regeneration	BP
2	14	1.51342106957	-	8.62e-02	GO:0010666	positive regulation of cardiac muscle cell apoptotic process	BP
1	7	1.51342106957	-	9.76e-02	GO:0045026	plasma membrane fusion	BP
2	14	1.51342106957	-	1.18e-01	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	BP
2	14	1.51342106957	-	1.18e-01	GO:0042325	regulation of phosphorylation	BP
2	14	1.51342106957	-	1.36e-01	GO:0001817	regulation of cytokine production	BP
2	14	1.51342106957	-	1.36e-01	GO:1903351	cellular response to dopamine	BP
2	14	1.51342106957	-	1.36e-01	GO:0060441	epithelial tube branching involved in lung morphogenesis	BP
2	14	1.51342106957	-	1.36e-01	GO:0045589	regulation of regulatory T cell differentiation	BP
1	7	1.51342106957	-	1.43e-01	GO:0019367	fatty acid elongation, saturated fatty acid	BP
1	7	1.51342106957	-	1.43e-01	GO:0034625	fatty acid elongation, monounsaturated fatty acid	BP
1	7	1.51342106957	-	1.43e-01	GO:0034626	fatty acid elongation, polyunsaturated fatty acid	BP
1	7	1.51342106957	-	1.43e-01	GO:0015816	glycine transport	BP
2	14	1.51342106957	-	1.53e-01	GO:0045088	regulation of innate immune response	BP
2	14	1.51342106957	-	1.53e-01	GO:0022904	respiratory electron transport chain	BP
2	14	1.51342106957	-	1.53e-01	GO:0010243	response to organonitrogen compound	BP
2	14	1.51342106957	-	1.53e-01	GO:0030970	retrograde protein transport, ER to cytosol	BP
1	7	1.51342106957	-	1.86e-01	GO:0001945	lymph vessel development	BP
1	7	1.51342106957	-	1.86e-01	GO:0051694	pointed-end actin filament capping	BP
1	7	1.51342106957	-	1.86e-01	GO:0048680	positive regulation of axon regeneration	BP
1	7	1.51342106957	-	1.86e-01	GO:0045606	positive regulation of epidermal cell differentiation	BP
1	7	1.51342106957	-	1.86e-01	GO:0035356	cellular triglyceride homeostasis	BP
1	7	1.51342106957	-	1.86e-01	GO:0015808	L-alanine transport	BP
1	7	1.51342106957	-	1.86e-01	GO:0085029	extracellular matrix assembly	BP
1	7	1.51342106957	-	2.26e-01	GO:0003209	cardiac atrium morphogenesis	BP
1	7	1.51342106957	-	2.26e-01	GO:0043654	recognition of apoptotic cell	BP
1	7	1.51342106957	-	2.26e-01	GO:0048646	anatomical structure formation involved in morphogenesis	BP
1	7	1.51342106957	-	2.26e-01	GO:0060740	prostate gland epithelium morphogenesis	BP
1	7	1.51342106957	-	2.26e-01	GO:0003416	endochondral bone growth	BP
1	7	1.51342106957	-	2.26e-01	GO:1903546	protein localization to photoreceptor outer segment	BP
1	7	1.51342106957	-	2.26e-01	GO:0031119	tRNA pseudouridine synthesis	BP
1	7	1.51342106957	-	2.26e-01	GO:0034144	negative regulation of toll-like receptor 4 signaling pathway	BP
1	7	1.51342106957	-	2.26e-01	GO:1904948	midbrain dopaminergic neuron differentiation	BP
1	7	1.51342106957	-	2.26e-01	GO:0006739	NADP metabolic process	BP
1	7	1.51342106957	-	2.26e-01	GO:0035878	nail development	BP
1	7	1.51342106957	-	2.26e-01	GO:0003344	pericardium morphogenesis	BP
1	7	1.51342106957	-	2.26e-01	GO:0051045	negative regulation of membrane protein ectodomain proteolysis	BP
1	7	1.51342106957	-	2.26e-01	GO:0060323	head morphogenesis	BP
1	7	1.51342106957	-	2.26e-01	GO:0045577	regulation of B cell differentiation	BP
1	7	1.51342106957	-	2.26e-01	GO:0003360	brainstem development	BP
1	7	1.51342106957	-	2.26e-01	GO:0021559	trigeminal nerve development	BP
1	7	1.51342106957	-	2.26e-01	GO:0007530	sex determination	BP
1	7	1.51342106957	-	2.26e-01	GO:0070233	negative regulation of T cell apoptotic process	BP
1	7	1.51342106957	-	2.26e-01	GO:0070234	positive regulation of T cell apoptotic process	BP
1	7	1.51342106957	-	2.26e-01	GO:0060710	chorio-allantoic fusion	BP
1	7	1.51342106957	-	2.65e-01	GO:0048539	bone marrow development	BP
1	7	1.51342106957	-	2.65e-01	GO:0034138	toll-like receptor 3 signaling pathway	BP
1	7	1.51342106957	-	2.65e-01	GO:0014009	glial cell proliferation	BP
1	7	1.51342106957	-	2.65e-01	GO:0032287	peripheral nervous system myelin maintenance	BP
1	7	1.51342106957	-	2.65e-01	GO:0060998	regulation of dendritic spine development	BP
1	7	1.51342106957	-	2.65e-01	GO:2000650	negative regulation of sodium ion transmembrane transporter activity	BP
1	7	1.51342106957	-	2.65e-01	GO:0014037	Schwann cell differentiation	BP
1	7	1.51342106957	-	2.65e-01	GO:0022612	gland morphogenesis	BP
1	7	1.51342106957	-	2.65e-01	GO:0000578	embryonic axis specification	BP
1	7	1.51342106957	-	2.65e-01	GO:0006475	internal protein amino acid acetylation	BP
1	7	1.51342106957	-	2.65e-01	GO:0043305	negative regulation of mast cell degranulation	BP
1	7	1.51342106957	-	2.65e-01	GO:0061384	heart trabecula morphogenesis	BP
1	7	1.51342106957	-	2.65e-01	GO:0031102	neuron projection regeneration	BP
1	7	1.51342106957	-	2.65e-01	GO:0006972	hyperosmotic response	BP
1	7	1.51342106957	-	2.65e-01	GO:1900246	positive regulation of RIG-I signaling pathway	BP
1	7	1.51342106957	-	2.65e-01	GO:0061154	endothelial tube morphogenesis	BP
1	7	1.51342106957	-	2.65e-01	GO:0097237	cellular response to toxic substance	BP
1	7	1.51342106957	-	2.65e-01	GO:0060080	inhibitory postsynaptic potential	BP
1	7	1.51342106957	-	2.65e-01	GO:0034983	peptidyl-lysine deacetylation	BP
1	7	1.51342106957	-	2.65e-01	GO:0030510	regulation of BMP signaling pathway	BP
1	7	1.51342106957	-	2.65e-01	GO:0060576	intestinal epithelial cell development	BP
1	7	1.51342106957	-	2.65e-01	GO:0015872	dopamine transport	BP
1	7	1.51342106957	-	2.65e-01	GO:0071281	cellular response to iron ion	BP
1	7	1.51342106957	-	2.65e-01	GO:0021554	optic nerve development	BP
1	7	1.51342106957	-	2.65e-01	GO:0046069	cGMP catabolic process	BP
1	7	1.51342106957	-	2.65e-01	GO:2001028	positive regulation of endothelial cell chemotaxis	BP
1	7	1.51342106957	-	2.65e-01	GO:0050861	positive regulation of B cell receptor signaling pathway	BP
1	7	1.51342106957	-	2.65e-01	GO:0021860	pyramidal neuron development	BP
1	7	1.51342106957	-	2.65e-01	GO:0008595	anterior/posterior axis specification, embryo	BP
1	7	1.51342106957	-	2.65e-01	GO:0072205	metanephric collecting duct development	BP
1	7	1.51342106957	-	2.65e-01	GO:0014902	myotube differentiation	BP
1	7	1.51342106957	-	2.65e-01	GO:0060449	bud elongation involved in lung branching	BP
1	7	1.51342106957	-	2.65e-01	GO:0008366	axon ensheathment	BP
1	7	1.51342106957	-	2.65e-01	GO:0035726	common myeloid progenitor cell proliferation	BP
1	7	1.51342106957	-	2.65e-01	GO:0060017	parathyroid gland development	BP
1	7	1.51342106957	-	2.65e-01	GO:0045822	negative regulation of heart contraction	BP
1	7	1.51342106957	-	2.65e-01	GO:0060563	neuroepithelial cell differentiation	BP
1	7	1.51342106957	-	3.02e-01	GO:0006625	protein targeting to peroxisome	BP
1	7	1.51342106957	-	3.02e-01	GO:0019896	axonal transport of mitochondrion	BP
1	7	1.51342106957	-	3.02e-01	GO:0090050	positive regulation of cell migration involved in sprouting angiogenesis	BP
1	7	1.51342106957	-	3.02e-01	GO:0044770	cell cycle phase transition	BP
1	7	1.51342106957	-	3.02e-01	GO:0032324	molybdopterin cofactor biosynthetic process	BP
1	7	1.51342106957	-	3.02e-01	GO:0036010	protein localization to endosome	BP
1	7	1.51342106957	-	3.02e-01	GO:0099565	chemical synaptic transmission, postsynaptic	BP
1	7	1.51342106957	-	3.02e-01	GO:0032825	positive regulation of natural killer cell differentiation	BP
1	7	1.51342106957	-	3.02e-01	GO:0030042	actin filament depolymerization	BP
1	7	1.51342106957	-	3.02e-01	GO:2000483	negative regulation of interleukin-8 secretion	BP
1	7	1.51342106957	-	3.02e-01	GO:0001961	positive regulation of cytokine-mediated signaling pathway	BP
1	7	1.51342106957	-	3.02e-01	GO:0003337	mesenchymal to epithelial transition involved in metanephros morphogenesis	BP
1	7	1.51342106957	-	3.02e-01	GO:0090091	positive regulation of extracellular matrix disassembly	BP
1	7	1.51342106957	-	3.02e-01	GO:0042921	glucocorticoid receptor signaling pathway	BP
1	7	1.51342106957	-	3.02e-01	GO:0061626	pharyngeal arch artery morphogenesis	BP
1	7	1.51342106957	-	3.02e-01	GO:1903071	positive regulation of ER-associated ubiquitin-dependent protein catabolic process	BP
1	7	1.51342106957	-	3.02e-01	GO:0010870	positive regulation of receptor biosynthetic process	BP
1	7	1.51342106957	-	3.02e-01	GO:0048102	autophagic cell death	BP
1	7	1.51342106957	-	3.02e-01	GO:0006544	glycine metabolic process	BP
1	7	1.51342106957	-	3.02e-01	GO:0034351	negative regulation of glial cell apoptotic process	BP
1	7	1.51342106957	-	3.02e-01	GO:1903896	positive regulation of IRE1-mediated unfolded protein response	BP
1	7	1.51342106957	-	3.02e-01	GO:0090267	positive regulation of mitotic cell cycle spindle assembly checkpoint	BP
1	7	1.51342106957	-	3.02e-01	GO:0042148	strand invasion	BP
1	7	1.51342106957	-	3.02e-01	GO:0048261	negative regulation of receptor-mediated endocytosis	BP
1	7	1.51342106957	-	3.02e-01	GO:0051988	regulation of attachment of spindle microtubules to kinetochore	BP
1	7	1.51342106957	-	3.02e-01	GO:0010642	negative regulation of platelet-derived growth factor receptor signaling pathway	BP
1	7	1.51342106957	-	3.02e-01	GO:0030916	otic vesicle formation	BP
1	7	1.51342106957	-	3.02e-01	GO:0035360	positive regulation of peroxisome proliferator activated receptor signaling pathway	BP
1	7	1.51342106957	-	3.02e-01	GO:2001171	positive regulation of ATP biosynthetic process	BP
1	7	1.51342106957	-	3.02e-01	GO:0021785	branchiomotor neuron axon guidance	BP
1	7	1.51342106957	-	3.02e-01	GO:2000394	positive regulation of lamellipodium morphogenesis	BP
1	7	1.51342106957	-	3.02e-01	GO:0003183	mitral valve morphogenesis	BP
1	7	1.51342106957	-	3.02e-01	GO:0034616	response to laminar fluid shear stress	BP
1	7	1.51342106957	-	3.02e-01	GO:0060290	transdifferentiation	BP
1	7	1.51342106957	-	3.02e-01	GO:0060008	Sertoli cell differentiation	BP
1	7	1.51342106957	-	3.02e-01	GO:0060575	intestinal epithelial cell differentiation	BP
1	7	1.51342106957	-	3.02e-01	GO:0060687	regulation of branching involved in prostate gland morphogenesis	BP
1	7	1.51342106957	-	3.02e-01	GO:0032609	interferon-gamma production	BP
1	7	1.51342106957	-	3.02e-01	GO:0010918	positive regulation of mitochondrial membrane potential	BP
1	7	1.51342106957	-	3.02e-01	GO:0044351	macropinocytosis	BP
1	7	1.51342106957	-	3.02e-01	GO:0032873	negative regulation of stress-activated MAPK cascade	BP
1	7	1.51342106957	-	3.02e-01	GO:0071447	cellular response to hydroperoxide	BP
1	7	1.51342106957	-	3.02e-01	GO:0070417	cellular response to cold	BP
1	7	1.51342106957	-	3.02e-01	GO:0035065	regulation of histone acetylation	BP
1	7	1.51342106957	-	3.02e-01	GO:0061002	negative regulation of dendritic spine morphogenesis	BP
1	7	1.51342106957	-	3.02e-01	GO:0043496	regulation of protein homodimerization activity	BP
1	7	1.51342106957	-	3.02e-01	GO:2000144	positive regulation of DNA-templated transcription, initiation	BP
1	7	1.51342106957	-	3.02e-01	GO:2000601	positive regulation of Arp2/3 complex-mediated actin nucleation	BP
1	7	1.51342106957	-	9.76e-02	GO:0050291	sphingosine N-acyltransferase activity	MF
2	14	1.51342106957	-	1.18e-01	GO:0043274	phospholipase binding	MF
2	14	1.51342106957	-	1.18e-01	GO:0000982	transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding	MF
1	7	1.51342106957	-	1.43e-01	GO:0102337	3-oxo-cerotoyl-CoA synthase activity	MF
1	7	1.51342106957	-	1.43e-01	GO:0102336	3-oxo-arachidoyl-CoA synthase activity	MF
1	7	1.51342106957	-	1.43e-01	GO:0102338	3-oxo-lignoceronyl-CoA synthase activity	MF
1	7	1.51342106957	-	1.43e-01	GO:0015101	organic cation transmembrane transporter activity	MF
1	7	1.51342106957	-	1.43e-01	GO:0009922	fatty acid elongase activity	MF
2	14	1.51342106957	-	1.53e-01	GO:0070063	RNA polymerase binding	MF
2	14	1.51342106957	-	1.53e-01	GO:0032794	GTPase activating protein binding	MF
1	7	1.51342106957	-	1.86e-01	GO:0015180	L-alanine transmembrane transporter activity	MF
1	7	1.51342106957	-	1.86e-01	GO:0008519	ammonium transmembrane transporter activity	MF
1	7	1.51342106957	-	2.26e-01	GO:0016308	1-phosphatidylinositol-4-phosphate 5-kinase activity	MF
1	7	1.51342106957	-	2.26e-01	GO:0030297	transmembrane receptor protein tyrosine kinase activator activity	MF
1	7	1.51342106957	-	2.65e-01	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	MF
1	7	1.51342106957	-	2.65e-01	GO:0042608	T cell receptor binding	MF
1	7	1.51342106957	-	2.65e-01	GO:0030619	U1 snRNA binding	MF
1	7	1.51342106957	-	2.65e-01	GO:0000405	bubble DNA binding	MF
1	7	1.51342106957	-	2.65e-01	GO:1901981	phosphatidylinositol phosphate binding	MF
1	7	1.51342106957	-	3.02e-01	GO:0031433	telethonin binding	MF
1	7	1.51342106957	-	3.02e-01	GO:0042609	CD4 receptor binding	MF
1	7	1.51342106957	-	3.02e-01	GO:0003720	telomerase activity	MF
1	7	1.51342106957	-	3.02e-01	GO:0004972	NMDA glutamate receptor activity	MF
1	7	1.51342106957	-	3.02e-01	GO:0005114	type II transforming growth factor beta receptor binding	MF
1	7	1.51342106957	-	3.02e-01	GO:0005138	interleukin-6 receptor binding	MF
1	7	1.51342106957	-	3.02e-01	GO:0009931	calcium-dependent protein serine/threonine kinase activity	MF
62	438	1.50018524242	-	2.16e-15	GO:0006468	protein phosphorylation	BP
56	398	1.49150629315	-	9.80e-14	GO:0019901	protein kinase binding	MF
9	64	1.49070099307	-	1.31e-03	GO:0043627	response to estrogen	BP
6	43	1.47947373765	-	8.28e-03	GO:0030178	negative regulation of Wnt signaling pathway	BP
6	43	1.47947373765	-	1.93e-02	GO:0050681	androgen receptor binding	MF
5	36	1.47277908508	-	1.17e-02	GO:0045859	regulation of protein kinase activity	BP
5	36	1.47277908508	-	1.56e-02	GO:0001568	blood vessel development	BP
5	36	1.47277908508	-	2.58e-02	GO:0001837	epithelial to mesenchymal transition	BP
5	36	1.47277908508	-	2.89e-02	GO:0043407	negative regulation of MAP kinase activity	BP
17	123	1.46572432754	-	5.83e-07	GO:0019221	cytokine-mediated signaling pathway	BP
4	29	1.4627949965	-	3.87e-02	GO:0042056	chemoattractant activity	MF
19	138	1.4601790483	-	1.95e-05	GO:0008360	regulation of cell shape	BP
11	80	1.45827951538	-	1.34e-03	GO:0006928	movement of cell or subcellular component	BP
7	51	1.45570557172	-	6.58e-03	GO:0048146	positive regulation of fibroblast proliferation	BP
9	66	1.44630687372	-	1.94e-03	GO:0051291	protein heterooligomerization	BP
6	44	1.44630687372	-	7.20e-03	GO:0032870	cellular response to hormone stimulus	BP
6	44	1.44630687372	-	1.73e-02	GO:0045785	positive regulation of cell adhesion	BP
3	22	1.44630687372	-	5.81e-02	GO:0045671	negative regulation of osteoclast differentiation	BP
3	22	1.44630687372	-	7.55e-02	GO:0060999	positive regulation of dendritic spine development	BP
3	22	1.44630687372	-	8.49e-02	GO:0010165	response to X-ray	BP
3	22	1.44630687372	-	8.49e-02	GO:0002092	positive regulation of receptor internalization	BP
3	22	1.44630687372	-	8.49e-02	GO:2000378	negative regulation of reactive oxygen species metabolic process	BP
3	22	1.44630687372	-	8.49e-02	GO:0050769	positive regulation of neurogenesis	BP
3	22	1.44630687372	-	9.48e-02	GO:0030316	osteoclast differentiation	BP
3	22	1.44630687372	-	8.49e-02	GO:0004683	calmodulin-dependent protein kinase activity	MF
14	103	1.44163038651	-	7.57e-05	GO:0006469	negative regulation of protein kinase activity	BP
65	480	1.43625320905	-	8.09e-18	GO:0008284	positive regulation of cell proliferation	BP
10	74	1.43325072089	-	8.21e-04	GO:0007623	circadian rhythm	BP
10	74	1.43325072089	-	2.68e-03	GO:0043154	negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	BP
5	37	1.43325072089	-	2.03e-02	GO:0032720	negative regulation of tumor necrosis factor production	BP
5	37	1.43325072089	-	2.29e-02	GO:0009790	embryo development	BP
5	37	1.43325072089	-	2.89e-02	GO:0034446	substrate adhesion-dependent cell spreading	BP
8	60	1.41388539602	-	7.12e-03	GO:0070301	cellular response to hydrogen peroxide	BP
4	30	1.41388539602	-	3.40e-02	GO:0060325	face morphogenesis	BP
2	15	1.41388539602	-	4.44e-02	GO:0015695	organic cation transport	BP
2	15	1.41388539602	-	5.73e-02	GO:0016254	preassembly of GPI anchor in ER membrane	BP
2	15	1.41388539602	-	8.62e-02	GO:0003382	epithelial cell morphogenesis	BP
2	15	1.41388539602	-	1.18e-01	GO:0010759	positive regulation of macrophage chemotaxis	BP
2	15	1.41388539602	-	1.18e-01	GO:0006940	regulation of smooth muscle contraction	BP
2	15	1.41388539602	-	1.18e-01	GO:0032461	positive regulation of protein oligomerization	BP
2	15	1.41388539602	-	1.18e-01	GO:0035050	embryonic heart tube development	BP
2	15	1.41388539602	-	1.36e-01	GO:0007548	sex differentiation	BP
2	15	1.41388539602	-	1.36e-01	GO:0050965	detection of temperature stimulus involved in sensory perception of pain	BP
2	15	1.41388539602	-	1.36e-01	GO:0002042	cell migration involved in sprouting angiogenesis	BP
2	15	1.41388539602	-	1.36e-01	GO:2000310	regulation of NMDA receptor activity	BP
2	15	1.41388539602	-	1.36e-01	GO:0006309	apoptotic DNA fragmentation	BP
2	15	1.41388539602	-	1.36e-01	GO:0090303	positive regulation of wound healing	BP
2	15	1.41388539602	-	1.53e-01	GO:0033146	regulation of intracellular estrogen receptor signaling pathway	BP
2	15	1.41388539602	-	1.53e-01	GO:0043277	apoptotic cell clearance	BP
2	15	1.41388539602	-	1.53e-01	GO:0030330	DNA damage response, signal transduction by p53 class mediator	BP
2	15	1.41388539602	-	1.53e-01	GO:0090141	positive regulation of mitochondrial fission	BP
2	15	1.41388539602	-	1.53e-01	GO:0043162	ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway	BP
2	15	1.41388539602	-	1.71e-01	GO:0060997	dendritic spine morphogenesis	BP
2	15	1.41388539602	-	1.71e-01	GO:0030949	positive regulation of vascular endothelial growth factor receptor signaling pathway	BP
2	15	1.41388539602	-	1.71e-01	GO:1903543	positive regulation of exosomal secretion	BP
2	15	1.41388539602	-	1.71e-01	GO:2000679	positive regulation of transcription regulatory region DNA binding	BP
2	15	1.41388539602	-	1.36e-01	GO:0030676	Rac guanyl-nucleotide exchange factor activity	MF
2	15	1.41388539602	-	1.53e-01	GO:0004702	signal transducer, downstream of receptor, with serine/threonine kinase activity	MF
2	15	1.41388539602	-	1.71e-01	GO:0004708	MAP kinase kinase activity	MF
2	15	1.41388539602	-	1.71e-01	GO:0005123	death receptor binding	MF
2	15	1.41388539602	-	1.71e-01	GO:0070742	C2H2 zinc finger domain binding	MF
10	76	1.39477657308	-	4.03e-03	GO:1900034	regulation of cellular response to heat	BP
5	38	1.39477657308	-	3.96e-02	GO:0031623	receptor internalization	BP
5	38	1.39477657308	-	1.78e-02	GO:0001786	phosphatidylserine binding	MF
5	38	1.39477657308	-	2.89e-02	GO:0004721	phosphoprotein phosphatase activity	MF
8	61	1.39003865407	-	8.75e-03	GO:0031398	positive regulation of protein ubiquitination	BP
6	46	1.3821765363	-	2.14e-02	GO:0031100	animal organ regeneration	BP
3	23	1.3821765363	-	6.65e-02	GO:0009954	proximal/distal pattern formation	BP
3	23	1.3821765363	-	8.49e-02	GO:0048870	cell motility	BP
3	23	1.3821765363	-	8.49e-02	GO:0071345	cellular response to cytokine stimulus	BP
3	23	1.3821765363	-	9.48e-02	GO:0003009	skeletal muscle contraction	BP
3	23	1.3821765363	-	1.05e-01	GO:0051894	positive regulation of focal adhesion assembly	BP
3	23	1.3821765363	-	1.05e-01	GO:0001954	positive regulation of cell-matrix adhesion	BP
3	23	1.3821765363	-	1.05e-01	GO:0045736	negative regulation of cyclin-dependent protein serine/threonine kinase activity	BP
3	23	1.3821765363	-	7.55e-02	GO:0017134	fibroblast growth factor binding	MF
3	23	1.3821765363	-	9.48e-02	GO:0035255	ionotropic glutamate receptor binding	MF
7	54	1.37324341153	-	1.05e-02	GO:0008104	protein localization	BP
4	31	1.36657968124	-	2.97e-02	GO:0017147	Wnt-protein binding	MF
17	132	1.36384471352	-	9.62e-05	GO:0043524	negative regulation of neuron apoptotic process	BP
9	70	1.36141797613	-	1.71e-03	GO:0001558	regulation of cell growth	BP
5	39	1.35730186766	-	3.23e-02	GO:0050714	positive regulation of protein secretion	BP
5	39	1.35730186766	-	3.96e-02	GO:0030890	positive regulation of B cell proliferation	BP
5	39	1.35730186766	-	4.36e-02	GO:0030522	intracellular receptor signaling pathway	BP
17	133	1.35295639738	-	2.84e-04	GO:1901796	regulation of signal transduction by p53 class mediator	BP
6	47	1.35114964068	-	1.55e-02	GO:0051591	response to cAMP	BP
6	47	1.35114964068	-	1.93e-02	GO:0006909	phagocytosis	BP
24	188	1.35114964068	-	9.00e-06	GO:0004672	protein kinase activity	MF
7	55	1.34677120016	-	6.58e-03	GO:0000902	cell morphogenesis	BP
8	63	1.34349606813	-	5.72e-03	GO:0009611	response to wounding	BP
13	103	1.33471518259	-	8.69e-04	GO:0045471	response to ethanol	BP
14	111	1.33371504734	-	2.57e-04	GO:0044325	ion channel binding	MF
51	407	1.32431634934	-	2.65e-12	GO:0008285	negative regulation of cell proliferation	BP
8	64	1.32077599163	-	8.75e-03	GO:0035690	cellular response to drug	BP
6	48	1.32077599163	-	2.37e-02	GO:0042752	regulation of circadian rhythm	BP
4	32	1.32077599163	-	2.97e-02	GO:0048701	embryonic cranial skeleton morphogenesis	BP
5	40	1.32077599163	-	3.23e-02	GO:0043434	response to peptide hormone	BP
1	8	1.32077599163	-	5.00e-02	GO:0010455	positive regulation of cell fate commitment	BP
4	32	1.32077599163	-	5.47e-02	GO:0071479	cellular response to ionizing radiation	BP
4	32	1.32077599163	-	6.71e-02	GO:0006513	protein monoubiquitination	BP
4	32	1.32077599163	-	7.38e-02	GO:0008625	extrinsic apoptotic signaling pathway via death domain receptors	BP
3	24	1.32077599163	-	7.55e-02	GO:0014003	oligodendrocyte development	BP
3	24	1.32077599163	-	7.55e-02	GO:0031334	positive regulation of protein complex assembly	BP
2	16	1.32077599163	-	8.62e-02	GO:0030322	stabilization of membrane potential	BP
3	24	1.32077599163	-	9.48e-02	GO:0042113	B cell activation	BP
3	24	1.32077599163	-	9.48e-02	GO:0033137	negative regulation of peptidyl-serine phosphorylation	BP
3	24	1.32077599163	-	9.48e-02	GO:0042327	positive regulation of phosphorylation	BP
2	16	1.32077599163	-	1.18e-01	GO:0043409	negative regulation of MAPK cascade	BP
2	16	1.32077599163	-	1.36e-01	GO:0035567	non-canonical Wnt signaling pathway	BP
2	16	1.32077599163	-	1.36e-01	GO:0045616	regulation of keratinocyte differentiation	BP
2	16	1.32077599163	-	1.53e-01	GO:0031293	membrane protein intracellular domain proteolysis	BP
2	16	1.32077599163	-	1.53e-01	GO:0042307	positive regulation of protein import into nucleus	BP
2	16	1.32077599163	-	1.53e-01	GO:0001709	cell fate determination	BP
2	16	1.32077599163	-	1.53e-01	GO:0048593	camera-type eye morphogenesis	BP
2	16	1.32077599163	-	1.53e-01	GO:0060292	long term synaptic depression	BP
2	16	1.32077599163	-	1.53e-01	GO:0043508	negative regulation of JUN kinase activity	BP
2	16	1.32077599163	-	1.53e-01	GO:0003222	ventricular trabecula myocardium morphogenesis	BP
2	16	1.32077599163	-	1.71e-01	GO:0046037	GMP metabolic process	BP
2	16	1.32077599163	-	1.71e-01	GO:0010608	posttranscriptional regulation of gene expression	BP
2	16	1.32077599163	-	1.71e-01	GO:0006349	regulation of gene expression by genetic imprinting	BP
2	16	1.32077599163	-	1.71e-01	GO:0071732	cellular response to nitric oxide	BP
2	16	1.32077599163	-	1.71e-01	GO:0007026	negative regulation of microtubule depolymerization	BP
1	8	1.32077599163	-	1.86e-01	GO:1900747	negative regulation of vascular endothelial growth factor signaling pathway	BP
1	8	1.32077599163	-	1.86e-01	GO:0030210	heparin biosynthetic process	BP
2	16	1.32077599163	-	1.89e-01	GO:0036503	ERAD pathway	BP
2	16	1.32077599163	-	1.89e-01	GO:0031396	regulation of protein ubiquitination	BP
2	16	1.32077599163	-	1.89e-01	GO:0032270	positive regulation of cellular protein metabolic process	BP
2	16	1.32077599163	-	1.89e-01	GO:0030889	negative regulation of B cell proliferation	BP
2	16	1.32077599163	-	1.89e-01	GO:0030214	hyaluronan catabolic process	BP
1	8	1.32077599163	-	2.26e-01	GO:0031017	exocrine pancreas development	BP
1	8	1.32077599163	-	2.26e-01	GO:0034392	negative regulation of smooth muscle cell apoptotic process	BP
1	8	1.32077599163	-	2.26e-01	GO:0097264	self proteolysis	BP
1	8	1.32077599163	-	2.26e-01	GO:0060373	regulation of ventricular cardiac muscle cell membrane depolarization	BP
1	8	1.32077599163	-	2.26e-01	GO:0051151	negative regulation of smooth muscle cell differentiation	BP
1	8	1.32077599163	-	2.26e-01	GO:0035865	cellular response to potassium ion	BP
1	8	1.32077599163	-	2.65e-01	GO:0044342	type B pancreatic cell proliferation	BP
1	8	1.32077599163	-	2.65e-01	GO:0006704	glucocorticoid biosynthetic process	BP
1	8	1.32077599163	-	2.65e-01	GO:0040016	embryonic cleavage	BP
1	8	1.32077599163	-	2.65e-01	GO:0009743	response to carbohydrate	BP
1	8	1.32077599163	-	2.65e-01	GO:2000369	regulation of clathrin-dependent endocytosis	BP
1	8	1.32077599163	-	2.65e-01	GO:0008535	respiratory chain complex IV assembly	BP
1	8	1.32077599163	-	2.65e-01	GO:0097178	ruffle assembly	BP
1	8	1.32077599163	-	2.65e-01	GO:0007494	midgut development	BP
1	8	1.32077599163	-	2.65e-01	GO:0040036	regulation of fibroblast growth factor receptor signaling pathway	BP
1	8	1.32077599163	-	2.65e-01	GO:0060539	diaphragm development	BP
1	8	1.32077599163	-	2.65e-01	GO:0042987	amyloid precursor protein catabolic process	BP
1	8	1.32077599163	-	2.65e-01	GO:0008593	regulation of Notch signaling pathway	BP
1	8	1.32077599163	-	2.65e-01	GO:0048339	paraxial mesoderm development	BP
1	8	1.32077599163	-	2.65e-01	GO:0051026	chiasma assembly	BP
1	8	1.32077599163	-	2.65e-01	GO:0071313	cellular response to caffeine	BP
1	8	1.32077599163	-	3.02e-01	GO:0000012	single strand break repair	BP
1	8	1.32077599163	-	3.02e-01	GO:0051103	DNA ligation involved in DNA repair	BP
1	8	1.32077599163	-	3.02e-01	GO:0003139	secondary heart field specification	BP
1	8	1.32077599163	-	3.02e-01	GO:0009629	response to gravity	BP
1	8	1.32077599163	-	3.02e-01	GO:0045410	positive regulation of interleukin-6 biosynthetic process	BP
1	8	1.32077599163	-	3.02e-01	GO:0048103	somatic stem cell division	BP
1	8	1.32077599163	-	3.02e-01	GO:0070474	positive regulation of uterine smooth muscle contraction	BP
1	8	1.32077599163	-	3.02e-01	GO:0038003	opioid receptor signaling pathway	BP
1	8	1.32077599163	-	3.02e-01	GO:0009651	response to salt stress	BP
1	8	1.32077599163	-	3.02e-01	GO:0050663	cytokine secretion	BP
1	8	1.32077599163	-	3.02e-01	GO:0072678	T cell migration	BP
1	8	1.32077599163	-	3.02e-01	GO:0032691	negative regulation of interleukin-1 beta production	BP
1	8	1.32077599163	-	3.02e-01	GO:0051549	positive regulation of keratinocyte migration	BP
1	8	1.32077599163	-	3.02e-01	GO:0001766	membrane raft polarization	BP
1	8	1.32077599163	-	3.02e-01	GO:0050869	negative regulation of B cell activation	BP
1	8	1.32077599163	-	3.02e-01	GO:0071394	cellular response to testosterone stimulus	BP
1	8	1.32077599163	-	3.02e-01	GO:0090150	establishment of protein localization to membrane	BP
1	8	1.32077599163	-	3.02e-01	GO:0035912	dorsal aorta morphogenesis	BP
1	8	1.32077599163	-	3.02e-01	GO:0051963	regulation of synapse assembly	BP
1	8	1.32077599163	-	3.02e-01	GO:0071316	cellular response to nicotine	BP
1	8	1.32077599163	-	3.37e-01	GO:1990416	cellular response to brain-derived neurotrophic factor stimulus	BP
1	8	1.32077599163	-	3.37e-01	GO:0071493	cellular response to UV-B	BP
1	8	1.32077599163	-	3.37e-01	GO:1900029	positive regulation of ruffle assembly	BP
1	8	1.32077599163	-	3.37e-01	GO:0001825	blastocyst formation	BP
1	8	1.32077599163	-	3.37e-01	GO:0006012	galactose metabolic process	BP
1	8	1.32077599163	-	3.37e-01	GO:0035148	tube formation	BP
1	8	1.32077599163	-	3.37e-01	GO:0033598	mammary gland epithelial cell proliferation	BP
1	8	1.32077599163	-	3.37e-01	GO:0071550	death-inducing signaling complex assembly	BP
1	8	1.32077599163	-	3.37e-01	GO:0010888	negative regulation of lipid storage	BP
1	8	1.32077599163	-	3.37e-01	GO:0035331	negative regulation of hippo signaling	BP
1	8	1.32077599163	-	3.37e-01	GO:0006987	activation of signaling protein activity involved in unfolded protein response	BP
1	8	1.32077599163	-	3.37e-01	GO:0035372	protein localization to microtubule	BP
1	8	1.32077599163	-	3.37e-01	GO:2000177	regulation of neural precursor cell proliferation	BP
1	8	1.32077599163	-	3.37e-01	GO:2000510	positive regulation of dendritic cell chemotaxis	BP
1	8	1.32077599163	-	3.37e-01	GO:0072383	plus-end-directed vesicle transport along microtubule	BP
1	8	1.32077599163	-	3.37e-01	GO:0035234	ectopic germ cell programmed cell death	BP
1	8	1.32077599163	-	3.37e-01	GO:0048227	plasma membrane to endosome transport	BP
1	8	1.32077599163	-	3.37e-01	GO:0060732	positive regulation of inositol phosphate biosynthetic process	BP
1	8	1.32077599163	-	3.37e-01	GO:0030851	granulocyte differentiation	BP
1	8	1.32077599163	-	3.37e-01	GO:2000096	positive regulation of Wnt signaling pathway, planar cell polarity pathway	BP
1	8	1.32077599163	-	3.37e-01	GO:1990253	cellular response to leucine starvation	BP
1	8	1.32077599163	-	3.37e-01	GO:0010467	gene expression	BP
1	8	1.32077599163	-	3.37e-01	GO:0043297	apical junction assembly	BP
1	8	1.32077599163	-	3.37e-01	GO:0085020	protein K6-linked ubiquitination	BP
1	8	1.32077599163	-	3.37e-01	GO:1901838	positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter	BP
1	8	1.32077599163	-	3.37e-01	GO:0007184	SMAD protein import into nucleus	BP
1	8	1.32077599163	-	3.37e-01	GO:0035457	cellular response to interferon-alpha	BP
1	8	1.32077599163	-	3.37e-01	GO:0032872	regulation of stress-activated MAPK cascade	BP
1	8	1.32077599163	-	3.37e-01	GO:0033151	V(D)J recombination	BP
1	8	1.32077599163	-	3.37e-01	GO:0007270	neuron-neuron synaptic transmission	BP
1	8	1.32077599163	-	3.37e-01	GO:0050691	regulation of defense response to virus by host	BP
1	8	1.32077599163	-	3.37e-01	GO:2000020	positive regulation of male gonad development	BP
1	8	1.32077599163	-	3.37e-01	GO:0051683	establishment of Golgi localization	BP
1	8	1.32077599163	-	3.37e-01	GO:0051646	mitochondrion localization	BP
2	16	1.32077599163	-	1.71e-01	GO:0031435	mitogen-activated protein kinase kinase kinase binding	MF
2	16	1.32077599163	-	1.71e-01	GO:0023026	MHC class II protein complex binding	MF
1	8	1.32077599163	-	1.86e-01	GO:0015108	chloride transmembrane transporter activity	MF
1	8	1.32077599163	-	1.86e-01	GO:0005243	gap junction channel activity	MF
2	16	1.32077599163	-	1.89e-01	GO:0070182	DNA polymerase binding	MF
2	16	1.32077599163	-	1.89e-01	GO:0000400	four-way junction DNA binding	MF
1	8	1.32077599163	-	2.26e-01	GO:0004022	alcohol dehydrogenase (NAD) activity	MF
1	8	1.32077599163	-	3.02e-01	GO:0003954	NADH dehydrogenase activity	MF
1	8	1.32077599163	-	3.02e-01	GO:0017151	DEAD/H-box RNA helicase binding	MF
1	8	1.32077599163	-	3.02e-01	GO:0016655	oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor	MF
1	8	1.32077599163	-	3.02e-01	GO:0005113	patched binding	MF
1	8	1.32077599163	-	3.02e-01	GO:0015450	P-P-bond-hydrolysis-driven protein transmembrane transporter activity	MF
1	8	1.32077599163	-	3.02e-01	GO:0005005	transmembrane-ephrin receptor activity	MF
1	8	1.32077599163	-	3.02e-01	GO:0043008	ATP-dependent protein binding	MF
1	8	1.32077599163	-	3.37e-01	GO:0097157	pre-mRNA intronic binding	MF
1	8	1.32077599163	-	3.37e-01	GO:0030983	mismatched DNA binding	MF
1	8	1.32077599163	-	3.37e-01	GO:0003857	3-hydroxyacyl-CoA dehydrogenase activity	MF
1	8	1.32077599163	-	3.37e-01	GO:0000150	recombinase activity	MF
1	8	1.32077599163	-	3.37e-01	GO:0008432	JUN kinase binding	MF
1	8	1.32077599163	-	3.37e-01	GO:0032036	myosin heavy chain binding	MF
1	8	1.32077599163	-	3.37e-01	GO:0031748	D1 dopamine receptor binding	MF
1	8	1.32077599163	-	3.37e-01	GO:0001849	complement component C1q binding	MF
1	8	1.32077599163	-	3.37e-01	GO:0030306	ADP-ribosylation factor binding	MF
1	8	1.32077599163	-	3.37e-01	GO:0070878	primary miRNA binding	MF
25	203	1.29929626422	-	5.24e-09	GO:0050900	leukocyte migration	BP
15	122	1.29692924968	-	6.03e-04	GO:0017124	SH3 domain binding	MF
7	57	1.29524089952	-	9.38e-03	GO:0045669	positive regulation of osteoblast differentiation	BP
15	123	1.2851520819	-	3.37e-04	GO:0002223	stimulatory C-type lectin receptor signaling pathway	BP
10	82	1.2851520819	-	1.06e-03	GO:0007409	axonogenesis	BP
10	82	1.2851520819	-	2.16e-03	GO:0060021	palate development	BP
5	41	1.2851520819	-	3.96e-02	GO:0097191	extrinsic apoptotic signaling pathway	BP
4	33	1.27638187227	-	4.90e-02	GO:0051262	protein tetramerization	BP
4	33	1.27638187227	-	4.90e-02	GO:0003007	heart morphogenesis	BP
4	33	1.27638187227	-	7.38e-02	GO:0030100	regulation of endocytosis	BP
4	33	1.27638187227	-	3.87e-02	GO:0004866	endopeptidase inhibitor activity	MF
4	33	1.27638187227	-	6.07e-02	GO:0016791	phosphatase activity	MF
7	58	1.27014991856	-	2.29e-02	GO:0045732	positive regulation of protein catabolic process	BP
3	25	1.26188230258	-	9.48e-02	GO:0021983	pituitary gland development	BP
3	25	1.26188230258	-	9.48e-02	GO:0034612	response to tumor necrosis factor	BP
3	25	1.26188230258	-	1.05e-01	GO:0007569	cell aging	BP
3	25	1.26188230258	-	1.05e-01	GO:0006611	protein export from nucleus	BP
3	25	1.26188230258	-	1.05e-01	GO:0060612	adipose tissue development	BP
3	25	1.26188230258	-	1.05e-01	GO:0051602	response to electrical stimulus	BP
3	25	1.26188230258	-	1.16e-01	GO:0048678	response to axon injury	BP
3	25	1.26188230258	-	1.27e-01	GO:0051149	positive regulation of muscle cell differentiation	BP
3	25	1.26188230258	-	1.27e-01	GO:0032735	positive regulation of interleukin-12 production	BP
5	42	1.25038666374	-	4.36e-02	GO:0008630	intrinsic apoptotic signaling pathway in response to DNA damage	BP
7	59	1.24548786433	-	9.38e-03	GO:0006968	cellular defense response	BP
7	59	1.24548786433	-	5.80e-03	GO:0004860	protein kinase inhibitor activity	MF
9	76	1.24277347963	-	5.37e-03	GO:0006661	phosphatidylinositol biosynthetic process	BP
8	68	1.23331315038	-	9.67e-03	GO:0009749	response to glucose	BP
4	34	1.23331315038	-	2.21e-02	GO:0060045	positive regulation of cardiac muscle cell proliferation	BP
4	34	1.23331315038	-	2.97e-02	GO:0030282	bone mineralization	BP
4	34	1.23331315038	-	4.37e-02	GO:0001890	placenta development	BP
4	34	1.23331315038	-	6.07e-02	GO:0002931	response to ischemia	BP
4	34	1.23331315038	-	6.71e-02	GO:0031098	stress-activated protein kinase signaling cascade	BP
4	34	1.23331315038	-	8.81e-02	GO:0000731	DNA synthesis involved in DNA repair	BP
2	17	1.23331315038	-	1.18e-01	GO:0044030	regulation of DNA methylation	BP
2	17	1.23331315038	-	1.18e-01	GO:0043537	negative regulation of blood vessel endothelial cell migration	BP
2	17	1.23331315038	-	1.18e-01	GO:0097009	energy homeostasis	BP
2	17	1.23331315038	-	1.18e-01	GO:0006796	phosphate-containing compound metabolic process	BP
2	17	1.23331315038	-	1.36e-01	GO:0043171	peptide catabolic process	BP
2	17	1.23331315038	-	1.36e-01	GO:0001708	cell fate specification	BP
2	17	1.23331315038	-	1.36e-01	GO:0014850	response to muscle activity	BP
2	17	1.23331315038	-	1.53e-01	GO:0043651	linoleic acid metabolic process	BP
2	17	1.23331315038	-	1.53e-01	GO:0030902	hindbrain development	BP
2	17	1.23331315038	-	1.53e-01	GO:0006970	response to osmotic stress	BP
2	17	1.23331315038	-	1.53e-01	GO:0030193	regulation of blood coagulation	BP
2	17	1.23331315038	-	1.71e-01	GO:0048255	mRNA stabilization	BP
2	17	1.23331315038	-	1.71e-01	GO:0031290	retinal ganglion cell axon guidance	BP
2	17	1.23331315038	-	1.71e-01	GO:0045926	negative regulation of growth	BP
2	17	1.23331315038	-	1.71e-01	GO:0021542	dentate gyrus development	BP
2	17	1.23331315038	-	1.71e-01	GO:0002407	dendritic cell chemotaxis	BP
2	17	1.23331315038	-	1.71e-01	GO:0032722	positive regulation of chemokine production	BP
2	17	1.23331315038	-	1.89e-01	GO:1902041	regulation of extrinsic apoptotic signaling pathway via death domain receptors	BP
2	17	1.23331315038	-	1.89e-01	GO:0048814	regulation of dendrite morphogenesis	BP
2	17	1.23331315038	-	2.08e-01	GO:0007094	mitotic spindle assembly checkpoint	BP
2	17	1.23331315038	-	1.36e-01	GO:0008301	DNA binding, bending	MF
2	17	1.23331315038	-	1.89e-01	GO:0070300	phosphatidic acid binding	MF
2	17	1.23331315038	-	1.89e-01	GO:0050431	transforming growth factor beta binding	MF
2	17	1.23331315038	-	1.89e-01	GO:0001223	transcription coactivator binding	MF
5	43	1.21643933182	-	2.29e-02	GO:0001756	somitogenesis	BP
5	43	1.21643933182	-	2.58e-02	GO:0045599	negative regulation of fat cell differentiation	BP
5	43	1.21643933182	-	3.58e-02	GO:0007566	embryo implantation	BP
5	43	1.21643933182	-	3.96e-02	GO:0048538	thymus development	BP
5	43	1.21643933182	-	5.24e-02	GO:1901215	negative regulation of neuron death	BP
19	164	1.21115150046	-	1.23e-04	GO:0090090	negative regulation of canonical Wnt signaling pathway	BP
11	95	1.21035200194	-	6.62e-03	GO:0016236	macroautophagy	BP
3	26	1.20529877421	-	7.55e-02	GO:0010719	negative regulation of epithelial to mesenchymal transition	BP
3	26	1.20529877421	-	7.55e-02	GO:0009966	regulation of signal transduction	BP
3	26	1.20529877421	-	9.48e-02	GO:0051930	regulation of sensory perception of pain	BP
3	26	1.20529877421	-	1.05e-01	GO:0032715	negative regulation of interleukin-6 production	BP
3	26	1.20529877421	-	1.16e-01	GO:0070371	ERK1 and ERK2 cascade	BP
3	26	1.20529877421	-	1.27e-01	GO:0000732	strand displacement	BP
3	26	1.20529877421	-	1.27e-01	GO:0071480	cellular response to gamma radiation	BP
3	26	1.20529877421	-	1.39e-01	GO:0043388	positive regulation of DNA binding	BP
7	61	1.19739357613	-	1.17e-02	GO:0005518	collagen binding	MF
4	35	1.19149297469	-	3.87e-02	GO:0051480	regulation of cytosolic calcium ion concentration	BP
4	35	1.19149297469	-	7.38e-02	GO:0045787	positive regulation of cell cycle	BP
8	70	1.19149297469	-	1.82e-02	GO:0002039	p53 binding	MF
5	44	1.18327246788	-	4.36e-02	GO:0071363	cellular response to growth factor stimulus	BP
12	106	1.17781803779	-	9.23e-04	GO:0005178	integrin binding	MF
23	205	1.16485784818	-	4.31e-05	GO:0004871	signal transducer activity	MF
12	107	1.16427150595	-	1.26e-03	GO:0030336	negative regulation of cell migration	BP
24	216	1.15085099019	-	2.28e-05	GO:0001525	angiogenesis	BP
12	108	1.15085099019	-	2.48e-03	GO:0006914	autophagy	BP
9	81	1.15085099019	-	7.20e-03	GO:0060070	canonical Wnt signaling pathway	BP
6	54	1.15085099019	-	3.45e-02	GO:0030097	hemopoiesis	BP
6	54	1.15085099019	-	4.09e-02	GO:0071560	cellular response to transforming growth factor beta stimulus	BP
5	45	1.15085099019	-	4.36e-02	GO:0030900	forebrain development	BP
6	54	1.15085099019	-	4.44e-02	GO:0016049	cell growth	BP
5	45	1.15085099019	-	5.72e-02	GO:0006094	gluconeogenesis	BP
4	36	1.15085099019	-	6.71e-02	GO:0051209	release of sequestered calcium ion into cytosol	BP
3	27	1.15085099019	-	9.48e-02	GO:0010575	positive regulation of vascular endothelial growth factor production	BP
2	18	1.15085099019	-	1.18e-01	GO:0036342	post-anal tail morphogenesis	BP
3	27	1.15085099019	-	1.39e-01	GO:0007093	mitotic cell cycle checkpoint	BP
3	27	1.15085099019	-	1.39e-01	GO:0043392	negative regulation of DNA binding	BP
1	9	1.15085099019	-	1.43e-01	GO:0006688	glycosphingolipid biosynthetic process	BP
3	27	1.15085099019	-	1.51e-01	GO:0045931	positive regulation of mitotic cell cycle	BP
2	18	1.15085099019	-	1.53e-01	GO:0035249	synaptic transmission, glutamatergic	BP
2	18	1.15085099019	-	1.71e-01	GO:0002076	osteoblast development	BP
2	18	1.15085099019	-	1.71e-01	GO:0060324	face development	BP
2	18	1.15085099019	-	1.71e-01	GO:0045089	positive regulation of innate immune response	BP
1	9	1.15085099019	-	1.86e-01	GO:0001574	ganglioside biosynthetic process	BP
1	9	1.15085099019	-	1.86e-01	GO:0060371	regulation of atrial cardiac muscle cell membrane depolarization	BP
1	9	1.15085099019	-	1.86e-01	GO:0036444	mitochondrial calcium uptake	BP
2	18	1.15085099019	-	1.89e-01	GO:0045954	positive regulation of natural killer cell mediated cytotoxicity	BP
2	18	1.15085099019	-	2.08e-01	GO:0048260	positive regulation of receptor-mediated endocytosis	BP
2	18	1.15085099019	-	2.08e-01	GO:0009416	response to light stimulus	BP
2	18	1.15085099019	-	2.08e-01	GO:0045664	regulation of neuron differentiation	BP
2	18	1.15085099019	-	2.08e-01	GO:0045948	positive regulation of translational initiation	BP
1	9	1.15085099019	-	2.26e-01	GO:0009247	glycolipid biosynthetic process	BP
1	9	1.15085099019	-	2.26e-01	GO:0051205	protein insertion into membrane	BP
1	9	1.15085099019	-	2.26e-01	GO:0043583	ear development	BP
1	9	1.15085099019	-	2.26e-01	GO:0001973	adenosine receptor signaling pathway	BP
1	9	1.15085099019	-	2.26e-01	GO:0045580	regulation of T cell differentiation	BP
2	18	1.15085099019	-	2.27e-01	GO:0010039	response to iron ion	BP
1	9	1.15085099019	-	2.65e-01	GO:2000726	negative regulation of cardiac muscle cell differentiation	BP
1	9	1.15085099019	-	2.65e-01	GO:0003073	regulation of systemic arterial blood pressure	BP
1	9	1.15085099019	-	2.65e-01	GO:0043569	negative regulation of insulin-like growth factor receptor signaling pathway	BP
1	9	1.15085099019	-	2.65e-01	GO:0098773	skin epidermis development	BP
1	9	1.15085099019	-	2.65e-01	GO:0048617	embryonic foregut morphogenesis	BP
1	9	1.15085099019	-	2.65e-01	GO:0043117	positive regulation of vascular permeability	BP
1	9	1.15085099019	-	2.65e-01	GO:0042448	progesterone metabolic process	BP
1	9	1.15085099019	-	2.65e-01	GO:1900165	negative regulation of interleukin-6 secretion	BP
1	9	1.15085099019	-	2.65e-01	GO:0071679	commissural neuron axon guidance	BP
1	9	1.15085099019	-	2.65e-01	GO:0046887	positive regulation of hormone secretion	BP
1	9	1.15085099019	-	2.65e-01	GO:2000304	positive regulation of ceramide biosynthetic process	BP
1	9	1.15085099019	-	2.65e-01	GO:0015866	ADP transport	BP
1	9	1.15085099019	-	3.02e-01	GO:2000648	positive regulation of stem cell proliferation	BP
1	9	1.15085099019	-	3.02e-01	GO:0086014	atrial cardiac muscle cell action potential	BP
1	9	1.15085099019	-	3.02e-01	GO:0046548	retinal rod cell development	BP
1	9	1.15085099019	-	3.02e-01	GO:0042118	endothelial cell activation	BP
1	9	1.15085099019	-	3.02e-01	GO:0097105	presynaptic membrane assembly	BP
1	9	1.15085099019	-	3.02e-01	GO:0070072	vacuolar proton-transporting V-type ATPase complex assembly	BP
1	9	1.15085099019	-	3.02e-01	GO:0048806	genitalia development	BP
1	9	1.15085099019	-	3.02e-01	GO:0021702	cerebellar Purkinje cell differentiation	BP
1	9	1.15085099019	-	3.02e-01	GO:0071374	cellular response to parathyroid hormone stimulus	BP
1	9	1.15085099019	-	3.02e-01	GO:0072358	cardiovascular system development	BP
1	9	1.15085099019	-	3.02e-01	GO:0097120	receptor localization to synapse	BP
1	9	1.15085099019	-	3.02e-01	GO:0046620	regulation of organ growth	BP
1	9	1.15085099019	-	3.02e-01	GO:0090277	positive regulation of peptide hormone secretion	BP
1	9	1.15085099019	-	3.02e-01	GO:0061314	Notch signaling involved in heart development	BP
1	9	1.15085099019	-	3.02e-01	GO:0061351	neural precursor cell proliferation	BP
1	9	1.15085099019	-	3.02e-01	GO:0097011	cellular response to granulocyte macrophage colony-stimulating factor stimulus	BP
1	9	1.15085099019	-	3.02e-01	GO:2000270	negative regulation of fibroblast apoptotic process	BP
1	9	1.15085099019	-	3.02e-01	GO:0046339	diacylglycerol metabolic process	BP
1	9	1.15085099019	-	3.37e-01	GO:1900027	regulation of ruffle assembly	BP
1	9	1.15085099019	-	3.37e-01	GO:0060068	vagina development	BP
1	9	1.15085099019	-	3.37e-01	GO:1904153	negative regulation of retrograde protein transport, ER to cytosol	BP
1	9	1.15085099019	-	3.37e-01	GO:0032731	positive regulation of interleukin-1 beta production	BP
1	9	1.15085099019	-	3.37e-01	GO:0016126	sterol biosynthetic process	BP
1	9	1.15085099019	-	3.37e-01	GO:0007019	microtubule depolymerization	BP
1	9	1.15085099019	-	3.37e-01	GO:0042473	outer ear morphogenesis	BP
1	9	1.15085099019	-	3.37e-01	GO:0021675	nerve development	BP
1	9	1.15085099019	-	3.37e-01	GO:0002544	chronic inflammatory response	BP
1	9	1.15085099019	-	3.37e-01	GO:1990403	embryonic brain development	BP
1	9	1.15085099019	-	3.37e-01	GO:0034101	erythrocyte homeostasis	BP
1	9	1.15085099019	-	3.37e-01	GO:1902857	positive regulation of non-motile cilium assembly	BP
1	9	1.15085099019	-	3.37e-01	GO:2000001	regulation of DNA damage checkpoint	BP
1	9	1.15085099019	-	3.37e-01	GO:0000733	DNA strand renaturation	BP
1	9	1.15085099019	-	3.37e-01	GO:0006930	substrate-dependent cell migration, cell extension	BP
1	9	1.15085099019	-	3.37e-01	GO:0042754	negative regulation of circadian rhythm	BP
1	9	1.15085099019	-	3.37e-01	GO:0010950	positive regulation of endopeptidase activity	BP
1	9	1.15085099019	-	3.37e-01	GO:0042088	T-helper 1 type immune response	BP
1	9	1.15085099019	-	3.37e-01	GO:0046855	inositol phosphate dephosphorylation	BP
1	9	1.15085099019	-	3.37e-01	GO:0032836	glomerular basement membrane development	BP
1	9	1.15085099019	-	3.37e-01	GO:0030299	intestinal cholesterol absorption	BP
1	9	1.15085099019	-	3.37e-01	GO:0097484	dendrite extension	BP
1	9	1.15085099019	-	3.70e-01	GO:0007196	adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway	BP
1	9	1.15085099019	-	3.70e-01	GO:0008090	retrograde axonal transport	BP
1	9	1.15085099019	-	3.70e-01	GO:0043653	mitochondrial fragmentation involved in apoptotic process	BP
1	9	1.15085099019	-	3.70e-01	GO:0031053	primary miRNA processing	BP
1	9	1.15085099019	-	3.70e-01	GO:0048489	synaptic vesicle transport	BP
1	9	1.15085099019	-	3.70e-01	GO:0060627	regulation of vesicle-mediated transport	BP
1	9	1.15085099019	-	3.70e-01	GO:0016558	protein import into peroxisome matrix	BP
1	9	1.15085099019	-	3.70e-01	GO:0010761	fibroblast migration	BP
1	9	1.15085099019	-	3.70e-01	GO:0071340	skeletal muscle acetylcholine-gated channel clustering	BP
1	9	1.15085099019	-	3.70e-01	GO:0008228	opsonization	BP
1	9	1.15085099019	-	3.70e-01	GO:0032463	negative regulation of protein homooligomerization	BP
1	9	1.15085099019	-	3.70e-01	GO:2000008	regulation of protein localization to cell surface	BP
1	9	1.15085099019	-	3.70e-01	GO:0006265	DNA topological change	BP
1	9	1.15085099019	-	3.70e-01	GO:0070933	histone H4 deacetylation	BP
1	9	1.15085099019	-	3.70e-01	GO:0002262	myeloid cell homeostasis	BP
1	9	1.15085099019	-	3.70e-01	GO:0000722	telomere maintenance via recombination	BP
1	9	1.15085099019	-	3.70e-01	GO:0045080	positive regulation of chemokine biosynthetic process	BP
1	9	1.15085099019	-	3.70e-01	GO:0048245	eosinophil chemotaxis	BP
1	9	1.15085099019	-	3.70e-01	GO:0043497	regulation of protein heterodimerization activity	BP
1	9	1.15085099019	-	3.70e-01	GO:0043281	regulation of cysteine-type endopeptidase activity involved in apoptotic process	BP
3	27	1.15085099019	-	6.65e-02	GO:0001530	lipopolysaccharide binding	MF
1	9	1.15085099019	-	1.86e-01	GO:0008510	sodium:bicarbonate symporter activity	MF
1	9	1.15085099019	-	1.86e-01	GO:0033691	sialic acid binding	MF
1	9	1.15085099019	-	2.26e-01	GO:0055056	D-glucose transmembrane transporter activity	MF
1	9	1.15085099019	-	2.26e-01	GO:0052650	NADP-retinol dehydrogenase activity	MF
1	9	1.15085099019	-	2.65e-01	GO:0005126	cytokine receptor binding	MF
1	9	1.15085099019	-	2.65e-01	GO:0046703	natural killer cell lectin-like receptor binding	MF
1	9	1.15085099019	-	3.37e-01	GO:0045499	chemorepellent activity	MF
1	9	1.15085099019	-	3.37e-01	GO:0070679	inositol 1,4,5 trisphosphate binding	MF
1	9	1.15085099019	-	3.37e-01	GO:0000774	adenyl-nucleotide exchange factor activity	MF
1	9	1.15085099019	-	3.37e-01	GO:0046790	virion binding	MF
1	9	1.15085099019	-	3.37e-01	GO:0030291	protein serine/threonine kinase inhibitor activity	MF
1	9	1.15085099019	-	3.37e-01	GO:0045236	CXCR chemokine receptor binding	MF
1	9	1.15085099019	-	3.70e-01	GO:0004862	cAMP-dependent protein kinase inhibitor activity	MF
1	9	1.15085099019	-	3.70e-01	GO:0003691	double-stranded telomeric DNA binding	MF
1	9	1.15085099019	-	3.70e-01	GO:0032183	SUMO binding	MF
1	9	1.15085099019	-	3.70e-01	GO:0002162	dystroglycan binding	MF
1	9	1.15085099019	-	3.70e-01	GO:0019855	calcium channel inhibitor activity	MF
64	579	1.14335645364	-	2.87e-12	GO:0043547	positive regulation of GTPase activity	BP
18	164	1.13314898846	-	2.80e-04	GO:0007507	heart development	BP
18	164	1.13314898846	-	5.04e-04	GO:0007568	aging	BP
9	82	1.13314898846	-	1.33e-02	GO:0030307	positive regulation of cell growth	BP
9	82	1.13314898846	-	1.44e-02	GO:0008543	fibroblast growth factor receptor signaling pathway	BP
42	383	1.13189283249	-	2.52e-08	GO:0035556	intracellular signal transduction	BP
16	146	1.13095143275	-	2.52e-03	GO:0018105	peptidyl-serine phosphorylation	BP
6	55	1.12437877883	-	2.88e-02	GO:0042733	embryonic digit morphogenesis	BP
6	55	1.12437877883	-	4.44e-02	GO:0043621	protein self-association	MF
32	294	1.1211036468	-	1.38e-06	GO:0010628	positive regulation of gene expression	BP
5	46	1.11914213046	-	3.96e-02	GO:0043647	inositol phosphate metabolic process	BP
5	46	1.11914213046	-	3.96e-02	GO:0003151	outflow tract morphogenesis	BP
5	46	1.11914213046	-	5.24e-02	GO:0007611	learning or memory	BP
5	46	1.11914213046	-	5.72e-02	GO:0007519	skeletal muscle tissue development	BP
5	46	1.11914213046	-	6.21e-02	GO:0031532	actin cytoskeleton reorganization	BP
5	46	1.11914213046	-	6.74e-02	GO:0030521	androgen receptor signaling pathway	BP
4	37	1.111322626	-	8.08e-02	GO:0042149	cellular response to glucose starvation	BP
4	37	1.111322626	-	9.57e-02	GO:0006605	protein targeting	BP
7	65	1.10576310066	-	3.72e-02	GO:0000226	microtubule cytoskeleton organization	BP
6	56	1.0983835703	-	2.62e-02	GO:0009612	response to mechanical stimulus	BP
6	56	1.0983835703	-	2.88e-02	GO:0042475	odontogenesis of dentin-containing tooth	BP
6	56	1.0983835703	-	4.09e-02	GO:0006006	glucose metabolic process	BP
3	28	1.0983835703	-	1.05e-01	GO:0003281	ventricular septum development	BP
3	28	1.0983835703	-	1.05e-01	GO:0048873	homeostasis of number of cells within a tissue	BP
3	28	1.0983835703	-	1.39e-01	GO:0007528	neuromuscular junction development	BP
3	28	1.0983835703	-	1.51e-01	GO:0051603	proteolysis involved in cellular protein catabolic process	BP
3	28	1.0983835703	-	1.63e-01	GO:0045739	positive regulation of DNA repair	BP
3	28	1.0983835703	-	1.63e-01	GO:0010332	response to gamma radiation	BP
38	356	1.09297007411	-	1.34e-07	GO:0005102	receptor binding	MF
5	47	1.08811523484	-	8.44e-02	GO:0034644	cellular response to UV	BP
17	160	1.08631073799	-	5.73e-04	GO:0032496	response to lipopolysaccharide	BP
19	179	1.08488772781	-	1.42e-03	GO:0008022	protein C-terminus binding	MF
14	133	1.07284847819	-	4.40e-04	GO:0007204	positive regulation of cytosolic calcium ion concentration	BP
6	57	1.07284847819	-	3.16e-02	GO:0007612	learning	BP
4	38	1.07284847819	-	9.57e-02	GO:0010634	positive regulation of epithelial cell migration	BP
2	19	1.07284847819	-	1.36e-01	GO:0033280	response to vitamin D	BP
2	19	1.07284847819	-	1.71e-01	GO:0014032	neural crest cell development	BP
2	19	1.07284847819	-	1.71e-01	GO:0048557	embryonic digestive tract morphogenesis	BP
2	19	1.07284847819	-	1.71e-01	GO:0048663	neuron fate commitment	BP
2	19	1.07284847819	-	1.71e-01	GO:0002028	regulation of sodium ion transport	BP
2	19	1.07284847819	-	2.08e-01	GO:0008589	regulation of smoothened signaling pathway	BP
2	19	1.07284847819	-	2.08e-01	GO:0010613	positive regulation of cardiac muscle hypertrophy	BP
2	19	1.07284847819	-	2.08e-01	GO:0050770	regulation of axonogenesis	BP
2	19	1.07284847819	-	2.27e-01	GO:0090190	positive regulation of branching involved in ureteric bud morphogenesis	BP
2	19	1.07284847819	-	2.27e-01	GO:0042776	mitochondrial ATP synthesis coupled proton transport	BP
2	19	1.07284847819	-	2.27e-01	GO:0046597	negative regulation of viral entry into host cell	BP
2	19	1.07284847819	-	2.27e-01	GO:0048169	regulation of long-term neuronal synaptic plasticity	BP
2	19	1.07284847819	-	2.46e-01	GO:0008637	apoptotic mitochondrial changes	BP
2	19	1.07284847819	-	2.46e-01	GO:0043011	myeloid dendritic cell differentiation	BP
6	57	1.07284847819	-	5.18e-02	GO:0003684	damaged DNA binding	MF
49	467	1.06820709604	-	1.28e-08	GO:0043066	negative regulation of apoptotic process	BP
12	115	1.06024844141	-	4.88e-03	GO:0005085	guanyl-nucleotide exchange factor activity	MF
6	58	1.04775749723	-	3.16e-02	GO:0050680	negative regulation of epithelial cell proliferation	BP
3	29	1.04775749723	-	1.05e-01	GO:0045776	negative regulation of blood pressure	BP
3	29	1.04775749723	-	1.39e-01	GO:0008234	cysteine-type peptidase activity	MF
7	68	1.04066807244	-	2.95e-02	GO:0045444	fat cell differentiation	BP
18	175	1.03948988124	-	3.62e-04	GO:0016055	Wnt signaling pathway	BP
8	78	1.03537377277	-	1.17e-02	GO:0030324	lung development	BP
4	39	1.03537377277	-	8.81e-02	GO:0060291	long-term synaptic potentiation	BP
4	39	1.03537377277	-	1.12e-01	GO:0001102	RNA polymerase II activating transcription factor binding	MF
33	322	1.03425323288	-	5.67e-06	GO:0043065	positive regulation of apoptotic process	BP
5	49	1.0279942424	-	2.58e-02	GO:0051898	negative regulation of protein kinase B signaling	BP
5	49	1.0279942424	-	9.05e-02	GO:0032481	positive regulation of type I interferon production	BP
5	49	1.0279942424	-	7.28e-02	GO:0001085	RNA polymerase II transcription factor binding	MF
6	59	1.02309544299	-	1.55e-02	GO:0007338	single fertilization	BP
6	59	1.02309544299	-	2.62e-02	GO:0002244	hematopoietic progenitor cell differentiation	BP
6	59	1.02309544299	-	2.88e-02	GO:0042277	peptide binding	MF
12	120	0.998847896744	-	1.28e-02	GO:0071222	cellular response to lipopolysaccharide	BP
7	70	0.998847896744	-	4.62e-02	GO:0007584	response to nutrient	BP
6	60	0.998847896744	-	6.00e-02	GO:0030334	regulation of cell migration	BP
5	50	0.998847896744	-	7.85e-02	GO:0071407	cellular response to organic cyclic compound	BP
3	30	0.998847896744	-	8.49e-02	GO:0046676	negative regulation of insulin secretion	BP
3	30	0.998847896744	-	9.48e-02	GO:0042104	positive regulation of activated T cell proliferation	BP
3	30	0.998847896744	-	1.16e-01	GO:0030901	midbrain development	BP
3	30	0.998847896744	-	1.27e-01	GO:0031667	response to nutrient levels	BP
3	30	0.998847896744	-	1.27e-01	GO:0007163	establishment or maintenance of cell polarity	BP
4	40	0.998847896744	-	7.38e-02	GO:0032526	response to retinoic acid	BP
4	40	0.998847896744	-	8.08e-02	GO:0032570	response to progesterone	BP
4	40	0.998847896744	-	1.04e-01	GO:0021762	substantia nigra development	BP
2	20	0.998847896744	-	1.18e-01	GO:0015711	organic anion transport	BP
2	20	0.998847896744	-	1.18e-01	GO:0055074	calcium ion homeostasis	BP
2	20	0.998847896744	-	1.53e-01	GO:0001659	temperature homeostasis	BP
2	20	0.998847896744	-	1.53e-01	GO:0010596	negative regulation of endothelial cell migration	BP
2	20	0.998847896744	-	2.08e-01	GO:0061436	establishment of skin barrier	BP
1	10	0.998847896744	-	2.26e-01	GO:0006278	RNA-dependent DNA biosynthetic process	BP
1	10	0.998847896744	-	2.26e-01	GO:0015747	urate transport	BP
2	20	0.998847896744	-	2.27e-01	GO:0010971	positive regulation of G2/M transition of mitotic cell cycle	BP
2	20	0.998847896744	-	2.27e-01	GO:0071310	cellular response to organic substance	BP
2	20	0.998847896744	-	2.64e-01	GO:0016601	Rac protein signal transduction	BP
2	20	0.998847896744	-	2.64e-01	GO:0071526	semaphorin-plexin signaling pathway	BP
1	10	0.998847896744	-	2.65e-01	GO:1903825	organic acid transmembrane transport	BP
1	10	0.998847896744	-	2.65e-01	GO:0060174	limb bud formation	BP
1	10	0.998847896744	-	2.65e-01	GO:0008343	adult feeding behavior	BP
1	10	0.998847896744	-	3.02e-01	GO:0060306	regulation of membrane repolarization	BP
1	10	0.998847896744	-	3.02e-01	GO:0001867	complement activation, lectin pathway	BP
1	10	0.998847896744	-	3.02e-01	GO:0010838	positive regulation of keratinocyte proliferation	BP
1	10	0.998847896744	-	3.02e-01	GO:0051983	regulation of chromosome segregation	BP
1	10	0.998847896744	-	3.02e-01	GO:0001886	endothelial cell morphogenesis	BP
1	10	0.998847896744	-	3.02e-01	GO:0032525	somite rostral/caudal axis specification	BP
1	10	0.998847896744	-	3.37e-01	GO:0048096	chromatin-mediated maintenance of transcription	BP
1	10	0.998847896744	-	3.37e-01	GO:0031665	negative regulation of lipopolysaccharide-mediated signaling pathway	BP
1	10	0.998847896744	-	3.37e-01	GO:0021680	cerebellar Purkinje cell layer development	BP
1	10	0.998847896744	-	3.37e-01	GO:2000480	negative regulation of cAMP-dependent protein kinase activity	BP
1	10	0.998847896744	-	3.37e-01	GO:0050966	detection of mechanical stimulus involved in sensory perception of pain	BP
1	10	0.998847896744	-	3.37e-01	GO:0051256	mitotic spindle midzone assembly	BP
1	10	0.998847896744	-	3.37e-01	GO:0031953	negative regulation of protein autophosphorylation	BP
1	10	0.998847896744	-	3.37e-01	GO:0043267	negative regulation of potassium ion transport	BP
1	10	0.998847896744	-	3.37e-01	GO:0045741	positive regulation of epidermal growth factor-activated receptor activity	BP
1	10	0.998847896744	-	3.37e-01	GO:0048853	forebrain morphogenesis	BP
1	10	0.998847896744	-	3.37e-01	GO:0048048	embryonic eye morphogenesis	BP
1	10	0.998847896744	-	3.37e-01	GO:0009117	nucleotide metabolic process	BP
1	10	0.998847896744	-	3.37e-01	GO:0051156	glucose 6-phosphate metabolic process	BP
1	10	0.998847896744	-	3.37e-01	GO:0016322	neuron remodeling	BP
1	10	0.998847896744	-	3.37e-01	GO:0019370	leukotriene biosynthetic process	BP
1	10	0.998847896744	-	3.70e-01	GO:0086013	membrane repolarization during cardiac muscle cell action potential	BP
1	10	0.998847896744	-	3.70e-01	GO:0090197	positive regulation of chemokine secretion	BP
1	10	0.998847896744	-	3.70e-01	GO:0090394	negative regulation of excitatory postsynaptic potential	BP
1	10	0.998847896744	-	3.70e-01	GO:0003334	keratinocyte development	BP
1	10	0.998847896744	-	3.70e-01	GO:0010226	response to lithium ion	BP
1	10	0.998847896744	-	3.70e-01	GO:0016331	morphogenesis of embryonic epithelium	BP
1	10	0.998847896744	-	3.70e-01	GO:0003184	pulmonary valve morphogenesis	BP
1	10	0.998847896744	-	3.70e-01	GO:0003181	atrioventricular valve morphogenesis	BP
1	10	0.998847896744	-	3.70e-01	GO:0032060	bleb assembly	BP
1	10	0.998847896744	-	3.70e-01	GO:0002218	activation of innate immune response	BP
1	10	0.998847896744	-	3.70e-01	GO:1902894	negative regulation of pri-miRNA transcription from RNA polymerase II promoter	BP
1	10	0.998847896744	-	3.70e-01	GO:0048715	negative regulation of oligodendrocyte differentiation	BP
1	10	0.998847896744	-	3.70e-01	GO:0048711	positive regulation of astrocyte differentiation	BP
1	10	0.998847896744	-	3.70e-01	GO:0010820	positive regulation of T cell chemotaxis	BP
1	10	0.998847896744	-	3.70e-01	GO:0060081	membrane hyperpolarization	BP
1	10	0.998847896744	-	3.70e-01	GO:0045475	locomotor rhythm	BP
1	10	0.998847896744	-	3.70e-01	GO:2001022	positive regulation of response to DNA damage stimulus	BP
1	10	0.998847896744	-	3.70e-01	GO:0046626	regulation of insulin receptor signaling pathway	BP
1	10	0.998847896744	-	3.70e-01	GO:0032940	secretion by cell	BP
1	10	0.998847896744	-	4.02e-01	GO:0051272	positive regulation of cellular component movement	BP
1	10	0.998847896744	-	4.02e-01	GO:0048280	vesicle fusion with Golgi apparatus	BP
1	10	0.998847896744	-	4.02e-01	GO:0001771	immunological synapse formation	BP
1	10	0.998847896744	-	4.02e-01	GO:0033148	positive regulation of intracellular estrogen receptor signaling pathway	BP
1	10	0.998847896744	-	4.02e-01	GO:0043248	proteasome assembly	BP
1	10	0.998847896744	-	4.02e-01	GO:0071711	basement membrane organization	BP
1	10	0.998847896744	-	4.02e-01	GO:0034063	stress granule assembly	BP
1	10	0.998847896744	-	4.02e-01	GO:0051247	positive regulation of protein metabolic process	BP
1	10	0.998847896744	-	4.02e-01	GO:2000178	negative regulation of neural precursor cell proliferation	BP
1	10	0.998847896744	-	4.02e-01	GO:2001214	positive regulation of vasculogenesis	BP
1	10	0.998847896744	-	4.02e-01	GO:1902188	positive regulation of viral release from host cell	BP
1	10	0.998847896744	-	4.02e-01	GO:0060546	negative regulation of necroptotic process	BP
1	10	0.998847896744	-	4.02e-01	GO:0071985	multivesicular body sorting pathway	BP
1	10	0.998847896744	-	4.02e-01	GO:0007178	transmembrane receptor protein serine/threonine kinase signaling pathway	BP
1	10	0.998847896744	-	4.02e-01	GO:0060009	Sertoli cell development	BP
1	10	0.998847896744	-	4.02e-01	GO:2000300	regulation of synaptic vesicle exocytosis	BP
1	10	0.998847896744	-	4.02e-01	GO:2000637	positive regulation of gene silencing by miRNA	BP
1	10	0.998847896744	-	4.02e-01	GO:0060487	lung epithelial cell differentiation	BP
1	10	0.998847896744	-	4.02e-01	GO:2001020	regulation of response to DNA damage stimulus	BP
1	10	0.998847896744	-	4.02e-01	GO:2000772	regulation of cellular senescence	BP
1	10	0.998847896744	-	4.02e-01	GO:0035067	negative regulation of histone acetylation	BP
1	10	0.998847896744	-	4.02e-01	GO:0046785	microtubule polymerization	BP
2	20	0.998847896744	-	1.71e-01	GO:0031267	small GTPase binding	MF
2	20	0.998847896744	-	1.89e-01	GO:0042813	Wnt-activated receptor activity	MF
2	20	0.998847896744	-	2.27e-01	GO:0071949	FAD binding	MF
2	20	0.998847896744	-	2.27e-01	GO:0031683	G-protein beta/gamma-subunit complex binding	MF
1	10	0.998847896744	-	2.65e-01	GO:0015143	urate transmembrane transporter activity	MF
1	10	0.998847896744	-	2.65e-01	GO:0033130	acetylcholine receptor binding	MF
1	10	0.998847896744	-	3.02e-01	GO:0042577	lipid phosphatase activity	MF
1	10	0.998847896744	-	3.37e-01	GO:0019911	structural constituent of myelin sheath	MF
1	10	0.998847896744	-	3.37e-01	GO:0004185	serine-type carboxypeptidase activity	MF
1	10	0.998847896744	-	3.70e-01	GO:0019104	DNA N-glycosylase activity	MF
1	10	0.998847896744	-	3.70e-01	GO:0016504	peptidase activator activity	MF
1	10	0.998847896744	-	4.02e-01	GO:0044877	macromolecular complex binding	MF
1	10	0.998847896744	-	4.02e-01	GO:0070016	armadillo repeat domain binding	MF
1	10	0.998847896744	-	4.02e-01	GO:0097200	cysteine-type endopeptidase activity involved in execution phase of apoptosis	MF
1	10	0.998847896744	-	4.02e-01	GO:0017166	vinculin binding	MF
1	10	0.998847896744	-	4.02e-01	GO:0042975	peroxisome proliferator activated receptor binding	MF
7	71	0.978383794185	-	4.01e-02	GO:0060333	interferon-gamma-mediated signaling pathway	BP
18	183	0.97500115479	-	1.48e-03	GO:0007596	blood coagulation	BP
11	112	0.972852688212	-	3.98e-03	GO:0007417	central nervous system development	BP
5	51	0.970278744548	-	8.44e-02	GO:0051592	response to calcium ion	BP
5	51	0.970278744548	-	8.44e-02	GO:0040008	regulation of growth	BP
9	92	0.967139037017	-	1.13e-02	GO:0009636	response to toxic substance	BP
9	92	0.967139037017	-	2.10e-02	GO:0032355	response to estradiol	BP
4	41	0.963223987014	-	8.81e-02	GO:0009725	response to hormone	BP
4	41	0.963223987014	-	1.29e-01	GO:0043124	negative regulation of I-kappaB kinase/NF-kappaB signaling	BP
10	103	0.956203559336	-	2.60e-02	GO:0031175	neuron projection development	BP
3	31	0.951542181966	-	3.62e-02	GO:0010667	negative regulation of cardiac muscle cell apoptotic process	BP
3	31	0.951542181966	-	1.16e-01	GO:0035115	embryonic forelimb morphogenesis	BP
3	31	0.951542181966	-	1.39e-01	GO:0048286	lung alveolus development	BP
3	31	0.951542181966	-	1.51e-01	GO:0060412	ventricular septum morphogenesis	BP
3	31	0.951542181966	-	1.63e-01	GO:0048662	negative regulation of smooth muscle cell proliferation	BP
3	31	0.951542181966	-	1.75e-01	GO:0006284	base-excision repair	BP
3	31	0.951542181966	-	1.39e-01	GO:0050699	WW domain binding	MF
42	436	0.944909089634	-	9.65e-10	GO:0045087	innate immune response	BP
10	104	0.942264368378	-	2.68e-02	GO:0071456	cellular response to hypoxia	BP
21	220	0.931733700886	-	2.10e-03	GO:0032403	protein complex binding	MF
4	42	0.928458568853	-	8.08e-02	GO:0001658	branching involved in ureteric bud morphogenesis	BP
4	42	0.928458568853	-	8.81e-02	GO:0001541	ovarian follicle development	BP
2	21	0.928458568853	-	2.27e-01	GO:0051493	regulation of cytoskeleton organization	BP
2	21	0.928458568853	-	2.27e-01	GO:0045672	positive regulation of osteoclast differentiation	BP
2	21	0.928458568853	-	2.27e-01	GO:0007492	endoderm development	BP
2	21	0.928458568853	-	2.46e-01	GO:0097150	neuronal stem cell population maintenance	BP
2	21	0.928458568853	-	2.46e-01	GO:0001782	B cell homeostasis	BP
2	21	0.928458568853	-	2.83e-01	GO:0060828	regulation of canonical Wnt signaling pathway	BP
2	21	0.928458568853	-	2.83e-01	GO:0043393	regulation of protein binding	BP
2	21	0.928458568853	-	1.36e-01	GO:0008514	organic anion transmembrane transporter activity	MF
2	21	0.928458568853	-	2.08e-01	GO:0048018	receptor agonist activity	MF
6	63	0.928458568853	-	5.18e-02	GO:0030593	neutrophil chemotaxis	BP
7	74	0.91867754806	-	8.73e-02	GO:0001843	neural tube closure	BP
15	159	0.914783631956	-	1.97e-03	GO:0010629	negative regulation of gene expression	BP
10	106	0.914783631956	-	2.77e-02	GO:0051091	positive regulation of sequence-specific DNA binding transcription factor activity	BP
15	160	0.905738492353	-	1.24e-02	GO:0001666	response to hypoxia	BP
3	32	0.905738492353	-	1.39e-01	GO:0071773	cellular response to BMP stimulus	BP
3	32	0.905738492353	-	1.75e-01	GO:0043200	response to amino acid	BP
3	32	0.905738492353	-	2.01e-01	GO:1900026	positive regulation of substrate adhesion-dependent cell spreading	BP
11	118	0.897564560907	-	8.37e-03	GO:0045766	positive regulation of angiogenesis	BP
4	43	0.89451123693	-	7.38e-02	GO:0045165	cell fate commitment	BP
4	43	0.89451123693	-	1.04e-01	GO:0007188	adenylate cyclase-modulating G-protein coupled receptor signaling pathway	BP
4	43	0.89451123693	-	1.38e-01	GO:0043280	positive regulation of cysteine-type endopeptidase activity involved in apoptotic process	BP
4	43	0.89451123693	-	1.57e-01	GO:0051496	positive regulation of stress fiber assembly	BP
4	43	0.89451123693	-	1.67e-01	GO:1904837	beta-catenin-TCF complex assembly	BP
6	65	0.883370679325	-	4.80e-02	GO:0030183	B cell differentiation	BP
6	65	0.883370679325	-	6.00e-02	GO:0050796	regulation of insulin secretion	BP
8	88	0.861344372995	-	2.69e-02	GO:0007565	female pregnancy	BP
7	77	0.861344372995	-	4.01e-02	GO:0043085	positive regulation of catalytic activity	BP
5	55	0.861344372995	-	9.05e-02	GO:0060548	negative regulation of cell death	BP
5	55	0.861344372995	-	9.05e-02	GO:0048812	neuron projection morphogenesis	BP
7	77	0.861344372995	-	9.85e-02	GO:0071260	cellular response to mechanical stimulus	BP
3	33	0.861344372995	-	1.05e-01	GO:0042100	B cell proliferation	BP
3	33	0.861344372995	-	1.27e-01	GO:0001937	negative regulation of endothelial cell proliferation	BP
4	44	0.861344372995	-	1.57e-01	GO:0002224	toll-like receptor signaling pathway	BP
3	33	0.861344372995	-	1.63e-01	GO:0006298	mismatch repair	BP
3	33	0.861344372995	-	1.75e-01	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	BP
1	11	0.861344372995	-	1.86e-01	GO:0050910	detection of mechanical stimulus involved in sensory perception of sound	BP
2	22	0.861344372995	-	1.89e-01	GO:0019915	lipid storage	BP
2	22	0.861344372995	-	2.27e-01	GO:0010842	retina layer formation	BP
2	22	0.861344372995	-	2.27e-01	GO:0048488	synaptic vesicle endocytosis	BP
2	22	0.861344372995	-	2.27e-01	GO:0030101	natural killer cell activation	BP
2	22	0.861344372995	-	2.46e-01	GO:0001816	cytokine production	BP
2	22	0.861344372995	-	2.46e-01	GO:0042832	defense response to protozoan	BP
2	22	0.861344372995	-	2.46e-01	GO:0030111	regulation of Wnt signaling pathway	BP
2	22	0.861344372995	-	2.64e-01	GO:1901224	positive regulation of NIK/NF-kappaB signaling	BP
1	11	0.861344372995	-	2.65e-01	GO:0030166	proteoglycan biosynthetic process	BP
1	11	0.861344372995	-	2.65e-01	GO:0046839	phospholipid dephosphorylation	BP
1	11	0.861344372995	-	2.65e-01	GO:0070166	enamel mineralization	BP
1	11	0.861344372995	-	3.02e-01	GO:0006636	unsaturated fatty acid biosynthetic process	BP
1	11	0.861344372995	-	3.02e-01	GO:0008406	gonad development	BP
1	11	0.861344372995	-	3.02e-01	GO:0022010	central nervous system myelination	BP
2	22	0.861344372995	-	3.02e-01	GO:0016050	vesicle organization	BP
1	11	0.861344372995	-	3.37e-01	GO:0009435	NAD biosynthetic process	BP
1	11	0.861344372995	-	3.37e-01	GO:0010764	negative regulation of fibroblast migration	BP
1	11	0.861344372995	-	3.37e-01	GO:0006346	methylation-dependent chromatin silencing	BP
1	11	0.861344372995	-	3.37e-01	GO:0060088	auditory receptor cell stereocilium organization	BP
1	11	0.861344372995	-	3.37e-01	GO:0009268	response to pH	BP
1	11	0.861344372995	-	3.37e-01	GO:0033690	positive regulation of osteoblast proliferation	BP
1	11	0.861344372995	-	3.70e-01	GO:0030431	sleep	BP
1	11	0.861344372995	-	3.70e-01	GO:0050673	epithelial cell proliferation	BP
1	11	0.861344372995	-	3.70e-01	GO:0001893	maternal placenta development	BP
1	11	0.861344372995	-	3.70e-01	GO:0017187	peptidyl-glutamic acid carboxylation	BP
1	11	0.861344372995	-	3.70e-01	GO:0022038	corpus callosum development	BP
1	11	0.861344372995	-	3.70e-01	GO:0045670	regulation of osteoclast differentiation	BP
1	11	0.861344372995	-	3.70e-01	GO:0097202	activation of cysteine-type endopeptidase activity	BP
1	11	0.861344372995	-	3.70e-01	GO:0022409	positive regulation of cell-cell adhesion	BP
1	11	0.861344372995	-	3.70e-01	GO:0060055	angiogenesis involved in wound healing	BP
1	11	0.861344372995	-	3.70e-01	GO:2000188	regulation of cholesterol homeostasis	BP
1	11	0.861344372995	-	3.70e-01	GO:0010996	response to auditory stimulus	BP
1	11	0.861344372995	-	4.02e-01	GO:0032434	regulation of proteasomal ubiquitin-dependent protein catabolic process	BP
1	11	0.861344372995	-	4.02e-01	GO:0071223	cellular response to lipoteichoic acid	BP
1	11	0.861344372995	-	4.02e-01	GO:1903204	negative regulation of oxidative stress-induced neuron death	BP
1	11	0.861344372995	-	4.02e-01	GO:0040015	negative regulation of multicellular organism growth	BP
1	11	0.861344372995	-	4.02e-01	GO:0001823	mesonephros development	BP
1	11	0.861344372995	-	4.02e-01	GO:0017156	calcium ion regulated exocytosis	BP
1	11	0.861344372995	-	4.02e-01	GO:0033234	negative regulation of protein sumoylation	BP
1	11	0.861344372995	-	4.02e-01	GO:1990440	positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress	BP
1	11	0.861344372995	-	4.02e-01	GO:0050848	regulation of calcium-mediated signaling	BP
1	11	0.861344372995	-	4.02e-01	GO:0098911	regulation of ventricular cardiac muscle cell action potential	BP
1	11	0.861344372995	-	4.02e-01	GO:0014075	response to amine	BP
1	11	0.861344372995	-	4.02e-01	GO:2000009	negative regulation of protein localization to cell surface	BP
1	11	0.861344372995	-	4.02e-01	GO:0006476	protein deacetylation	BP
1	11	0.861344372995	-	4.02e-01	GO:0032515	negative regulation of phosphoprotein phosphatase activity	BP
1	11	0.861344372995	-	4.02e-01	GO:0006937	regulation of muscle contraction	BP
1	11	0.861344372995	-	4.02e-01	GO:0031915	positive regulation of synaptic plasticity	BP
1	11	0.861344372995	-	4.02e-01	GO:0010591	regulation of lamellipodium assembly	BP
1	11	0.861344372995	-	4.02e-01	GO:0001833	inner cell mass cell proliferation	BP
1	11	0.861344372995	-	4.32e-01	GO:0043249	erythrocyte maturation	BP
1	11	0.861344372995	-	4.32e-01	GO:0031581	hemidesmosome assembly	BP
1	11	0.861344372995	-	4.32e-01	GO:0045762	positive regulation of adenylate cyclase activity	BP
1	11	0.861344372995	-	4.32e-01	GO:0006983	ER overload response	BP
1	11	0.861344372995	-	4.32e-01	GO:0090161	Golgi ribbon formation	BP
1	11	0.861344372995	-	4.32e-01	GO:0045806	negative regulation of endocytosis	BP
1	11	0.861344372995	-	4.32e-01	GO:0030238	male sex determination	BP
1	11	0.861344372995	-	4.32e-01	GO:0060544	regulation of necroptotic process	BP
1	11	0.861344372995	-	4.32e-01	GO:0071372	cellular response to follicle-stimulating hormone stimulus	BP
1	11	0.861344372995	-	4.32e-01	GO:0033120	positive regulation of RNA splicing	BP
1	11	0.861344372995	-	4.32e-01	GO:0035563	positive regulation of chromatin binding	BP
1	11	0.861344372995	-	4.32e-01	GO:0000302	response to reactive oxygen species	BP
1	11	0.861344372995	-	4.32e-01	GO:0060765	regulation of androgen receptor signaling pathway	BP
1	11	0.861344372995	-	4.32e-01	GO:0090331	negative regulation of platelet aggregation	BP
1	11	0.861344372995	-	4.32e-01	GO:1902902	negative regulation of autophagosome assembly	BP
1	11	0.861344372995	-	4.32e-01	GO:0071481	cellular response to X-ray	BP
1	11	0.861344372995	-	4.32e-01	GO:0032727	positive regulation of interferon-alpha production	BP
1	11	0.861344372995	-	4.32e-01	GO:0034379	very-low-density lipoprotein particle assembly	BP
1	11	0.861344372995	-	4.32e-01	GO:0061001	regulation of dendritic spine morphogenesis	BP
2	22	0.861344372995	-	2.27e-01	GO:0005104	fibroblast growth factor receptor binding	MF
1	11	0.861344372995	-	3.02e-01	GO:0015278	calcium-release channel activity	MF
1	11	0.861344372995	-	3.02e-01	GO:0016175	superoxide-generating NADPH oxidase activity	MF
2	22	0.861344372995	-	3.02e-01	GO:0004709	MAP kinase kinase kinase activity	MF
1	11	0.861344372995	-	3.37e-01	GO:0003993	acid phosphatase activity	MF
1	11	0.861344372995	-	3.37e-01	GO:0015075	ion transmembrane transporter activity	MF
1	11	0.861344372995	-	3.37e-01	GO:0004143	diacylglycerol kinase activity	MF
1	11	0.861344372995	-	3.37e-01	GO:0043394	proteoglycan binding	MF
1	11	0.861344372995	-	4.02e-01	GO:0008349	MAP kinase kinase kinase kinase activity	MF
1	11	0.861344372995	-	4.02e-01	GO:0016407	acetyltransferase activity	MF
1	11	0.861344372995	-	4.02e-01	GO:0050786	RAGE receptor binding	MF
1	11	0.861344372995	-	4.02e-01	GO:0005536	glucose binding	MF
1	11	0.861344372995	-	4.32e-01	GO:0008066	glutamate receptor activity	MF
1	11	0.861344372995	-	4.32e-01	GO:0031996	thioesterase binding	MF
1	11	0.861344372995	-	4.32e-01	GO:0017154	semaphorin receptor activity	MF
1	11	0.861344372995	-	4.32e-01	GO:0070410	co-SMAD binding	MF
1	11	0.861344372995	-	4.32e-01	GO:0032041	NAD-dependent histone deacetylase activity (H3-K14 specific)	MF
100	1114	0.843098664067	-	1.22e-15	GO:0007165	signal transduction	BP
7	78	0.842728694827	-	2.72e-02	GO:0008544	epidermis development	BP
7	78	0.842728694827	-	9.85e-02	GO:0006919	activation of cysteine-type endopeptidase activity involved in apoptotic process	BP
5	56	0.835349164462	-	3.23e-02	GO:0042472	inner ear morphogenesis	BP
17	191	0.830810004846	-	2.44e-05	GO:0002250	adaptive immune response	BP
4	45	0.828922895302	-	9.57e-02	GO:0048839	inner ear development	BP
4	45	0.828922895302	-	1.04e-01	GO:0042552	myelination	BP
4	45	0.828922895302	-	1.29e-01	GO:0034605	cellular response to heat	BP
3	34	0.818275651103	-	1.63e-01	GO:0030501	positive regulation of bone mineralization	BP
3	34	0.818275651103	-	2.14e-01	GO:2001240	negative regulation of extrinsic apoptotic signaling pathway in absence of ligand	BP
3	34	0.818275651103	-	2.27e-01	GO:0051973	positive regulation of telomerase activity	BP
3	34	0.818275651103	-	2.41e-01	GO:0051020	GTPase binding	MF
5	57	0.809814072354	-	1.10e-01	GO:0071333	cellular response to glucose stimulus	BP
31	354	0.807366751936	-	6.77e-04	GO:0008283	cell proliferation	BP
9	103	0.804200465891	-	1.96e-02	GO:0010468	regulation of gene expression	BP
11	126	0.802927686769	-	2.75e-02	GO:0007264	small GTPase mediated signal transduction	BP
6	69	0.797214035575	-	1.33e-01	GO:0050790	regulation of catalytic activity	BP
4	46	0.797214035575	-	1.47e-01	GO:0009408	response to heat	BP
2	23	0.797214035575	-	1.89e-01	GO:1904707	positive regulation of vascular smooth muscle cell proliferation	BP
2	23	0.797214035575	-	2.08e-01	GO:0002376	immune system process	BP
2	23	0.797214035575	-	2.27e-01	GO:0001819	positive regulation of cytokine production	BP
2	23	0.797214035575	-	2.27e-01	GO:0009617	response to bacterium	BP
2	23	0.797214035575	-	2.46e-01	GO:0030488	tRNA methylation	BP
2	23	0.797214035575	-	2.64e-01	GO:0071398	cellular response to fatty acid	BP
2	23	0.797214035575	-	2.83e-01	GO:2000463	positive regulation of excitatory postsynaptic potential	BP
2	23	0.797214035575	-	3.02e-01	GO:0005978	glycogen biosynthetic process	BP
2	23	0.797214035575	-	3.21e-01	GO:0090316	positive regulation of intracellular protein transport	BP
2	23	0.797214035575	-	3.21e-01	GO:2001235	positive regulation of apoptotic signaling pathway	BP
2	23	0.797214035575	-	5.73e-02	GO:0015301	anion:anion antiporter activity	MF
4	46	0.797214035575	-	1.57e-01	GO:0046332	SMAD binding	MF
2	23	0.797214035575	-	1.89e-01	GO:0050840	extracellular matrix binding	MF
2	23	0.797214035575	-	3.02e-01	GO:0070412	R-SMAD binding	MF
5	58	0.784723091392	-	1.90e-01	GO:0050729	positive regulation of inflammatory response	BP
6	70	0.776455475408	-	1.37e-01	GO:0001889	liver development	BP
3	35	0.776455475408	-	2.27e-01	GO:0045786	negative regulation of cell cycle	BP
7	82	0.770578909071	-	8.98e-02	GO:0035264	multicellular organism growth	BP
43	505	0.766901168695	-	1.07e-07	GO:0030154	cell differentiation	BP
8	94	0.766187139954	-	7.46e-02	GO:0008584	male gonad development	BP
4	47	0.766187139954	-	1.04e-01	GO:0006631	fatty acid metabolic process	BP
4	47	0.766187139954	-	1.57e-01	GO:0051781	positive regulation of cell division	BP
4	47	0.766187139954	-	2.81e-01	GO:0010595	positive regulation of endothelial cell migration	BP
4	47	0.766187139954	-	2.97e-01	GO:0007254	JNK cascade	BP
4	47	0.766187139954	-	1.67e-01	GO:0005080	protein kinase C binding	MF
9	106	0.762780538511	-	1.05e-01	GO:0042826	histone deacetylase binding	MF
5	59	0.760061037157	-	3.58e-02	GO:0016266	O-glycan processing	BP
5	59	0.760061037157	-	9.69e-02	GO:0005546	phosphatidylinositol-4,5-bisphosphate binding	MF
5	59	0.760061037157	-	1.94e-01	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	MF
25	295	0.760061037157	-	8.57e-03	GO:0031625	ubiquitin protein ligase binding	MF
30	355	0.755991372848	-	1.97e-03	GO:0004674	protein serine/threonine kinase activity	MF
7	83	0.753091482343	-	3.72e-02	GO:0050728	negative regulation of inflammatory response	BP
10	119	0.747886323211	-	2.98e-02	GO:0006935	chemotaxis	BP
24	286	0.745867155575	-	1.19e-02	GO:0045296	cadherin binding	MF
27	322	0.744746615681	-	5.37e-03	GO:0016032	viral process	BP
4	48	0.735813490911	-	9.57e-02	GO:0010862	positive regulation of pathway-restricted SMAD protein phosphorylation	BP
4	48	0.735813490911	-	1.67e-01	GO:0008542	visual learning	BP
5	60	0.735813490911	-	1.86e-01	GO:0050727	regulation of inflammatory response	BP
1	12	0.735813490911	-	2.26e-01	GO:0042446	hormone biosynthetic process	BP
2	24	0.735813490911	-	2.27e-01	GO:0030878	thyroid gland development	BP
2	24	0.735813490911	-	2.46e-01	GO:0051899	membrane depolarization	BP
2	24	0.735813490911	-	2.46e-01	GO:0048589	developmental growth	BP
2	24	0.735813490911	-	2.64e-01	GO:0007159	leukocyte cell-cell adhesion	BP
2	24	0.735813490911	-	2.64e-01	GO:0060135	maternal process involved in female pregnancy	BP
2	24	0.735813490911	-	2.64e-01	GO:0055088	lipid homeostasis	BP
1	12	0.735813490911	-	2.65e-01	GO:1902475	L-alpha-amino acid transmembrane transport	BP
1	12	0.735813490911	-	2.65e-01	GO:1901652	response to peptide	BP
1	12	0.735813490911	-	2.65e-01	GO:0036066	protein O-linked fucosylation	BP
1	12	0.735813490911	-	3.02e-01	GO:0032966	negative regulation of collagen biosynthetic process	BP
1	12	0.735813490911	-	3.02e-01	GO:0001964	startle response	BP
2	24	0.735813490911	-	3.02e-01	GO:0055007	cardiac muscle cell differentiation	BP
2	24	0.735813490911	-	3.21e-01	GO:0051966	regulation of synaptic transmission, glutamatergic	BP
2	24	0.735813490911	-	3.21e-01	GO:0097352	autophagosome maturation	BP
1	12	0.735813490911	-	3.37e-01	GO:0006820	anion transport	BP
1	12	0.735813490911	-	3.37e-01	GO:0030208	dermatan sulfate biosynthetic process	BP
1	12	0.735813490911	-	3.37e-01	GO:0032026	response to magnesium ion	BP
2	24	0.735813490911	-	3.40e-01	GO:0051403	stress-activated MAPK cascade	BP
2	24	0.735813490911	-	3.40e-01	GO:2001238	positive regulation of extrinsic apoptotic signaling pathway	BP
1	12	0.735813490911	-	3.70e-01	GO:0000050	urea cycle	BP
1	12	0.735813490911	-	3.70e-01	GO:0010524	positive regulation of calcium ion transport into cytosol	BP
1	12	0.735813490911	-	3.70e-01	GO:0060416	response to growth hormone	BP
1	12	0.735813490911	-	3.70e-01	GO:0046834	lipid phosphorylation	BP
1	12	0.735813490911	-	3.70e-01	GO:0030277	maintenance of gastrointestinal epithelium	BP
1	12	0.735813490911	-	3.70e-01	GO:0046849	bone remodeling	BP
1	12	0.735813490911	-	3.70e-01	GO:1900016	negative regulation of cytokine production involved in inflammatory response	BP
1	12	0.735813490911	-	4.02e-01	GO:0045078	positive regulation of interferon-gamma biosynthetic process	BP
1	12	0.735813490911	-	4.02e-01	GO:0008210	estrogen metabolic process	BP
1	12	0.735813490911	-	4.02e-01	GO:0043616	keratinocyte proliferation	BP
1	12	0.735813490911	-	4.02e-01	GO:0010447	response to acidic pH	BP
1	12	0.735813490911	-	4.02e-01	GO:0019430	removal of superoxide radicals	BP
1	12	0.735813490911	-	4.02e-01	GO:0002009	morphogenesis of an epithelium	BP
1	12	0.735813490911	-	4.02e-01	GO:0002003	angiotensin maturation	BP
1	12	0.735813490911	-	4.02e-01	GO:0002437	inflammatory response to antigenic stimulus	BP
1	12	0.735813490911	-	4.02e-01	GO:0006069	ethanol oxidation	BP
1	12	0.735813490911	-	4.02e-01	GO:0032695	negative regulation of interleukin-12 production	BP
1	12	0.735813490911	-	4.02e-01	GO:0030516	regulation of axon extension	BP
1	12	0.735813490911	-	4.02e-01	GO:0042592	homeostatic process	BP
1	12	0.735813490911	-	4.02e-01	GO:0046622	positive regulation of organ growth	BP
1	12	0.735813490911	-	4.02e-01	GO:0048333	mesodermal cell differentiation	BP
1	12	0.735813490911	-	4.02e-01	GO:0016540	protein autoprocessing	BP
1	12	0.735813490911	-	4.02e-01	GO:2000279	negative regulation of DNA biosynthetic process	BP
1	12	0.735813490911	-	4.32e-01	GO:0045651	positive regulation of macrophage differentiation	BP
1	12	0.735813490911	-	4.32e-01	GO:0043922	negative regulation by host of viral transcription	BP
1	12	0.735813490911	-	4.32e-01	GO:0001946	lymphangiogenesis	BP
1	12	0.735813490911	-	4.32e-01	GO:0008154	actin polymerization or depolymerization	BP
1	12	0.735813490911	-	4.32e-01	GO:2000406	positive regulation of T cell migration	BP
1	12	0.735813490911	-	4.32e-01	GO:0060707	trophoblast giant cell differentiation	BP
1	12	0.735813490911	-	4.32e-01	GO:0021670	lateral ventricle development	BP
1	12	0.735813490911	-	4.32e-01	GO:0008340	determination of adult lifespan	BP
1	12	0.735813490911	-	4.32e-01	GO:0045779	negative regulation of bone resorption	BP
1	12	0.735813490911	-	4.32e-01	GO:0014067	negative regulation of phosphatidylinositol 3-kinase signaling	BP
1	12	0.735813490911	-	4.32e-01	GO:0045744	negative regulation of G-protein coupled receptor protein signaling pathway	BP
1	12	0.735813490911	-	4.32e-01	GO:0007034	vacuolar transport	BP
1	12	0.735813490911	-	4.32e-01	GO:0060766	negative regulation of androgen receptor signaling pathway	BP
1	12	0.735813490911	-	4.32e-01	GO:0003215	cardiac right ventricle morphogenesis	BP
1	12	0.735813490911	-	4.32e-01	GO:0034497	protein localization to pre-autophagosomal structure	BP
1	12	0.735813490911	-	4.32e-01	GO:0071257	cellular response to electrical stimulus	BP
1	12	0.735813490911	-	4.60e-01	GO:0021819	layer formation in cerebral cortex	BP
1	12	0.735813490911	-	4.60e-01	GO:0045086	positive regulation of interleukin-2 biosynthetic process	BP
1	12	0.735813490911	-	4.60e-01	GO:0046902	regulation of mitochondrial membrane permeability	BP
1	12	0.735813490911	-	4.60e-01	GO:0007252	I-kappaB phosphorylation	BP
1	12	0.735813490911	-	4.60e-01	GO:0036499	PERK-mediated unfolded protein response	BP
1	12	0.735813490911	-	4.60e-01	GO:0042994	cytoplasmic sequestering of transcription factor	BP
1	12	0.735813490911	-	4.60e-01	GO:0090179	planar cell polarity pathway involved in neural tube closure	BP
1	12	0.735813490911	-	4.60e-01	GO:0003198	epithelial to mesenchymal transition involved in endocardial cushion formation	BP
1	12	0.735813490911	-	4.60e-01	GO:0006301	postreplication repair	BP
1	12	0.735813490911	-	4.60e-01	GO:0046710	GDP metabolic process	BP
1	12	0.735813490911	-	4.60e-01	GO:0061014	positive regulation of mRNA catabolic process	BP
1	12	0.735813490911	-	4.60e-01	GO:0048747	muscle fiber development	BP
1	12	0.735813490911	-	4.60e-01	GO:0097284	hepatocyte apoptotic process	BP
1	12	0.735813490911	-	4.60e-01	GO:0040007	growth	BP
1	12	0.735813490911	-	4.60e-01	GO:0090656	t-circle formation	BP
5	60	0.735813490911	-	7.28e-02	GO:0008237	metallopeptidase activity	MF
5	60	0.735813490911	-	7.85e-02	GO:0003777	microtubule motor activity	MF
2	24	0.735813490911	-	1.02e-01	GO:0005452	inorganic anion exchanger activity	MF
1	12	0.735813490911	-	2.65e-01	GO:0015179	L-amino acid transmembrane transporter activity	MF
2	24	0.735813490911	-	3.40e-01	GO:0043425	bHLH transcription factor binding	MF
1	12	0.735813490911	-	3.70e-01	GO:0016829	lyase activity	MF
1	12	0.735813490911	-	4.02e-01	GO:0005247	voltage-gated chloride channel activity	MF
1	12	0.735813490911	-	4.02e-01	GO:0030898	actin-dependent ATPase activity	MF
1	12	0.735813490911	-	4.02e-01	GO:0043495	protein membrane anchor	MF
1	12	0.735813490911	-	4.32e-01	GO:0030695	GTPase regulator activity	MF
1	12	0.735813490911	-	4.60e-01	GO:0004861	cyclin-dependent protein serine/threonine kinase inhibitor activity	MF
1	12	0.735813490911	-	4.60e-01	GO:0042623	ATPase activity, coupled	MF
1	12	0.735813490911	-	4.60e-01	GO:0050998	nitric-oxide synthase binding	MF
1	12	0.735813490911	-	4.60e-01	GO:0042974	retinoic acid receptor binding	MF
6	72	0.735813490911	-	1.27e-01	GO:0007018	microtubule-based movement	BP
3	36	0.735813490911	-	1.51e-01	GO:0086091	regulation of heart rate by cardiac conduction	BP
3	36	0.735813490911	-	2.27e-01	GO:0071392	cellular response to estradiol stimulus	BP
3	36	0.735813490911	-	4.25e-01	GO:0007257	activation of JUN kinase activity	BP
3	36	0.735813490911	-	2.41e-01	GO:0043531	ADP binding	MF
6	73	0.715913933473	-	2.37e-02	GO:0030216	keratinocyte differentiation	BP
27	330	0.709341279549	-	5.92e-03	GO:0019899	enzyme binding	MF
4	49	0.706066147517	-	1.12e-01	GO:0016485	protein processing	BP
3	37	0.696285126724	-	4.31e-01	GO:0006110	regulation of glycolytic process	BP
10	124	0.688507776132	-	3.99e-02	GO:0030036	actin cytoskeleton organization	BP
10	124	0.688507776132	-	8.80e-02	GO:0006461	protein complex assembly	BP
5	62	0.688507776132	-	1.99e-01	GO:0045727	positive regulation of translation	BP
5	62	0.688507776132	-	2.20e-01	GO:0006977	DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest	BP
13	162	0.681365706888	-	1.08e-02	GO:0008083	growth factor activity	MF
4	50	0.676919801857	-	1.04e-01	GO:0045600	positive regulation of fat cell differentiation	BP
2	25	0.676919801857	-	2.46e-01	GO:0045880	positive regulation of smoothened signaling pathway	BP
2	25	0.676919801857	-	2.46e-01	GO:0032689	negative regulation of interferon-gamma production	BP
4	50	0.676919801857	-	2.86e-01	GO:0034097	response to cytokine	BP
4	50	0.676919801857	-	2.97e-01	GO:0019827	stem cell population maintenance	BP
2	25	0.676919801857	-	3.02e-01	GO:0051924	regulation of calcium ion transport	BP
2	25	0.676919801857	-	3.21e-01	GO:0022604	regulation of cell morphogenesis	BP
2	25	0.676919801857	-	3.21e-01	GO:0030041	actin filament polymerization	BP
2	25	0.676919801857	-	3.21e-01	GO:0001975	response to amphetamine	BP
2	25	0.676919801857	-	3.40e-01	GO:0055010	ventricular cardiac muscle tissue morphogenesis	BP
2	25	0.676919801857	-	3.40e-01	GO:0045737	positive regulation of cyclin-dependent protein serine/threonine kinase activity	BP
2	25	0.676919801857	-	3.40e-01	GO:0032757	positive regulation of interleukin-8 production	BP
2	25	0.676919801857	-	3.58e-01	GO:0061621	canonical glycolysis	BP
4	50	0.676919801857	-	1.57e-01	GO:0017112	Rab guanyl-nucleotide exchange factor activity	MF
2	25	0.676919801857	-	3.40e-01	GO:0030332	cyclin binding	MF
24	302	0.667333753028	-	6.63e-03	GO:0042493	response to drug	BP
5	63	0.665424163019	-	1.86e-01	GO:0007613	memory	BP
5	63	0.665424163019	-	2.14e-01	GO:0032091	negative regulation of protein binding	BP
5	63	0.665424163019	-	2.14e-01	GO:0051384	response to glucocorticoid	BP
9	114	0.657810978909	-	9.91e-02	GO:0071356	cellular response to tumor necrosis factor	BP
3	38	0.657810978909	-	1.16e-01	GO:0009409	response to cold	BP
3	38	0.657810978909	-	4.38e-01	GO:0030049	muscle filament sliding	BP
4	51	0.64835064966	-	3.03e-01	GO:0010977	negative regulation of neuron projection development	BP
4	51	0.64835064966	-	1.47e-01	GO:0030145	manganese ion binding	MF
5	64	0.642704086519	-	1.94e-01	GO:0072659	protein localization to plasma membrane	BP
5	64	0.642704086519	-	2.14e-01	GO:0035019	somatic stem cell population maintenance	BP
6	77	0.638951951658	-	6.00e-02	GO:0045666	positive regulation of neuron differentiation	BP
5	65	0.620336273491	-	9.69e-02	GO:0030512	negative regulation of transforming growth factor beta receptor signaling pathway	BP
3	39	0.620336273491	-	1.05e-01	GO:0007631	feeding behavior	BP
2	26	0.620336273491	-	1.53e-01	GO:0016339	calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	BP
2	26	0.620336273491	-	1.53e-01	GO:0006836	neurotransmitter transport	BP
2	26	0.620336273491	-	1.71e-01	GO:0009311	oligosaccharide metabolic process	BP
3	39	0.620336273491	-	2.01e-01	GO:0030326	embryonic limb morphogenesis	BP
3	39	0.620336273491	-	2.14e-01	GO:0048704	embryonic skeletal system morphogenesis	BP
3	39	0.620336273491	-	2.41e-01	GO:0000422	autophagy of mitochondrion	BP
2	26	0.620336273491	-	2.46e-01	GO:0090102	cochlea development	BP
2	26	0.620336273491	-	2.64e-01	GO:0030534	adult behavior	BP
2	26	0.620336273491	-	2.64e-01	GO:0031069	hair follicle morphogenesis	BP
1	13	0.620336273491	-	2.65e-01	GO:0042761	very long-chain fatty acid biosynthetic process	BP
1	13	0.620336273491	-	3.02e-01	GO:1901386	negative regulation of voltage-gated calcium channel activity	BP
1	13	0.620336273491	-	3.37e-01	GO:0048599	oocyte development	BP
1	13	0.620336273491	-	3.37e-01	GO:0006044	N-acetylglucosamine metabolic process	BP
2	26	0.620336273491	-	3.58e-01	GO:0006096	glycolytic process	BP
1	13	0.620336273491	-	3.70e-01	GO:0010839	negative regulation of keratinocyte proliferation	BP
1	13	0.620336273491	-	3.70e-01	GO:0071318	cellular response to ATP	BP
2	26	0.620336273491	-	3.76e-01	GO:0007017	microtubule-based process	BP
1	13	0.620336273491	-	4.02e-01	GO:0050777	negative regulation of immune response	BP
1	13	0.620336273491	-	4.02e-01	GO:0043101	purine-containing compound salvage	BP
1	13	0.620336273491	-	4.02e-01	GO:0032230	positive regulation of synaptic transmission, GABAergic	BP
1	13	0.620336273491	-	4.02e-01	GO:0097435	supramolecular fiber organization	BP
1	13	0.620336273491	-	4.32e-01	GO:0051145	smooth muscle cell differentiation	BP
1	13	0.620336273491	-	4.32e-01	GO:0060996	dendritic spine development	BP
1	13	0.620336273491	-	4.32e-01	GO:0006359	regulation of transcription from RNA polymerase III promoter	BP
1	13	0.620336273491	-	4.32e-01	GO:0050872	white fat cell differentiation	BP
1	13	0.620336273491	-	4.32e-01	GO:0010248	establishment or maintenance of transmembrane electrochemical gradient	BP
1	13	0.620336273491	-	4.32e-01	GO:0071280	cellular response to copper ion	BP
1	13	0.620336273491	-	4.32e-01	GO:0036109	alpha-linolenic acid metabolic process	BP
1	13	0.620336273491	-	4.32e-01	GO:0044319	wound healing, spreading of cells	BP
1	13	0.620336273491	-	4.32e-01	GO:0045943	positive regulation of transcription from RNA polymerase I promoter	BP
1	13	0.620336273491	-	4.32e-01	GO:0071391	cellular response to estrogen stimulus	BP
1	13	0.620336273491	-	4.60e-01	GO:0035909	aorta morphogenesis	BP
1	13	0.620336273491	-	4.60e-01	GO:0046685	response to arsenic-containing substance	BP
1	13	0.620336273491	-	4.60e-01	GO:2001241	positive regulation of extrinsic apoptotic signaling pathway in absence of ligand	BP
1	13	0.620336273491	-	4.60e-01	GO:0010821	regulation of mitochondrion organization	BP
1	13	0.620336273491	-	4.60e-01	GO:0071285	cellular response to lithium ion	BP
1	13	0.620336273491	-	4.60e-01	GO:0010952	positive regulation of peptidase activity	BP
1	13	0.620336273491	-	4.87e-01	GO:0001774	microglial cell activation	BP
1	13	0.620336273491	-	4.87e-01	GO:1900025	negative regulation of substrate adhesion-dependent cell spreading	BP
1	13	0.620336273491	-	4.87e-01	GO:0009650	UV protection	BP
1	13	0.620336273491	-	4.87e-01	GO:0035815	positive regulation of renal sodium excretion	BP
1	13	0.620336273491	-	4.87e-01	GO:0035729	cellular response to hepatocyte growth factor stimulus	BP
1	13	0.620336273491	-	4.87e-01	GO:0010498	proteasomal protein catabolic process	BP
8	104	0.620336273491	-	1.76e-01	GO:0047485	protein N-terminus binding	MF
2	26	0.620336273491	-	2.64e-01	GO:0004177	aminopeptidase activity	MF
1	13	0.620336273491	-	2.65e-01	GO:0042834	peptidoglycan binding	MF
1	13	0.620336273491	-	3.02e-01	GO:0008195	phosphatidate phosphatase activity	MF
2	26	0.620336273491	-	3.58e-01	GO:0043015	gamma-tubulin binding	MF
2	26	0.620336273491	-	3.76e-01	GO:0035035	histone acetyltransferase binding	MF
1	13	0.620336273491	-	4.02e-01	GO:0009982	pseudouridine synthase activity	MF
1	13	0.620336273491	-	4.02e-01	GO:0008253	5'-nucleotidase activity	MF
1	13	0.620336273491	-	4.87e-01	GO:0008143	poly(A) binding	MF
1	13	0.620336273491	-	4.87e-01	GO:0034450	ubiquitin-ubiquitin ligase activity	MF
1	13	0.620336273491	-	4.87e-01	GO:0035259	glucocorticoid receptor binding	MF
1	13	0.620336273491	-	4.87e-01	GO:0004385	guanylate kinase activity	MF
7	91	0.620336273491	-	1.13e-01	GO:0006464	cellular protein modification process	BP
12	157	0.611117743461	-	7.33e-02	GO:0007010	cytoskeleton organization	BP
61	801	0.605854896786	-	1.89e-04	GO:0042802	identical protein binding	MF
5	66	0.598309967161	-	9.05e-02	GO:0051965	positive regulation of synapse assembly	BP
5	66	0.598309967161	-	2.14e-01	GO:0030855	epithelial cell differentiation	BP
5	66	0.598309967161	-	2.39e-01	GO:0046330	positive regulation of JNK cascade	BP
18	238	0.595883229766	-	4.31e-03	GO:0007166	cell surface receptor signaling pathway	BP
4	53	0.592855537069	-	3.03e-01	GO:0048511	rhythmic process	BP
9	120	0.583810397466	-	3.85e-02	GO:0010951	negative regulation of endopeptidase activity	BP
3	40	0.583810397466	-	1.51e-01	GO:0060348	bone development	BP
3	40	0.583810397466	-	2.55e-01	GO:0007162	negative regulation of cell adhesion	BP
6	80	0.583810397466	-	2.84e-01	GO:0007346	regulation of mitotic cell cycle	BP
3	40	0.583810397466	-	4.38e-01	GO:0034613	cellular protein localization	BP
3	40	0.583810397466	-	4.38e-01	GO:0031648	protein destabilization	BP
3	40	0.583810397466	-	4.38e-01	GO:0070527	platelet aggregation	BP
3	40	0.583810397466	-	4.52e-01	GO:0004407	histone deacetylase activity	MF
11	147	0.580535265433	-	6.45e-02	GO:0051015	actin filament binding	MF
18	241	0.577811656844	-	2.48e-02	GO:0042981	regulation of apoptotic process	BP
5	67	0.576614896061	-	2.60e-01	GO:0001047	core promoter binding	MF
13	175	0.570004597941	-	6.63e-02	GO:0001701	in utero embryonic development	BP
2	27	0.565888489468	-	3.94e-01	GO:0045070	positive regulation of viral genome replication	BP
2	27	0.565888489468	-	3.94e-01	GO:0043278	response to morphine	BP
2	27	0.565888489468	-	3.94e-01	GO:0050718	positive regulation of interleukin-1 beta secretion	BP
2	27	0.565888489468	-	3.94e-01	GO:0032728	positive regulation of interferon-beta production	BP
2	27	0.565888489468	-	2.64e-01	GO:0017046	peptide hormone binding	MF
2	27	0.565888489468	-	2.83e-01	GO:0003785	actin monomer binding	MF
2	27	0.565888489468	-	2.83e-01	GO:0005244	voltage-gated ion channel activity	MF
4	54	0.565888489468	-	3.09e-01	GO:0031072	heat shock protein binding	MF
2	27	0.565888489468	-	3.58e-01	GO:0001968	fibronectin binding	MF
6	81	0.565888489468	-	6.00e-02	GO:0008233	peptidase activity	MF
109	1472	0.565398360352	-	2.44e-08	GO:0005524	ATP binding	MF
11	150	0.551388919773	-	1.19e-01	GO:0050821	protein stabilization	BP
3	41	0.548186487735	-	2.01e-01	GO:0007189	adenylate cyclase-activating G-protein coupled receptor signaling pathway	BP
3	41	0.548186487735	-	2.55e-01	GO:0002548	monocyte chemotaxis	BP
4	55	0.539416278107	-	3.47e-01	GO:0032922	circadian regulation of gene expression	BP
6	83	0.530699061006	-	2.74e-01	GO:0046718	viral entry into host cell	BP
6	83	0.530699061006	-	3.01e-01	GO:0010389	regulation of G2/M transition of mitotic cell cycle	BP
15	208	0.527226869099	-	9.08e-02	GO:0006974	cellular response to DNA damage stimulus	BP
5	70	0.513421069574	-	2.39e-01	GO:0007015	actin filament organization	BP
2	28	0.513421069574	-	2.83e-01	GO:0001755	neural crest cell migration	BP
2	28	0.513421069574	-	2.83e-01	GO:0045746	negative regulation of Notch signaling pathway	BP
1	14	0.513421069574	-	3.02e-01	GO:0048149	behavioral response to ethanol	BP
2	28	0.513421069574	-	3.21e-01	GO:0097193	intrinsic apoptotic signaling pathway	BP
1	14	0.513421069574	-	3.37e-01	GO:0010614	negative regulation of cardiac muscle hypertrophy	BP
2	28	0.513421069574	-	3.40e-01	GO:0042407	cristae formation	BP
2	28	0.513421069574	-	3.40e-01	GO:0016358	dendrite development	BP
2	28	0.513421069574	-	3.58e-01	GO:0005977	glycogen metabolic process	BP
1	14	0.513421069574	-	3.70e-01	GO:0021854	hypothalamus development	BP
1	14	0.513421069574	-	3.70e-01	GO:1904262	negative regulation of TORC1 signaling	BP
1	14	0.513421069574	-	3.70e-01	GO:1901223	negative regulation of NIK/NF-kappaB signaling	BP
2	28	0.513421069574	-	3.76e-01	GO:0001662	behavioral fear response	BP
1	14	0.513421069574	-	4.02e-01	GO:0021591	ventricular system development	BP
1	14	0.513421069574	-	4.02e-01	GO:0002063	chondrocyte development	BP
1	14	0.513421069574	-	4.32e-01	GO:0030207	chondroitin sulfate catabolic process	BP
1	14	0.513421069574	-	4.32e-01	GO:0010875	positive regulation of cholesterol efflux	BP
1	14	0.513421069574	-	4.32e-01	GO:0003407	neural retina development	BP
1	14	0.513421069574	-	4.32e-01	GO:0090280	positive regulation of calcium ion import	BP
1	14	0.513421069574	-	4.32e-01	GO:0045717	negative regulation of fatty acid biosynthetic process	BP
1	14	0.513421069574	-	4.32e-01	GO:0022011	myelination in peripheral nervous system	BP
3	42	0.513421069574	-	4.52e-01	GO:0030218	erythrocyte differentiation	BP
1	14	0.513421069574	-	4.60e-01	GO:2000810	regulation of bicellular tight junction assembly	BP
1	14	0.513421069574	-	4.60e-01	GO:1903078	positive regulation of protein localization to plasma membrane	BP
1	14	0.513421069574	-	4.60e-01	GO:0071625	vocalization behavior	BP
1	14	0.513421069574	-	4.60e-01	GO:0071425	hematopoietic stem cell proliferation	BP
1	14	0.513421069574	-	4.60e-01	GO:0060038	cardiac muscle cell proliferation	BP
1	14	0.513421069574	-	4.60e-01	GO:0045056	transcytosis	BP
1	14	0.513421069574	-	4.60e-01	GO:0042711	maternal behavior	BP
1	14	0.513421069574	-	4.60e-01	GO:0048246	macrophage chemotaxis	BP
1	14	0.513421069574	-	4.60e-01	GO:0000712	resolution of meiotic recombination intermediates	BP
1	14	0.513421069574	-	4.87e-01	GO:0030837	negative regulation of actin filament polymerization	BP
1	14	0.513421069574	-	4.87e-01	GO:0033147	negative regulation of intracellular estrogen receptor signaling pathway	BP
1	14	0.513421069574	-	4.87e-01	GO:0044130	negative regulation of growth of symbiont in host	BP
1	14	0.513421069574	-	4.87e-01	GO:2000045	regulation of G1/S transition of mitotic cell cycle	BP
1	14	0.513421069574	-	4.87e-01	GO:0001921	positive regulation of receptor recycling	BP
1	14	0.513421069574	-	4.87e-01	GO:0030818	negative regulation of cAMP biosynthetic process	BP
1	14	0.513421069574	-	4.87e-01	GO:0071360	cellular response to exogenous dsRNA	BP
1	14	0.513421069574	-	4.87e-01	GO:0050892	intestinal absorption	BP
1	14	0.513421069574	-	4.87e-01	GO:0050768	negative regulation of neurogenesis	BP
1	14	0.513421069574	-	5.13e-01	GO:1902187	negative regulation of viral release from host cell	BP
1	14	0.513421069574	-	5.13e-01	GO:0051492	regulation of stress fiber assembly	BP
1	14	0.513421069574	-	5.13e-01	GO:0043122	regulation of I-kappaB kinase/NF-kappaB signaling	BP
1	14	0.513421069574	-	5.13e-01	GO:2001234	negative regulation of apoptotic signaling pathway	BP
1	14	0.513421069574	-	5.13e-01	GO:0043518	negative regulation of DNA damage response, signal transduction by p53 class mediator	BP
2	28	0.513421069574	-	2.83e-01	GO:0005496	steroid binding	MF
1	14	0.513421069574	-	3.02e-01	GO:0005355	glucose transmembrane transporter activity	MF
4	56	0.513421069574	-	3.31e-01	GO:0003712	transcription cofactor activity	MF
1	14	0.513421069574	-	3.37e-01	GO:0030280	structural constituent of epidermis	MF
4	56	0.513421069574	-	3.39e-01	GO:0004197	cysteine-type endopeptidase activity	MF
1	14	0.513421069574	-	3.70e-01	GO:0030553	cGMP binding	MF
1	14	0.513421069574	-	3.70e-01	GO:0005149	interleukin-1 receptor binding	MF
1	14	0.513421069574	-	4.32e-01	GO:0047555	3',5'-cyclic-GMP phosphodiesterase activity	MF
1	14	0.513421069574	-	4.32e-01	GO:0005523	tropomyosin binding	MF
3	42	0.513421069574	-	4.52e-01	GO:0032947	protein complex scaffold activity	MF
1	14	0.513421069574	-	4.60e-01	GO:0008528	G-protein coupled peptide receptor activity	MF
1	14	0.513421069574	-	4.60e-01	GO:0005344	oxygen transporter activity	MF
1	14	0.513421069574	-	4.87e-01	GO:0030169	low-density lipoprotein particle binding	MF
1	14	0.513421069574	-	4.87e-01	GO:0016538	cyclin-dependent protein serine/threonine kinase regulator activity	MF
1	14	0.513421069574	-	5.13e-01	GO:0031434	mitogen-activated protein kinase kinase binding	MF
1	14	0.513421069574	-	5.13e-01	GO:1990381	ubiquitin-specific protease binding	MF
1	14	0.513421069574	-	5.13e-01	GO:0034236	protein kinase A catalytic subunit binding	MF
2	28	0.513421069574	-	6.49e-01	GO:0051059	NF-kappaB binding	MF
34	479	0.504356987146	-	9.00e-03	GO:0045892	negative regulation of transcription, DNA-templated	BP
26	368	0.497653753716	-	3.05e-02	GO:0003682	chromatin binding	MF
14	199	0.491506293146	-	1.27e-01	GO:0003714	transcription corepressor activity	MF
4	57	0.487885977467	-	1.57e-01	GO:0060395	SMAD protein signal transduction	BP
4	57	0.487885977467	-	3.47e-01	GO:0035722	interleukin-12-mediated signaling pathway	BP
3	43	0.479473737651	-	2.41e-01	GO:0015485	cholesterol binding	MF
5	72	0.472779085077	-	2.53e-01	GO:0051289	protein homotetramerization	BP
15	217	0.466115354796	-	6.40e-02	GO:0044267	cellular protein metabolic process	BP
2	29	0.462794996504	-	2.83e-01	GO:0030163	protein catabolic process	BP
4	58	0.462794996504	-	3.09e-01	GO:0021766	hippocampus development	BP
2	29	0.462794996504	-	3.21e-01	GO:0044344	cellular response to fibroblast growth factor stimulus	BP
2	29	0.462794996504	-	3.40e-01	GO:0050873	brown fat cell differentiation	BP
2	29	0.462794996504	-	3.58e-01	GO:0090200	positive regulation of release of cytochrome c from mitochondria	BP
2	29	0.462794996504	-	6.55e-01	GO:0035666	TRIF-dependent toll-like receptor signaling pathway	BP
2	29	0.462794996504	-	6.55e-01	GO:0000077	DNA damage checkpoint	BP
2	29	0.462794996504	-	1.89e-01	GO:0005184	neuropeptide hormone activity	MF
17	248	0.454042522495	-	1.60e-04	GO:0004252	serine-type endopeptidase activity	MF
36	528	0.446306873716	-	1.28e-02	GO:0006915	apoptotic process	BP
6	88	0.446306873716	-	1.45e-01	GO:0030509	BMP signaling pathway	BP
3	44	0.446306873716	-	4.44e-01	GO:0032880	regulation of protein localization	BP
4	59	0.43813294227	-	3.47e-01	GO:0031490	chromatin DNA binding	MF
5	74	0.43325072089	-	3.23e-02	GO:0006501	C-terminal protein lipidation	BP
5	74	0.43325072089	-	2.09e-01	GO:0005089	Rho guanyl-nucleotide exchange factor activity	MF
6	89	0.430005061387	-	3.16e-01	GO:0034599	cellular response to oxidative stress	BP
1	15	0.413885396023	-	2.65e-01	GO:0018298	protein-chromophore linkage	BP
2	30	0.413885396023	-	3.02e-01	GO:0006637	acyl-CoA metabolic process	BP
2	30	0.413885396023	-	3.21e-01	GO:0042476	odontogenesis	BP
1	15	0.413885396023	-	3.37e-01	GO:0045603	positive regulation of endothelial cell differentiation	BP
1	15	0.413885396023	-	3.70e-01	GO:0010831	positive regulation of myotube differentiation	BP
1	15	0.413885396023	-	3.70e-01	GO:0001963	synaptic transmission, dopaminergic	BP
1	15	0.413885396023	-	3.70e-01	GO:0040037	negative regulation of fibroblast growth factor receptor signaling pathway	BP
2	30	0.413885396023	-	3.94e-01	GO:0007616	long-term memory	BP
1	15	0.413885396023	-	4.02e-01	GO:0008209	androgen metabolic process	BP
1	15	0.413885396023	-	4.32e-01	GO:0006198	cAMP catabolic process	BP
1	15	0.413885396023	-	4.32e-01	GO:0050901	leukocyte tethering or rolling	BP
1	15	0.413885396023	-	4.32e-01	GO:0010812	negative regulation of cell-substrate adhesion	BP
1	15	0.413885396023	-	4.60e-01	GO:0048485	sympathetic nervous system development	BP
1	15	0.413885396023	-	4.60e-01	GO:0010765	positive regulation of sodium ion transport	BP
1	15	0.413885396023	-	4.60e-01	GO:1901379	regulation of potassium ion transmembrane transport	BP
1	15	0.413885396023	-	4.60e-01	GO:0048665	neuron fate specification	BP
1	15	0.413885396023	-	4.60e-01	GO:0086005	ventricular cardiac muscle cell action potential	BP
1	15	0.413885396023	-	4.60e-01	GO:0006691	leukotriene metabolic process	BP
1	15	0.413885396023	-	4.87e-01	GO:0048738	cardiac muscle tissue development	BP
1	15	0.413885396023	-	4.87e-01	GO:0060347	heart trabecula formation	BP
1	15	0.413885396023	-	4.87e-01	GO:0070542	response to fatty acid	BP
1	15	0.413885396023	-	4.87e-01	GO:0032793	positive regulation of CREB transcription factor activity	BP
1	15	0.413885396023	-	4.87e-01	GO:0044849	estrous cycle	BP
1	15	0.413885396023	-	4.87e-01	GO:0050995	negative regulation of lipid catabolic process	BP
1	15	0.413885396023	-	4.87e-01	GO:0015671	oxygen transport	BP
1	15	0.413885396023	-	5.13e-01	GO:0006622	protein targeting to lysosome	BP
1	15	0.413885396023	-	5.13e-01	GO:0014898	cardiac muscle hypertrophy in response to stress	BP
1	15	0.413885396023	-	5.13e-01	GO:0031573	intra-S DNA damage checkpoint	BP
1	15	0.413885396023	-	5.13e-01	GO:0032469	endoplasmic reticulum calcium ion homeostasis	BP
1	15	0.413885396023	-	5.13e-01	GO:0071850	mitotic cell cycle arrest	BP
1	15	0.413885396023	-	5.13e-01	GO:2000353	positive regulation of endothelial cell apoptotic process	BP
1	15	0.413885396023	-	5.13e-01	GO:0051044	positive regulation of membrane protein ectodomain proteolysis	BP
1	15	0.413885396023	-	5.13e-01	GO:0007076	mitotic chromosome condensation	BP
1	15	0.413885396023	-	5.13e-01	GO:0000729	DNA double-strand break processing	BP
1	15	0.413885396023	-	5.13e-01	GO:0034162	toll-like receptor 9 signaling pathway	BP
1	15	0.413885396023	-	5.13e-01	GO:0006414	translational elongation	BP
1	15	0.413885396023	-	5.37e-01	GO:1902230	negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage	BP
1	15	0.413885396023	-	5.37e-01	GO:0044257	cellular protein catabolic process	BP
1	15	0.413885396023	-	5.37e-01	GO:0048168	regulation of neuronal synaptic plasticity	BP
1	15	0.413885396023	-	5.37e-01	GO:0051642	centrosome localization	BP
2	30	0.413885396023	-	6.49e-01	GO:0042177	negative regulation of protein catabolic process	BP
2	30	0.413885396023	-	6.49e-01	GO:0048705	skeletal system morphogenesis	BP
2	30	0.413885396023	-	6.61e-01	GO:0009314	response to radiation	BP
1	15	0.413885396023	-	2.26e-01	GO:0015106	bicarbonate transmembrane transporter activity	MF
1	15	0.413885396023	-	3.37e-01	GO:0004180	carboxypeptidase activity	MF
1	15	0.413885396023	-	3.70e-01	GO:0030247	polysaccharide binding	MF
1	15	0.413885396023	-	4.02e-01	GO:0047617	acyl-CoA hydrolase activity	MF
1	15	0.413885396023	-	4.32e-01	GO:0004115	3',5'-cyclic-AMP phosphodiesterase activity	MF
1	15	0.413885396023	-	4.60e-01	GO:0008191	metalloendopeptidase inhibitor activity	MF
1	15	0.413885396023	-	4.60e-01	GO:0000062	fatty-acyl-CoA binding	MF
1	15	0.413885396023	-	5.13e-01	GO:0004438	phosphatidylinositol-3-phosphatase activity	MF
1	15	0.413885396023	-	5.13e-01	GO:0035326	enhancer binding	MF
1	15	0.413885396023	-	5.13e-01	GO:0001076	transcription factor activity, RNA polymerase II transcription factor binding	MF
1	15	0.413885396023	-	5.37e-01	GO:0042809	vitamin D receptor binding	MF
1	15	0.413885396023	-	5.37e-01	GO:0005521	lamin binding	MF
1	15	0.413885396023	-	5.37e-01	GO:0004697	protein kinase C activity	MF
3	45	0.413885396023	-	2.14e-01	GO:0007187	G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger	BP
14	210	0.413885396023	-	1.88e-01	GO:0044212	transcription regulatory region DNA binding	MF
19	286	0.408832168297	-	1.59e-01	GO:0008134	transcription factor binding	MF
5	76	0.394776573076	-	2.03e-01	GO:0016525	negative regulation of angiogenesis	BP
5	76	0.394776573076	-	2.32e-01	GO:0022617	extracellular matrix disassembly	BP
9	137	0.392668910114	-	3.23e-01	GO:0051092	positive regulation of NF-kappaB transcription factor activity	BP
13	198	0.391859089693	-	5.66e-02	GO:0004872	receptor activity	MF
4	61	0.390038654069	-	1.38e-01	GO:0007416	synapse assembly	BP
4	61	0.390038654069	-	5.40e-01	GO:0007249	I-kappaB kinase/NF-kappaB signaling	BP
24	368	0.382176536296	-	2.07e-02	GO:0006954	inflammatory response	BP
3	46	0.382176536296	-	4.59e-01	GO:0030968	endoplasmic reticulum unfolded protein response	BP
3	46	0.382176536296	-	4.31e-01	GO:0008047	enzyme activator activity	MF
7	108	0.373243411526	-	3.45e-01	GO:0009615	response to virus	BP
2	31	0.366579681245	-	2.46e-01	GO:0006821	chloride transport	BP
2	31	0.366579681245	-	3.94e-01	GO:0072332	intrinsic apoptotic signaling pathway by p53 class mediator	BP
2	31	0.366579681245	-	6.49e-01	GO:0021510	spinal cord development	BP
4	62	0.366579681245	-	3.31e-01	GO:0050839	cell adhesion molecule binding	MF
9	141	0.351149640675	-	2.01e-01	GO:0051056	regulation of small GTPase mediated signal transduction	BP
3	47	0.351149640675	-	9.48e-02	GO:0045596	negative regulation of cell differentiation	BP
3	47	0.351149640675	-	4.92e-01	GO:0016575	histone deacetylation	BP
4	63	0.343496068132	-	1.47e-01	GO:0007200	phospholipase C-activating G-protein coupled receptor signaling pathway	BP
4	63	0.343496068132	-	3.39e-01	GO:0008203	cholesterol metabolic process	BP
12	189	0.343496068132	-	2.07e-01	GO:0005516	calmodulin binding	MF
5	79	0.338923338342	-	3.85e-01	GO:0005543	phospholipid binding	MF
5	79	0.338923338342	-	4.10e-01	GO:0051117	ATPase binding	MF
6	95	0.335882884022	-	4.75e-01	GO:0000278	mitotic cell cycle	BP
6	95	0.335882884022	-	1.27e-01	GO:0004867	serine-type endopeptidase inhibitor activity	MF
17	272	0.320775991632	-	1.31e-01	GO:0001077	transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding	MF
8	128	0.320775991632	-	6.46e-02	GO:0005975	carbohydrate metabolic process	BP
4	64	0.320775991632	-	1.38e-01	GO:0007586	digestion	BP
2	32	0.320775991632	-	3.02e-01	GO:1900087	positive regulation of G1/S transition of mitotic cell cycle	BP
1	16	0.320775991632	-	3.37e-01	GO:0050909	sensory perception of taste	BP
10	160	0.320775991632	-	3.38e-01	GO:0043123	positive regulation of I-kappaB kinase/NF-kappaB signaling	BP
4	64	0.320775991632	-	3.47e-01	GO:0006310	DNA recombination	BP
1	16	0.320775991632	-	3.70e-01	GO:0015012	heparan sulfate proteoglycan biosynthetic process	BP
2	32	0.320775991632	-	3.94e-01	GO:0048147	negative regulation of fibroblast proliferation	BP
1	16	0.320775991632	-	4.60e-01	GO:0006171	cAMP biosynthetic process	BP
6	96	0.320775991632	-	4.83e-01	GO:0097711	ciliary basal body-plasma membrane docking	BP
1	16	0.320775991632	-	4.87e-01	GO:0007220	Notch receptor processing	BP
1	16	0.320775991632	-	4.87e-01	GO:0019674	NAD metabolic process	BP
1	16	0.320775991632	-	4.87e-01	GO:0050708	regulation of protein secretion	BP
1	16	0.320775991632	-	5.13e-01	GO:0043032	positive regulation of macrophage activation	BP
1	16	0.320775991632	-	5.13e-01	GO:0055117	regulation of cardiac muscle contraction	BP
1	16	0.320775991632	-	5.13e-01	GO:0061036	positive regulation of cartilage development	BP
1	16	0.320775991632	-	5.13e-01	GO:0030502	negative regulation of bone mineralization	BP
1	16	0.320775991632	-	5.13e-01	GO:0048384	retinoic acid receptor signaling pathway	BP
1	16	0.320775991632	-	5.13e-01	GO:0060216	definitive hemopoiesis	BP
1	16	0.320775991632	-	5.13e-01	GO:0007405	neuroblast proliferation	BP
1	16	0.320775991632	-	5.13e-01	GO:0070498	interleukin-1-mediated signaling pathway	BP
1	16	0.320775991632	-	5.13e-01	GO:2000147	positive regulation of cell motility	BP
1	16	0.320775991632	-	5.37e-01	GO:0051893	regulation of focal adhesion assembly	BP
1	16	0.320775991632	-	5.37e-01	GO:0021772	olfactory bulb development	BP
1	16	0.320775991632	-	5.37e-01	GO:2000179	positive regulation of neural precursor cell proliferation	BP
1	16	0.320775991632	-	5.37e-01	GO:0051131	chaperone-mediated protein complex assembly	BP
1	16	0.320775991632	-	5.37e-01	GO:0010259	multicellular organism aging	BP
1	16	0.320775991632	-	5.37e-01	GO:0006261	DNA-dependent DNA replication	BP
1	16	0.320775991632	-	5.60e-01	GO:0003203	endocardial cushion morphogenesis	BP
1	16	0.320775991632	-	5.60e-01	GO:1900273	positive regulation of long-term synaptic potentiation	BP
1	16	0.320775991632	-	5.60e-01	GO:0034142	toll-like receptor 4 signaling pathway	BP
1	16	0.320775991632	-	5.60e-01	GO:0030518	intracellular steroid hormone receptor signaling pathway	BP
1	16	0.320775991632	-	5.60e-01	GO:0030224	monocyte differentiation	BP
1	16	0.320775991632	-	5.60e-01	GO:0006275	regulation of DNA replication	BP
2	32	0.320775991632	-	6.49e-01	GO:0072593	reactive oxygen species metabolic process	BP
2	32	0.320775991632	-	6.61e-01	GO:0043967	histone H4 acetylation	BP
2	32	0.320775991632	-	6.61e-01	GO:0070555	response to interleukin-1	BP
2	32	0.320775991632	-	6.67e-01	GO:0002755	MyD88-dependent toll-like receptor signaling pathway	BP
2	32	0.320775991632	-	6.74e-01	GO:0000281	mitotic cytokinesis	BP
2	32	0.320775991632	-	6.74e-01	GO:0070911	global genome nucleotide-excision repair	BP
2	32	0.320775991632	-	6.74e-01	GO:0010803	regulation of tumor necrosis factor-mediated signaling pathway	BP
3	48	0.320775991632	-	7.33e-01	GO:0043525	positive regulation of neuron apoptotic process	BP
1	16	0.320775991632	-	3.37e-01	GO:0005328	neurotransmitter:sodium symporter activity	MF
1	16	0.320775991632	-	3.70e-01	GO:0022841	potassium ion leak channel activity	MF
5	80	0.320775991632	-	4.15e-01	GO:0030674	protein binding, bridging	MF
3	48	0.320775991632	-	4.75e-01	GO:0000976	transcription regulatory region sequence-specific DNA binding	MF
1	16	0.320775991632	-	5.13e-01	GO:0019789	SUMO transferase activity	MF
1	16	0.320775991632	-	5.60e-01	GO:0051393	alpha-actinin binding	MF
2	32	0.320775991632	-	6.67e-01	GO:0051879	Hsp90 protein binding	MF
32	516	0.309548736209	-	1.08e-01	GO:0045893	positive regulation of transcription, DNA-templated	BP
7	113	0.307951951274	-	9.85e-02	GO:0070268	cornification	BP
7	113	0.307951951274	-	3.39e-01	GO:0007219	Notch signaling pathway	BP
12	195	0.298408178603	-	1.29e-01	GO:0030198	extracellular matrix organization	BP
4	65	0.298408178603	-	3.16e-01	GO:0030574	collagen catabolic process	BP
8	130	0.298408178603	-	5.38e-01	GO:0000086	G2/M transition of mitotic cell cycle	BP
4	65	0.298408178603	-	5.53e-01	GO:0030433	ubiquitin-dependent ERAD pathway	BP
4	65	0.298408178603	-	1.57e-01	GO:0008236	serine-type peptidase activity	MF
3	49	0.291028648238	-	5.09e-01	GO:0010212	response to ionizing radiation	BP
3	49	0.291028648238	-	5.01e-01	GO:0030374	ligand-dependent nuclear receptor transcription coactivator activity	MF
12	197	0.283686672897	-	2.20e-01	GO:0000287	magnesium ion binding	MF
2	33	0.276381872273	-	2.64e-01	GO:0006865	amino acid transport	BP
2	33	0.276381872273	-	6.55e-01	GO:0070830	bicellular tight junction assembly	BP
2	33	0.276381872273	-	6.80e-01	GO:0097192	extrinsic apoptotic signaling pathway in absence of ligand	BP
2	33	0.276381872273	-	3.02e-01	GO:0005267	potassium channel activity	MF
2	33	0.276381872273	-	3.21e-01	GO:0017080	sodium channel regulator activity	MF
6	100	0.261882302578	-	4.52e-01	GO:0006979	response to oxidative stress	BP
6	100	0.261882302578	-	4.88e-01	GO:0000082	G1/S transition of mitotic cell cycle	BP
12	200	0.261882302578	-	1.14e-03	GO:0004888	transmembrane signaling receptor activity	MF
4	67	0.254686801174	-	5.57e-01	GO:0042147	retrograde transport, endosome to Golgi	BP
4	67	0.254686801174	-	5.57e-01	GO:0051259	protein oligomerization	BP
1	17	0.233313150382	-	3.70e-01	GO:1904706	negative regulation of vascular smooth muscle cell proliferation	BP
1	17	0.233313150382	-	4.32e-01	GO:0007276	gamete generation	BP
1	17	0.233313150382	-	4.32e-01	GO:0042310	vasoconstriction	BP
1	17	0.233313150382	-	4.60e-01	GO:0046847	filopodium assembly	BP
1	17	0.233313150382	-	4.87e-01	GO:0045019	negative regulation of nitric oxide biosynthetic process	BP
1	17	0.233313150382	-	4.87e-01	GO:0006882	cellular zinc ion homeostasis	BP
1	17	0.233313150382	-	4.87e-01	GO:0006895	Golgi to endosome transport	BP
1	17	0.233313150382	-	5.13e-01	GO:1903506	regulation of nucleic acid-templated transcription	BP
1	17	0.233313150382	-	5.13e-01	GO:0050804	modulation of chemical synaptic transmission	BP
1	17	0.233313150382	-	5.13e-01	GO:0045582	positive regulation of T cell differentiation	BP
1	17	0.233313150382	-	5.13e-01	GO:0050767	regulation of neurogenesis	BP
1	17	0.233313150382	-	5.37e-01	GO:0071354	cellular response to interleukin-6	BP
1	17	0.233313150382	-	5.37e-01	GO:0045956	positive regulation of calcium ion-dependent exocytosis	BP
1	17	0.233313150382	-	5.37e-01	GO:0006541	glutamine metabolic process	BP
1	17	0.233313150382	-	5.37e-01	GO:1901800	positive regulation of proteasomal protein catabolic process	BP
1	17	0.233313150382	-	5.37e-01	GO:0071404	cellular response to low-density lipoprotein particle stimulus	BP
4	68	0.233313150382	-	5.53e-01	GO:0034976	response to endoplasmic reticulum stress	BP
1	17	0.233313150382	-	5.60e-01	GO:0048535	lymph node development	BP
1	17	0.233313150382	-	5.60e-01	GO:0031589	cell-substrate adhesion	BP
1	17	0.233313150382	-	5.60e-01	GO:0045638	negative regulation of myeloid cell differentiation	BP
1	17	0.233313150382	-	5.60e-01	GO:0008045	motor neuron axon guidance	BP
1	17	0.233313150382	-	5.82e-01	GO:0035994	response to muscle stretch	BP
1	17	0.233313150382	-	5.82e-01	GO:0071539	protein localization to centrosome	BP
2	34	0.233313150382	-	6.87e-01	GO:0032212	positive regulation of telomere maintenance via telomerase	BP
1	17	0.233313150382	-	3.37e-01	GO:0015269	calcium-activated potassium channel activity	MF
1	17	0.233313150382	-	3.70e-01	GO:0015297	antiporter activity	MF
1	17	0.233313150382	-	4.32e-01	GO:0005537	mannose binding	MF
1	17	0.233313150382	-	4.60e-01	GO:0003951	NAD+ kinase activity	MF
1	17	0.233313150382	-	5.13e-01	GO:0046933	proton-transporting ATP synthase activity, rotational mechanism	MF
1	17	0.233313150382	-	5.60e-01	GO:0003746	translation elongation factor activity	MF
5	85	0.233313150382	-	6.04e-01	GO:0030165	PDZ domain binding	MF
2	34	0.233313150382	-	6.80e-01	GO:0048487	beta-tubulin binding	MF
3	51	0.233313150382	-	4.52e-01	GO:0048666	neuron development	BP
6	102	0.233313150382	-	4.60e-01	GO:0001649	osteoblast differentiation	BP
3	51	0.233313150382	-	7.39e-01	GO:0006521	regulation of cellular amino acid metabolic process	BP
3	51	0.233313150382	-	4.92e-01	GO:0097110	scaffold protein binding	MF
10	171	0.224851571633	-	1.43e-01	GO:0000981	RNA polymerase II transcription factor activity, sequence-specific DNA binding	MF
4	69	0.212251534854	-	5.48e-01	GO:0006887	exocytosis	BP
4	69	0.212251534854	-	5.73e-01	GO:0097190	apoptotic signaling pathway	BP
7	121	0.209267676415	-	5.08e-01	GO:0090263	positive regulation of canonical Wnt signaling pathway	BP
3	52	0.205298774212	-	2.27e-01	GO:0030148	sphingolipid biosynthetic process	BP
3	52	0.205298774212	-	7.33e-01	GO:0008092	cytoskeletal protein binding	MF
60	1041	0.203912233941	-	3.47e-02	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	BP
5	87	0.19976059067	-	5.98e-01	GO:0019216	regulation of lipid metabolic process	BP
2	35	0.191492974687	-	3.40e-01	GO:0045494	photoreceptor cell maintenance	BP
2	35	0.191492974687	-	3.94e-01	GO:0035094	response to nicotine	BP
4	70	0.191492974687	-	5.62e-01	GO:0032088	negative regulation of NF-kappaB transcription factor activity	BP
2	35	0.191492974687	-	6.55e-01	GO:0010043	response to zinc ion	BP
2	35	0.191492974687	-	6.67e-01	GO:0033574	response to testosterone	BP
2	35	0.191492974687	-	6.74e-01	GO:0006641	triglyceride metabolic process	BP
2	35	0.191492974687	-	6.80e-01	GO:0048536	spleen development	BP
2	35	0.191492974687	-	6.87e-01	GO:0019985	translesion synthesis	BP
2	35	0.191492974687	-	6.94e-01	GO:0070491	repressing transcription factor binding	MF
5	88	0.183272467882	-	3.88e-01	GO:0090630	activation of GTPase activity	BP
13	229	0.182011921676	-	4.28e-01	GO:0061024	membrane organization	BP
3	53	0.17781803779	-	7.36e-01	GO:0043401	steroid hormone mediated signaling pathway	BP
4	71	0.171028872127	-	5.40e-01	GO:0009791	post-embryonic development	BP
42	755	0.152760580198	-	1.22e-01	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	BP
5	90	0.15085099019	-	4.01e-01	GO:0016311	dephosphorylation	BP
1	18	0.15085099019	-	4.02e-01	GO:2000117	negative regulation of cysteine-type endopeptidase activity	BP
1	18	0.15085099019	-	4.60e-01	GO:0060307	regulation of ventricular cardiac muscle cell membrane repolarization	BP
1	18	0.15085099019	-	4.60e-01	GO:0046907	intracellular transport	BP
1	18	0.15085099019	-	4.87e-01	GO:0006123	mitochondrial electron transport, cytochrome c to oxygen	BP
1	18	0.15085099019	-	4.87e-01	GO:0035338	long-chain fatty-acyl-CoA biosynthetic process	BP
1	18	0.15085099019	-	5.13e-01	GO:0030279	negative regulation of ossification	BP
1	18	0.15085099019	-	5.13e-01	GO:0001556	oocyte maturation	BP
1	18	0.15085099019	-	5.13e-01	GO:0071294	cellular response to zinc ion	BP
1	18	0.15085099019	-	5.13e-01	GO:2000377	regulation of reactive oxygen species metabolic process	BP
7	126	0.15085099019	-	5.19e-01	GO:0006897	endocytosis	BP
1	18	0.15085099019	-	5.37e-01	GO:0008585	female gonad development	BP
1	18	0.15085099019	-	5.37e-01	GO:0032331	negative regulation of chondrocyte differentiation	BP
1	18	0.15085099019	-	5.37e-01	GO:1903959	regulation of anion transmembrane transport	BP
1	18	0.15085099019	-	5.37e-01	GO:0007597	blood coagulation, intrinsic pathway	BP
1	18	0.15085099019	-	5.37e-01	GO:0030301	cholesterol transport	BP
1	18	0.15085099019	-	5.37e-01	GO:0016079	synaptic vesicle exocytosis	BP
1	18	0.15085099019	-	5.37e-01	GO:0030318	melanocyte differentiation	BP
1	18	0.15085099019	-	5.60e-01	GO:0032418	lysosome localization	BP
1	18	0.15085099019	-	5.82e-01	GO:0001894	tissue homeostasis	BP
1	18	0.15085099019	-	5.82e-01	GO:0001892	embryonic placenta development	BP
1	18	0.15085099019	-	5.82e-01	GO:1902236	negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway	BP
1	18	0.15085099019	-	5.82e-01	GO:0045445	myoblast differentiation	BP
1	18	0.15085099019	-	5.82e-01	GO:0000185	activation of MAPKKK activity	BP
1	18	0.15085099019	-	5.82e-01	GO:0030490	maturation of SSU-rRNA	BP
1	18	0.15085099019	-	6.03e-01	GO:0035904	aorta development	BP
1	18	0.15085099019	-	6.03e-01	GO:0031116	positive regulation of microtubule polymerization	BP
1	18	0.15085099019	-	6.03e-01	GO:1901741	positive regulation of myoblast fusion	BP
1	18	0.15085099019	-	6.03e-01	GO:0007004	telomere maintenance via telomerase	BP
1	18	0.15085099019	-	6.03e-01	GO:0010824	regulation of centrosome duplication	BP
1	18	0.15085099019	-	6.03e-01	GO:0031333	negative regulation of protein complex assembly	BP
1	18	0.15085099019	-	6.03e-01	GO:0002026	regulation of the force of heart contraction	BP
2	36	0.15085099019	-	6.67e-01	GO:0010942	positive regulation of cell death	BP
2	36	0.15085099019	-	6.74e-01	GO:0000079	regulation of cyclin-dependent protein serine/threonine kinase activity	BP
2	36	0.15085099019	-	6.80e-01	GO:0030177	positive regulation of Wnt signaling pathway	BP
2	36	0.15085099019	-	6.87e-01	GO:0007223	Wnt signaling pathway, calcium modulating pathway	BP
20	360	0.15085099019	-	2.33e-01	GO:0000978	RNA polymerase II core promoter proximal region sequence-specific DNA binding	MF
1	18	0.15085099019	-	3.37e-01	GO:0004745	retinol dehydrogenase activity	MF
1	18	0.15085099019	-	3.37e-01	GO:0008569	ATP-dependent microtubule motor activity, minus-end-directed	MF
2	36	0.15085099019	-	3.76e-01	GO:0008138	protein tyrosine/serine/threonine phosphatase activity	MF
1	18	0.15085099019	-	5.60e-01	GO:0001190	transcriptional activator activity, RNA polymerase II transcription factor binding	MF
1	18	0.15085099019	-	5.82e-01	GO:0051371	muscle alpha-actinin binding	MF
1	18	0.15085099019	-	5.82e-01	GO:0070577	lysine-acetylated histone binding	MF
1	18	0.15085099019	-	5.82e-01	GO:0030234	enzyme regulator activity	MF
2	36	0.15085099019	-	6.94e-01	GO:0019888	protein phosphatase regulator activity	MF
2	36	0.15085099019	-	7.01e-01	GO:0004879	RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding	MF
27	492	0.133148988456	-	2.13e-01	GO:0046982	protein heterodimerization activity	MF
4	73	0.130951432752	-	5.48e-01	GO:0006816	calcium ion transport	BP
4	73	0.130951432752	-	5.62e-01	GO:0001618	virus receptor activity	MF
3	55	0.124378778828	-	5.09e-01	GO:0071277	cellular response to calcium ion	BP
3	55	0.124378778828	-	7.42e-01	GO:0006417	regulation of translation	BP
25	460	0.119142130462	-	2.73e-02	GO:0007155	cell adhesion	BP
2	37	0.111322626003	-	6.55e-01	GO:0001942	hair follicle development	BP
7	130	0.105763100661	-	6.82e-01	GO:0042393	histone binding	MF
41	766	0.097127414325	-	1.70e-01	GO:0042803	protein homodimerization activity	MF
482	9019	0.0949135626036	-	9.06e-06	GO:0005515	protein binding	MF
15	282	0.0881152348416	-	4.61e-01	GO:0003924	GTPase activity	MF
1	19	0.0728484781883	-	4.32e-01	GO:2000649	regulation of sodium ion transmembrane transporter activity	BP
1	19	0.0728484781883	-	4.32e-01	GO:0023019	signal transduction involved in regulation of gene expression	BP
3	57	0.0728484781883	-	4.67e-01	GO:0006959	humoral immune response	BP
1	19	0.0728484781883	-	5.13e-01	GO:0002052	positive regulation of neuroblast proliferation	BP
1	19	0.0728484781883	-	5.13e-01	GO:0033198	response to ATP	BP
1	19	0.0728484781883	-	5.37e-01	GO:0045216	cell-cell junction organization	BP
1	19	0.0728484781883	-	5.37e-01	GO:0007520	myoblast fusion	BP
1	19	0.0728484781883	-	5.37e-01	GO:0048545	response to steroid hormone	BP
1	19	0.0728484781883	-	5.60e-01	GO:0032502	developmental process	BP
1	19	0.0728484781883	-	5.60e-01	GO:0008156	negative regulation of DNA replication	BP
1	19	0.0728484781883	-	5.60e-01	GO:0048026	positive regulation of mRNA splicing, via spliceosome	BP
1	19	0.0728484781883	-	5.60e-01	GO:0010592	positive regulation of lamellipodium assembly	BP
1	19	0.0728484781883	-	5.82e-01	GO:0071385	cellular response to glucocorticoid stimulus	BP
1	19	0.0728484781883	-	6.03e-01	GO:0045022	early endosome to late endosome transport	BP
1	19	0.0728484781883	-	6.03e-01	GO:0046716	muscle cell cellular homeostasis	BP
1	19	0.0728484781883	-	6.03e-01	GO:0007031	peroxisome organization	BP
1	19	0.0728484781883	-	6.03e-01	GO:0042311	vasodilation	BP
1	19	0.0728484781883	-	6.03e-01	GO:0030099	myeloid cell differentiation	BP
2	38	0.0728484781883	-	6.80e-01	GO:0045184	establishment of protein localization	BP
2	38	0.0728484781883	-	7.08e-01	GO:0008333	endosome to lysosome transport	BP
2	38	0.0728484781883	-	7.08e-01	GO:0006289	nucleotide-excision repair	BP
3	57	0.0728484781883	-	7.39e-01	GO:0071346	cellular response to interferon-gamma	BP
1	19	0.0728484781883	-	1.00e+00	GO:0006509	membrane protein ectodomain proteolysis	BP
1	19	0.0728484781883	-	1.00e+00	GO:0070507	regulation of microtubule cytoskeleton organization	BP
1	19	0.0728484781883	-	1.00e+00	GO:2001243	negative regulation of intrinsic apoptotic signaling pathway	BP
1	19	0.0728484781883	-	4.32e-01	GO:0004653	polypeptide N-acetylgalactosaminyltransferase activity	MF
1	19	0.0728484781883	-	4.60e-01	GO:0046914	transition metal ion binding	MF
2	38	0.0728484781883	-	7.08e-01	GO:0005484	SNAP receptor activity	MF
6	115	0.0602484414086	-	2.74e-01	GO:0004222	metalloendopeptidase activity	MF
14	269	0.0566685511328	-	5.49e-01	GO:0016579	protein deubiquitination	BP
4	77	0.0539894509369	-	5.78e-01	GO:0009952	anterior/posterior pattern specification	BP
3	58	0.0477574972254	-	7.51e-01	GO:0036498	IRE1-mediated unfolded protein response	BP
3	58	0.0477574972254	-	7.59e-01	GO:0007266	Rho protein signal transduction	BP
13	252	0.043935786273	-	7.69e-01	GO:0019904	protein domain specific binding	MF
14	272	0.0406680724391	-	5.48e-01	GO:0003779	actin binding	MF
8	156	0.0353737727696	-	6.06e-02	GO:0007156	homophilic cell adhesion via plasma membrane adhesion molecules	BP
2	39	0.0353737727696	-	3.40e-01	GO:2000134	negative regulation of G1/S transition of mitotic cell cycle	BP
4	78	0.0353737727696	-	5.40e-01	GO:0035023	regulation of Rho protein signal transduction	BP
2	39	0.0353737727696	-	6.74e-01	GO:0030819	positive regulation of cAMP biosynthetic process	BP
2	39	0.0353737727696	-	3.40e-01	GO:0022857	transmembrane transporter activity	MF
2	39	0.0353737727696	-	6.49e-01	GO:0015459	potassium channel regulator activity	MF
5	98	0.027994242404	-	6.01e-01	GO:0016310	phosphorylation	BP
21	413	0.0230954429912	-	3.80e-01	GO:0006357	regulation of transcription from RNA polymerase II promoter	BP
3	59	0.0230954429912	-	5.01e-01	GO:0006952	defense response	BP
3	59	0.0230954429912	-	2.27e-01	GO:0005249	voltage-gated potassium channel activity	MF
13	256	0.0212157097729	-	6.47e-01	GO:0007049	cell cycle	BP
18	355	0.0190257786821	-	5.08e-01	GO:0043687	post-translational protein modification	BP
4	79	0.0169952434547	-	5.73e-01	GO:0007626	locomotory behavior	BP
4	79	0.0169952434547	-	7.87e-01	GO:0007030	Golgi organization	BP
5	99	0.0133474664396	-	8.06e-01	GO:0051726	regulation of cell cycle	BP
